
<html lang="en"     class="pb-page"  data-request-id="7c8f65b6-6cf2-4bcd-beae-de6a07f847f8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-3;article:article:10.1021/jm401138v;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Biological Activity of Pyridopyrimidine Scaffolds as Novel PI3K/mTOR Dual Inhibitors" /></meta><meta name="dc.Creator" content="Thibault  Saurat" /></meta><meta name="dc.Creator" content="Frédéric  Buron" /></meta><meta name="dc.Creator" content="Nuno  Rodrigues" /></meta><meta name="dc.Creator" content="Marie-Ludivine  de Tauzia" /></meta><meta name="dc.Creator" content="Lionel  Colliandre" /></meta><meta name="dc.Creator" content="Stéphane  Bourg" /></meta><meta name="dc.Creator" content="Pascal  Bonnet" /></meta><meta name="dc.Creator" content="Gérald  Guillaumet" /></meta><meta name="dc.Creator" content="Mohamed  Akssira" /></meta><meta name="dc.Creator" content="Anne  Corlu" /></meta><meta name="dc.Creator" content="Christiane  Guillouzo" /></meta><meta name="dc.Creator" content="Pauline  Berthier" /></meta><meta name="dc.Creator" content="Pascale  Rio" /></meta><meta name="dc.Creator" content="Marie-Lise  Jourdan" /></meta><meta name="dc.Creator" content="Hélène  Bénédetti" /></meta><meta name="dc.Creator" content="Sylvain  Routier" /></meta><meta name="dc.Description" content="The design, synthesis, and screening of dual PI3K/mTOR inhibitors that gave nanomolar enzymatic and cellular activities on both targets with an acceptable kinase selectivity profile are described. ..." /></meta><meta name="Description" content="The design, synthesis, and screening of dual PI3K/mTOR inhibitors that gave nanomolar enzymatic and cellular activities on both targets with an acceptable kinase selectivity profile are described. ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 21, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401138v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401138v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401138v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401138v" /></link>
        
    
    

<title>Design, Synthesis, and Biological Activity of Pyridopyrimidine Scaffolds as Novel PI3K/mTOR Dual Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401138v" /></meta><meta property="og:title" content="Design, Synthesis, and Biological Activity of Pyridopyrimidine Scaffolds as Novel PI3K/mTOR Dual Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0017.jpeg" /></meta><meta property="og:description" content="The design, synthesis, and screening of dual PI3K/mTOR inhibitors that gave nanomolar enzymatic and cellular activities on both targets with an acceptable kinase selectivity profile are described. A docking study was performed to understand the binding mode of the compounds and to explain the differences in biological activity. In addition, cellular effects of the best dual inhibitors were determined on six cancer cell lines and compared to those on a healthy diploid cell line for cellular cytotoxicity. Two compounds are highly potent on cancer cells in the submicromolar range without any toxicity on healthy cells. A more detailed analysis of the cellular effect of these PI3K/mTOR dual inhibitors demonstrated that they induce G1-phase cell cycle arrest in breast cancer cells and trigger apoptosis. These compounds show an interesting kinase profile as dual PI3K/mTOR tool compounds or as a chemical series for further optimization to progress into in vivo experiments." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401138v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401138v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401138v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401138v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401138v&amp;href=/doi/10.1021/jm401138v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 613-631</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401117t" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401144z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Biological Activity of Pyridopyrimidine Scaffolds as Novel PI3K/mTOR Dual Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thibault++Saurat">Thibault Saurat</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fr%C3%A9d%C3%A9ric++Buron">Frédéric Buron</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nuno++Rodrigues">Nuno Rodrigues</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marie-Ludivine++de+Tauzia">Marie-Ludivine de Tauzia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lionel++Colliandre">Lionel Colliandre</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=St%C3%A9phane++Bourg">Stéphane Bourg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal++Bonnet">Pascal Bonnet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=G%C3%A9rald++Guillaumet">Gérald Guillaumet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mohamed++Akssira">Mohamed Akssira</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne++Corlu">Anne Corlu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christiane++Guillouzo">Christiane Guillouzo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pauline++Berthier">Pauline Berthier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascale++Rio">Pascale Rio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marie-Lise++Jourdan">Marie-Lise Jourdan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=H%C3%A9l%C3%A8ne++B%C3%A9n%C3%A9detti">Hélène Bénédetti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sylvain++Routier">Sylvain Routier</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Institut de Chimie Organique et Analytique, Université d’Orléans, UMR CNRS 7311, Rue de Chartres, BP 6759, 45067 OrléansCedex 2, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Centre de Biophysique Moléculaire, CNRS Orléans, Rue Charles Sadron, 45071 Orléans, France</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Équipe de Chimie Bioorganique & Analytique, URAC 22, Université Hassan II Mohammedia-Casablanca, BP 146, 28800 Mohammedia, Morocco</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Hôpital de Pontchaillou, Université de Rennes 1, INSERM, UMR-991, 65033 Rennes Cedex, France</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Faculté de Médecine, Centre Hospitalier Universitaire (CHU) Tours, INSERM U1069, 10 Boulevard Tonnellé, 37032 Tours Cedex, France</span></div><div class="corresp-info"><strong>*</strong>Phone: 33 238 494 853. Fax: 33 238 417 281. E-mail: <a href="/cdn-cgi/l/email-protection#15666c7963747c7b3b677a60617c706755607b7c63387a677970747b663b7367"><span class="__cf_email__" data-cfemail="ddaea4b1abbcb4b3f3afb2a8a9b4b8af9da8b3b4abf0b2afb1b8bcb3aef3bbaf">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401138v&amp;href=/doi/10.1021%2Fjm401138v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 613–631</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 17, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 July 2013</li><li><span class="item_label"><b>Published</b> online</span>21 January 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 February 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401138v" title="DOI URL">https://doi.org/10.1021/jm401138v</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D613%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DThibault%2BSaurat%252C%2BFr%25C3%25A9d%25C3%25A9ric%2BBuron%252C%2BNuno%2BRodrigues%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D3%26contentID%3Djm401138v%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BActivity%2Bof%2BPyridopyrimidine%2BScaffolds%2Bas%2BNovel%2BPI3K%252FmTOR%2BDual%2BInhibitors%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D631%26publicationDate%3DFebruary%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401138v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3573</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">48</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401138v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Biological Activity of Pyridopyrimidine Scaffolds as Novel PI3K/mTOR Dual Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Thibault&quot;,&quot;last_name&quot;:&quot;Saurat&quot;},{&quot;first_name&quot;:&quot;Frédéric&quot;,&quot;last_name&quot;:&quot;Buron&quot;},{&quot;first_name&quot;:&quot;Nuno&quot;,&quot;last_name&quot;:&quot;Rodrigues&quot;},{&quot;first_name&quot;:&quot;Marie-Ludivine&quot;,&quot;last_name&quot;:&quot;de Tauzia&quot;},{&quot;first_name&quot;:&quot;Lionel&quot;,&quot;last_name&quot;:&quot;Colliandre&quot;},{&quot;first_name&quot;:&quot;Stéphane&quot;,&quot;last_name&quot;:&quot;Bourg&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;Bonnet&quot;},{&quot;first_name&quot;:&quot;Gérald&quot;,&quot;last_name&quot;:&quot;Guillaumet&quot;},{&quot;first_name&quot;:&quot;Mohamed&quot;,&quot;last_name&quot;:&quot;Akssira&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;Corlu&quot;},{&quot;first_name&quot;:&quot;Christiane&quot;,&quot;last_name&quot;:&quot;Guillouzo&quot;},{&quot;first_name&quot;:&quot;Pauline&quot;,&quot;last_name&quot;:&quot;Berthier&quot;},{&quot;first_name&quot;:&quot;Pascale&quot;,&quot;last_name&quot;:&quot;Rio&quot;},{&quot;first_name&quot;:&quot;Marie-Lise&quot;,&quot;last_name&quot;:&quot;Jourdan&quot;},{&quot;first_name&quot;:&quot;Hélène&quot;,&quot;last_name&quot;:&quot;Bénédetti&quot;},{&quot;first_name&quot;:&quot;Sylvain&quot;,&quot;last_name&quot;:&quot;Routier&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;613-631&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401138v&quot;},&quot;abstract&quot;:&quot;The design, synthesis, and screening of dual PI3K/mTOR inhibitors that gave nanomolar enzymatic and cellular activities on both targets with an acceptable kinase selectivity profile are described. A docking study was performed to understand the binding mode of the compounds and to explain the differences in biological activity. In addition, cellular effects of the best dual inhibitors were determined on six cancer cell lines and compared to those on a healthy diploid cell line for cellular cytotoxicity. Two compounds are highly potent on cancer cells in the submicromolar range without any toxicity on healthy cells. A more detailed analysis of the cellular effect of these PI3K/mTOR dual inhibitors demonstrated that they induce G1-phase cell cycle arrest in breast cancer cells and trigger apoptosis. These compounds show an interesting kinase profile as dual PI3K/mTOR tool compounds or as a chemical series for further optimization to progress into in vivo experiments.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401138v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401138v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401138v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401138v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401138v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401138v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401138v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401138v&amp;href=/doi/10.1021/jm401138v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401138v" /></input><a href="/doi/pdf/10.1021/jm401138v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401138v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401138v%26sid%3Dliteratum%253Aachs%26pmid%3D24345273%26genre%3Darticle%26aulast%3DSaurat%26date%3D2014%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BActivity%2Bof%2BPyridopyrimidine%2BScaffolds%2Bas%2BNovel%2BPI3K%252FmTOR%2BDual%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D3%26spage%3D613%26epage%3D631%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291074" title="Purification">Purification</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=292234" title="Chromatography">Chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jmcmar.2014.57.issue-3/production/jmcmar.2014.57.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The design, synthesis, and screening of dual PI3K/mTOR inhibitors that gave nanomolar enzymatic and cellular activities on both targets with an acceptable kinase selectivity profile are described. A docking study was performed to understand the binding mode of the compounds and to explain the differences in biological activity. In addition, cellular effects of the best dual inhibitors were determined on six cancer cell lines and compared to those on a healthy diploid cell line for cellular cytotoxicity. Two compounds are highly potent on cancer cells in the submicromolar range without any toxicity on healthy cells. A more detailed analysis of the cellular effect of these PI3K/mTOR dual inhibitors demonstrated that they induce G1-phase cell cycle arrest in breast cancer cells and trigger apoptosis. These compounds show an interesting kinase profile as dual PI3K/mTOR tool compounds or as a chemical series for further optimization to progress into in vivo experiments.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The PI3K/Akt/mTOR pathway is associated with several receptor tyrosine kinases (RTKs) and G-protein-coupled receptors (GPCRs). PI3K (phosphoinositide 3-kinase), the first enzyme of the pathway, is a ubiquitous lipid kinase involved in a large variety of diseases. It catalyzes the transformation of phosphatidylinositol 4,5-diphosphate (PIP2) into phosphatidylinositol 3,4,5-triphosphate (PIP3).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Four PI3K isoforms<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> have been reported: PI3Kα in cancer,<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> PI3Kβ, which is more active in thrombosis-related phenomena,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and PI3Kδ in allergies and PI3Kγ in inflammatory responses.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">PI3Kα plays a significant role in cancer-related diseases and more specifically in insulin signaling.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7-10)</a> In addition, cancers are also associated with mTOR (mammalian target of rapamycin), the third kinase of the signaling pathway studied in the present research work, whose main targets are S6K1, which plays a key role in protein synthesis, and 4E-BP1, an actor in the translation initiation.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">In cancer, tumors exhibit a high frequency of activating mutations in the PI3K, Akt, and mTOR coding genes, leading to an elevated pathway activity and resulting in extended survival, growth, and angiogenesis of tumor cells.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Activation of the pathway is not vertical. It has been shown that mTOR exerts a negative feedback loop on PI3K: mTOR once activated will inhibit PI3K through IRS-1 (insulin receptor substrate 1).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Furthermore, it has been observed in several studies that external factors (growth factors, nutrient intake) can activate Akt and mTOR, thereby bypassing PI3K and thus restarting cancer genesis.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a></div><div class="NLM_p">For these reasons, the need to synthesize compounds that can inhibit the PI3K/Akt/mTOR pathway has been a great motivation for research teams around the world.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> In 2011, active drugs having an implication on PI3K, Akt, or mTOR were reported in more than 380 clinical trials. Three drugs have already been approved by the FDA (Food and Drug Administration) for mTOR (Afinitor, Torisel, and Zortress) but none yet for Akt or PI3K protein kinases. According to the National Cancer Institute, several drugs in phase I or II clinical trials are claimed as specific PI3Kα inhibitors.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Most of these PI3Kα inhibitors share similar structural and chemical features, i.e., a central six-membered heterocycle substituted by a morpholine and a (hetero)aromatic cycle having a hydrogen bond donor group (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, ZSTK-414, GDC-0941, GDC-0980, PI103). As mentioned in the pathway functioning, due to the existence of a regulatory feedback loop, an independent activation of mTOR or PI3K alone is not sufficient to block the signaling pathway efficiently in cancer cells.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> It is therefore crucial to consider the combined inhibition of both enzymes.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> To our knowledge, only a few drugs that affect PI3Kα and mTOR together are in an early phase of clinical trials. NVP-BEZ-235, XL765, and an orally available candidate, GDC-0980, are claimed to be dual PI3K/mTOR inhibitors.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of PI3K inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We recently developed a straightforward methodology able to selectively functionalize 2,4-dichloropyridopyrimidine by two successive S<sub>N</sub>Ar and Suzuki cross-coupling reactions.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We thus envisioned applying our method to the design of a dual PI3Kα/mTOR inhibitor library. In this report, we report the synthesis of newly formed pyrido[2,3-<i>d</i>]- and pyrido[3,2-<i>d</i>]pyrimidine libraries <b>I</b> and <b>II</b> starting from a dichloro derivative of type <b>III</b> or <b>IV</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Disubstituted pyridopyrimidine libraries <b>I</b> and <b>II</b> from precursors <b>III</b> and <b>IV</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">After introducing an amine and a (het)aryl at C-2 or C-4, we established a complete SAR study using PI3Kα, PI3Kδ, PI3Kγ, and mTOR as biological targets. In silico modeling studies were used to support medicinal chemistry efforts and proved to be successful in explaining the SAR of the tested compounds. Finally, the effects of the seven best inhibitors were measured on three cancer cell lines and normal fibroblasts. Further investigations were carried out for the two best compounds, which were tested on three other cancer cell lines and were shown to affect PI3K and mTOR activities in these cells, to block their cell cycle in the G1-phase, and to induce apoptosis.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62513" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62513" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis and Kinase Assays</h3><div class="NLM_p">The derivatives <b>3a</b>–<b>g</b> were obtained after a two-step synthesis from 2,4-dichloropyrido[3,2-<i>d</i>]pyrimidine (<b>1</b>). S<sub>N</sub>Ar regioselectively occurred at C-4 using aliphatic primary or secondary amines in the presence of Et<sub>3</sub>N at room temperature and afforded compounds <b>2a</b>–<b>g</b> in satisfying yields (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In the second step, the 3-hydroxyphenyl group was introduced using a Suzuki cross-coupling reaction under microwave irradiation to improve the yields, which are very low otherwise. This palladium-catalyzed reaction gave access to the attempted compounds in good to excellent yields, except in the case of <b>3f</b> (entry 6), which was only detected as molecular traces.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amine, Et<sub>3</sub>N, THF, rt, 12 h; (b) 3-HOC<sub>6</sub>H<sub>4</sub>B(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME, MW, 150 °C, 1 h. For yields see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Synthesis Yields and Biological Evaluation of Compounds <b>3a</b>–<b>g</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0012.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Yields are indicated for isolated products.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> values are presented as the mean of a triplicate experiment. Standard deviations are reported in Table S1 of the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></div><div></div></div><div class="NLM_p">The six final products (<b>3a</b>–<b>e</b> and <b>3g</b>) were evaluated for their PI3K inhibition potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Morpholine seems essential to strongly diminish PI3Kα activity, and the IC<sub>50</sub> was measured in the nanomolar range.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Replacement of this core by other cyclic amines causes a dramatic decrease in activity despite the presence of electron-rich atoms.</div><div class="NLM_p">As oxygen seems to be essential for activity,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> we used 2(<i>R</i>),6(<i>R</i>)-dimethylmorpholine to obtain <b>3g</b> (entry 7), but its activity dropped to the micromolar range. Finally, <b>3a</b> remains the best compound, showing comparable IC<sub>50</sub> values against PI3Kα and PI3Kγ and a remarkable potency for the δ isoform (IC<sub>50</sub> = 3 nM).</div><div class="NLM_p">Thus, we conserved the morpholino group to pursue our investigation and further explore the SAR. For the next C-2 (het)Ar optimization (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), we successfully achieved the cross-coupling reactions using several commercially available arylboronic acids or potassium aryltrifluoroborates (1.5 equiv) under the conditions described above.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Het)ArB(OH)<sub>2</sub> or (Het)ArBF<sub>3</sub>K, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME, MW, 150 °C, 1 h. For yields see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></p></figure><div class="NLM_p">The desired products <b>4a</b>–<b>m</b> were isolated in moderate to excellent yields (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Variations in the efficiency of the cross-coupling reaction were mostly related to the purification step. Most of the reaction appeared to be complete during the monitoring. Derivatives <b>4g</b> and <b>4h</b> (entries 8 and 9) were easily obtained from a cross-coupling reaction between <b>2a</b> and the corresponding nitrophenylboronic acid, followed by reduction of the nitro group using stannous chloride. In a complementary single-step synthesis, we also prepared the mono- and bisacetylated derivatives <b>5</b> and <b>6</b> from <b>4m</b> in the same reaction using an excess of Ac<sub>2</sub>O in DMF under microwave irradiation in 28% and 44% yields, respectively (entries 15 and 16).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Synthesis and Biological Evaluation of Derivatives <b>4</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0013.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Yields are given for the isolated product.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> values are presented as the mean of a triplicate experiment. Standard deviations are reported in Table S1 of the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Boronic acid was used.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Potassium trifluoroborate was used.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Overall yield of two steps.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">Compounds <b>5</b> (28%) and <b>6</b> (44%) were obtained from <b>4m</b> using Ac<sub>2</sub>O (10.0 equiv) and DMF (120 °C, 30 min).</p></div></div><div></div></div><div class="NLM_p">In vitro activities toward PI3K kinase isoforms were measured using the final compounds <b>4a</b>–<b>m</b>, <b>5</b>, and <b>6</b>, and the IC<sub>50</sub> values were compared to that of <b>3a</b> (entry 1). The best position for the OH phenol group remains at the <i>meta</i> position since its position shift to <i>ortho</i> or <i>para</i> leads to an overall inactivation of the drugs. The hydrophilic character and the ability of the drug to create a hydrogen bond in this region are certainly crucial as proposed from docking results. Spacing the OH group by addition of a methylene kneecap in the <i>meta</i> position of the phenyl ring was well tolerated (<b>4e</b> vs <b>4f</b>, entries 6 and 7), whereas methyl ethers <b>4c</b> and <b>4d</b> were also totally inactive (entries 4 and 5).</div><div class="NLM_p">Replacement of the phenyl hydroxyl group by a primary amine or the phenol by a 3-pyridine or a 4-indazole (entries 8–11) led to poorly active compounds <b>4i</b> and <b>4j</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Nevertheless, with the 4-indazole-containing derivative <b>4k</b>, we observed a global increase of activity for PI3Ks and in particular for the α isoform (entry 12).</div><div class="NLM_p">It appears that 2-aminopyridine and -pyrimidine moieties could be used as phenol isosters (entries 13 and 14). PI3Kα and PI3Kδ were more affected by the two novel lead compounds. <b>4m</b>, which inhibits PI3Kα with a remarkable IC<sub>50</sub> of 7 nM, is the most selective inhibitor ever designed in the disubstituted pyridopyrimidine series. The activity of the 2-aminopyrimidine-containing compound is due to the presence of an acidic hydrogen atom since acetylated compound <b>5</b> remains slightly active and diacetylated <b>6</b> is fully inactive (entries 15 and 16).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">To pursue the SAR exploration, we next investigated successively the effect of reversing the C-4 morpholine and the C-2 phenol groups on the pyrido[3,2-<i>d</i>]pyrimidine scaffold and of the switch of the central core for the [2,3-<i>d</i>] regioisomer (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> To obtain the expected derivatives, we adapted the previously reported robust synthetic methods and used the dichloro derivatives <b>1</b> and <b>10</b> as starting materials.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-(MOM)C<sub>6</sub>H<sub>4</sub>BF<sub>3</sub>K, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, 100 °C, 2 h, 45%; (b) morpholine, Et<sub>3</sub>N, THF, reflux, 12 h, 68%; (c) HCl (4 N), EtOH, rt, 1 h, 60%; (d) morpholine, Et<sub>3</sub>N, THF, rt, 12 h, 80%; (e) (Het)ArB(OH)<sub>2</sub> or (Het)ArBF<sub>3</sub>K, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME, MW, 150 °C, 1 h. For exact structures and yields see Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Synthesis and Biological Evaluation of Pyrido[2,3-<i>d</i>]pyrimidine-Type Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0014.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Yields are indicated for isolated products.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> values are presented as the mean of a triplicate experiment. Standard deviations are reported in Table S1 of the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></div><div></div></div><div class="NLM_p">For the synthesis of the “inverso” derivative <b>9</b>, 3-(methoxymethoxy)phenyltrifloroborate potassium was prepared to perform the Suzuki cross-coupling reaction.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The palladium-catalyzed reaction occurred selectively using a near stoichiometric amount of boronic acid in refluxing toluene at 100 °C for 2 h with our classical catalytic system and yielded <b>7</b> in 45% yield. The C-2 S<sub>N</sub>Ar was next carried out with morpholine and Et<sub>3</sub>N in refluxing THF and gave the desired compound <b>8</b> in 68% yield. Finally, the MOM protective group was removed with HCl (4 N in dioxane) at room temperature to afford <b>9</b> in 60% yield.</div><div class="NLM_p">For the compound synthesis in the pyrido[2,3-<i>d</i>]pyrimidine series, compound <b>10</b> was subjected to the reactions leading to compounds <b>2</b> and <b>3</b> from <b>1</b>. Derivatives of type <b>12</b> were isolated in fair yields.</div><div class="NLM_p">The derivative <b>9</b> showed an inhibition of PI3Kα (IC<sub>50</sub> = 59 nM) which was still 3-fold less efficient than that of <b>3a</b>, whereas against the γ and δ isoforms, dramatic decreases in activity were observed (IC<sub>50</sub>(PI3Kγ) = 1.06 μM, IC<sub>50</sub>(PI3Kδ) = 0.186 μM). The same general behavior was observed with pyrido[2,3-<i>d</i>]pyrimidine compounds <b>12a</b>–<b>c</b>; activities were partially lost especially for the PI3Kα and PI3Kγ isoforms (vs the corresponding compound <b>3a</b> in the [3,2-<i>d</i>] series, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Noteworthy, the preservation of the activity of compound <b>12c</b> against PI3Kδ is observed, leading to incipient selectivity against other isoforms.</div><div class="NLM_p">The last modification we performed is entirely based on the mTOR inhibitor discovery which mainly uses a urea to enhance binding.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Consequently, we prepared and evaluated ureas of type <b>13</b>. For this new proposal, the anilines <b>4g</b> and <b>4h</b> were converted to the corresponding in situ formed isocyanates by treatment with triphosgene in the presence of an excess of DIPEA in THF at −78 °C, and the unstable intermediates were immediately trapped with various amines to afford products <b>13</b> with moderate to good yields (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) triphosgene, DIPEA, THF, −78 °C, 40 min, then RNH<sub>2</sub>, DIPEA, THF, rt, 24 h. For exact structures and yields see Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</p></p></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Synthesis Yields and Biological Evaluation of Ureas <b>13</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0015.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Yields are given for isolated products.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> values are presented as the mean of a triplicate experiment. Standard deviations are reported in Table S1 of the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></div><div></div></div><div class="NLM_p">Regarding both the biological activity on PI3Kα and the nature of the urea substituents, a small methyl is well tolerated (entry 1), up to the size of a six-membered ring. To maintain the kinase inhibition, urea is better positioned in the <i>para</i> position of aryl ring A (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, entry 3 vs entry 8), indicating some additional interactions in the ATP binding pocket. In addition, if R bears a supplementary donor or acceptor of hydrogen bonds, the global activity increases.</div><div class="NLM_p">For this novel function, a hydroxymethyl is preferred in the <i>meta</i> position, whereas a simple hydroxyl is better tolerated in the <i>para</i> position (entry 2 vs entry 3 and entry 5 vs entry 4). In the pyridine series (entries 6 and 7), the <i>m</i>-nitrogen atom interacts better with the biological targets. Except for <b>13c</b> and <b>13h</b>, the urea derivatives are more active on PI3Kα and PI3Kγ than on the PI3Kδ isoform. The most selective compound is indubitably <b>13e</b> (entry 5), which exhibits a selective action on the α isoform (5- and 10-fold more potent compared to the γ and δ isoforms, respectively).</div><div class="NLM_p">Since mTOR and PI3K conserved a typical ATP site despite their little kinase fold resemblance, we focused on the inhibitory effect of our compounds on mTOR. As it turns out, all of our compounds displayed submicromolar activities against both mTOR and PI3Kα (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Our dual inhibitors are more efficient at inhibiting PI3Kα than mTOR (entries 1–8). However, our best PI3Kα inhibitors, <b>3a</b> and <b>4n</b>, displayed very good nanomolar inhibitions against mTOR (entries 1 and 4).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. IC<sub>50</sub> Values of the Best Inhibitors against PI3Kα and mTOR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0016.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values are presented as the mean of a triplicate experiment. Standard deviations are reported in Table S1 of the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></div><div></div></div><div class="NLM_p">Other derivatives such as <b>12a</b>, <b>12b</b>, <b>13e</b>, and <b>13f</b> have similar activity ratios on the two kinases (entries 6, 7, 13, and 14). Interestingly, the introduction of an aryl urea on ring B led to compounds which are more active against mTOR than against PI3Kα (entries 9–12). Compounds <b>13b</b> and <b>13c</b> in particular displayed the strongest activities (IC<sub>50</sub> = 1 and 5 nM, respectively) on mTOR, the last kinase in the pathway (entries 10 and 11).</div><div class="NLM_p">Finally, we examined the selectivity profile of <b>13c</b> on a diverse 50-kinase panel. The activity of the compound was confirmed on the PI3K family and mTOR, and the compound appeared to be very selective toward other kinases with the exception of CDK19 and CDK8 (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Protein Kinase Selectivity of <b>13c</b> in a Kinase Interaction Assay (KinomeScan)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">ctrl (%)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">ctrl (%)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">ctrl (%)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">ctrl (%)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">ctrl (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AAK1</td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="left">CDKL3</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="left">IRAK3</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="left">PCTK3</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">PIP5K1C</td><td class="colsep0 rowsep0" align="char" char=".">68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ACVR2A</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="left">CDKL5</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">LZK</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="left">PFTK1</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="left">PIP5K2B</td><td class="colsep0 rowsep0" align="char" char=".">93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ACVR2B</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="left">CIT</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">MAP3K15</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="left">PIK3C2B</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="left">PIP5K2C</td><td class="colsep0 rowsep0" align="char" char=".">87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ANKK1</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">CSNK1A1L</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="left">MAP3K4</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="left">PIK3C2G</td><td class="colsep0 rowsep0" align="char" char=".">0.95</td><td class="colsep0 rowsep0" align="left">PKMYT1</td><td class="colsep0 rowsep0" align="char" char=".">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIKE</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="left">EPHB6</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="left">MAST1</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="left">PIK3CA</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">PRP4</td><td class="colsep0 rowsep0" align="char" char=".">71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BUB1</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="left">ERBB3</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="left">MEK5</td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="left">PIK3CB</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="left">RIPK1</td><td class="colsep0 rowsep0" align="char" char=".">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDC2L1</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">ERK3</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">MKK7</td><td class="colsep0 rowsep0" align="char" char=".">91</td><td class="colsep0 rowsep0" align="left">PIK3CD</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="left">RIPK4</td><td class="colsep0 rowsep0" align="char" char=".">92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK11</td><td class="colsep0 rowsep0" align="char" char=".">8.8</td><td class="colsep0 rowsep0" align="left">ERK4</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">MTOR</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">PIK3CG</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="left">TIE1</td><td class="colsep0 rowsep0" align="char" char=".">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK8</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="left">ERN1</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="left">NEK10</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="left">PIK4CB</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="left">TNNI3K</td><td class="colsep0 rowsep0" align="char" char=".">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDKL1</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="left">GAK</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="left">PCTK2</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="left">PIP5K1A</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="left">YANK1</td><td class="colsep0 rowsep0" align="char" char=".">94</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last"><b>13c</b> was screened at a 10 μM concentration on a 50-kinase interaction panel, and results for primary screen binding interactions are reported as “ctrl (%)”, where lower numbers indicate stronger hits.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Molecular Modeling</h3><div class="NLM_p">Docking studies were carried out to investigate the binding mode of our compounds in the PI3Kα isoform. Among numerous crystallographic structures of PI3K, only three were available for the α isoform of human PI3K. Two apo structures (PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RD0">2RD0</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HIZ">3HIZ</a>)<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33-35)</a> and one complex with the covalent inhibitor wortmannin (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HHM">3HHM</a>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> were used as structural models of PI3Kα in our studies. Among all the crystallographic structures of PI3K, a majority contain reversible inhibitors that provide useful information on protein/ligand interactions found in their active site. More importantly, some of these inhibitors are structurally similar to our compounds. The strong sequence and structural similarities between the different classes and isoforms of PI3K (especially in their active sites)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> suggest that the interactions observed with these crystallographic inhibitors are likely to occur for our compounds.</div><div class="NLM_p">To select the best model for docking experiments, wortmannin and seven PI3Kγ cocrystallized inhibitors (ligands containing a pyrimidine 2-morpholino-4-heteroaryl or substituted 2-heteroaryl-4-morpholine motif) were docked in the three previously selected structures. The use of the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HHM">3HHM</a> structure enabled the reproduction of the crystallographic binding modes of the ligands. Nevertheless, the hydrogen bond interaction seen in the original complex between the ligand and the side chain of the catalytic Lys802 was not reproduced for two thienopyrimidine derivatives (PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L16">3L16</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L17">3L17</a>)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and a pyrazolopyrimidine derivative (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">After careful analysis of the active site, we established that these ligands need a different conformation of the flexible lateral chain of the catalytic Lys802 to correctly bind to our docking model. The conformation of the corresponding lysine observed in the structure of PI3Kγ in complex with the pyrazolopyrimidine derivative (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a>) was manually assigned to Lys802 in the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HHM">3HHM</a> structure. The use of this new model enabled all interactions to be reproduced for each docked inhibitor in the corresponding original structures. It was thus used for all further docking experiments.</div><div class="NLM_p">Next, our ligands were docked using the previously validated model. The 10 best docking poses according to GlideScore<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> were conserved for each ligand. All the compounds adopted orientations analogous to those of the cocrystallized inhibitors. The binding is driven by one hydrogen bond created between the oxygen atom of the morpholino group and the NH group of Val851 in the hinge region of the active site (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This hydrogen bond is considered as the key interaction that confers the binding capacity on the ligands. The strength of this hydrogen bond (or its absence) explains why the activity of our compounds decreases (or disappears) when the oxygen atom of the morpholino group is modified (<b>3a</b> ≫ <b>3b</b> ≫ <b>3c</b>).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representation of the predicted binding mode of compound <b>3a</b> in the active site of PI3Kα. Hydrogen bonds are represented in yellow-black dotted lines. For clarity, only polar hydrogens are represented and residues 767–772 overlaying the ligands are hidden in the ribbon representation (PDB reference codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HHM">3HHM</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a> for the positioning of Lys802).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The binding of the morpholino group to the hinge region leads to the orientation of the aryl group toward Asp810 and the catalytic Lys802. The hydroxyl position on this aryl group has a drastic influence on the activity of the compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Docking of <b>3a</b> shows that the hydroxyl function replaces a conserved water molecule, as has already been shown in some crystallographic structures of sufficient resolution (PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L54">3L54</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L08">3L08</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ML9">3ML9</a>).<a onclick="showRef(event, 'cit22b'); return false;" href="javascript:void(0);" class="ref cit22b">(22b)</a> This hydroxyl function forms two hydrogen bonds with the oxygen atom of the hydroxyl group of Tyr836 and with one oxygen atom of the carboxyl group of Asp810 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Moreover, the hydroxyl function of compound <b>4e</b> forms the same hydrogen bonds, slightly moving the pyrido[3,2-<i>d</i>]pyrimidine moiety in the active site.</div><div class="NLM_p">The docking of the pyrido[2,3-<i>d</i>]pyrimidine isomer derivatives (compounds <b>12a</b>–<b>c</b>) does not show significant differences in the global binding mode compared to that of the previous scaffold. Only a minor influence can be observed on the conformation of the morpholino group due to the introduction of a hydrogen atom in position 5 of the scaffold. This could explain the lower activity of such compounds.</div><div class="NLM_p">Inversion of the morpholino and aryl groups (compound <b>8</b>) does not induce any changes in the observed interactions of these groups but leads to a different orientation of the scaffold in the active site. The morpholino group still forms one hydrogen bond with Val851 in the hinge region, and the aryl group is still oriented toward Asp810 and the catalytic residue Lys802. The different orientation of the scaffold in the active site can explain the lower activity of this compound.</div><div class="NLM_p">Using urea derivatives, the binding site of PI3Kα was explored beyond the catalytic Lys802 (compounds <b>13a</b>–<b>h</b>). The predicted binding modes of the 4-urea derivatives are similar to that of the cocrystallized substituted pyrazolopyrimidine inhibitor (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a>), with the morpholino group still forming one hydrogen bond with Val851 in the hinge region. Nevertheless, some differences can be noticed. The crystallographic complex shows that the urea function forms three hydrogen bonds with the target. Each NH group of the urea forms a hydrogen bond with the oxygen atom of the carbonyl group of the side chain of Asp810, whereas the carbonyl group of the urea forms one hydrogen bond with the side chain of Lys802. In our docking poses, four hydrogen bonds can be observed. Due to a slightly different orientation of the side chain of Asp810 in our model, the NH groups of the urea of the docked ligands form two hydrogen bonds with the same oxygen atom of the carbonyl group of the side chain of Asp810. Moreover, the carbonyl group of the urea forms one hydrogen bond with the amino groups of the side chains of Lys802 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Lys776 is highlighted too because some poses of our different docked compounds form a hydrogen bond with this lysine (not shown), instead of the neighboring Lys802. This interaction is not present in the crystallographic structure because the conformation of the lysine in PI3Kγ (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a>) corresponding to Lys776 could not be defined, probably due to its flexibility.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representation of the predicted binding mode of compound <b>13c</b> in the active site of PI3Kα. Hydrogen bonds are represented in yellow-black dotted lines. For clarity, nonpolar H atoms are not represented and residues 767–772 overlaying the ligands are hidden in the ribbon representation (PDB reference codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HHM">3HHM</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a> for the positioning of Lys802).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">This study shows that our ligands adopt binding modes in PI3Kα that are similar to those of known inhibitors in PI3Kγ. Crystallographic studies of the complexes between PI3Kα and our ligands should be considered to confirm the predicted binding modes. In particular, these studies would enable the identification of important residues in the PI3Kα active site forming key interactions with the inhibitors (Lys776, Lys802, Asp810). This information would lead to a better optimization of our compounds.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cellular Assays</h3><div class="NLM_p">Compounds which exhibited dual activity on PI3Kα and mTOR with IC<sub>50</sub> values lower than 100 nM were selected for a primary cellular screening assay using six cancer cell lines (Tables <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> and <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>): hepatocellular colorectal and mammary carcinoma cells and immortalized keratinocytes. Human diploid skin fibroblasts were used as noncancer cells.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Cancer Cell Lines and Their PI3K Signaling Pathway Status</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center">human cell type</th><th class="colsep0 rowsep0" align="center">mutation</th><th class="colsep0 rowsep0" align="center">pathway overactivation</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Huh-7</td><td class="colsep0 rowsep0" align="left">hepatocellular carcinoma</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">yes</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41">39−41</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2</td><td class="colsep0 rowsep0" align="left">colorectal adenocarcinoma</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">42, 43</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HaCaT</td><td class="colsep0 rowsep0" align="left">immortalized keratinocyte</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">elevated Akt activity</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">44−46</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MCF-7</td><td class="colsep0 rowsep0" align="left">breast adenocarcinoma</td><td class="colsep0 rowsep0" align="left">PI3KCA</td><td class="colsep0 rowsep0" align="left">activated</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">47</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDA-MB-231</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">normal</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">47</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDA-MB-468</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">PTEN</td><td class="colsep0 rowsep0" align="left">over</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">47</a></td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. In Cellulo Activity of the Best Inhibitors, IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">breast<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">entry</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Huh-7 (liver)</th><th class="colsep0 rowsep0" align="center" char=".">Caco-2 (colon)</th><th class="colsep0 rowsep0" align="center" char=".">HaCaT (skin)</th><th class="colsep0 rowsep0" align="center" char=".">no. of fibroblasts</th><th class="colsep0 rowsep0" align="center" char=".">MCF-7</th><th class="colsep0 rowsep0" align="center" char=".">MDA-MB-231</th><th class="colsep0 rowsep0" align="center" char=".">MDA-MB-468</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">>25</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left"><b>4m</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">>25</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">>25</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">>25</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">>25</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left"><b>13e</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">>25</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="left"><b>13f</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">>25</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left"><b>PI103</b><a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">>25</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are presented as the mean of a triplicate experiment.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">We used PI103 as the reference compound.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Only <b>13b</b> and <b>13c</b> were tested on three breast cancer cell lines.</p></div></div></div><div class="NLM_p">First and foremost, our newly tested 2,4-disubstituted pyridopyrimidine did not affect the survival and proliferation of human skin fibroblasts. Regarding cancer and immortalized cell lines, the most potent PI3Kα inhibitors <b>3a</b> and <b>4m</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, entries 1 and 4) act in the same concentration range as PI103 but do not appear to be the best products with respect to cell toxicity. The results clearly show that the best in cellulo inhibitory effects were obtained with the best dual PI3K and mTOR inhibitors and more particularly with the more potent mTOR inhibitors <b>13b</b> and <b>13c</b>.</div><div class="NLM_p">The best cellular effects were measured with the dual inhibitors <b>13b</b> and <b>13c</b> showing IC<sub>50</sub> values around 50 nM on PI3K and close to nanomolar IC<sub>50</sub> values on mTOR (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>, entries 4 and 5). For these two compounds, the micromolar barrier is reached. For <b>13a</b>, <b>13e</b>, and <b>13f</b>, the partial decrease of PI3K or mTOR inhibition as compared to <b>13b</b> and <b>13c</b> resulted in a cell survival enhancement.</div><div class="NLM_p">Since the PI3K pathway is frequently activated in human breast cancers and activation is associated with a poor prognosis and resistance to treatment,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> the most cytotoxic derivatives <b>13b</b> and <b>13c</b> were further tested on three additional breast cancer cell lines differing in their level of PI3K pathway activation (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). A high activity of the best inhibitors <b>13b</b> and <b>13c</b> was observed on all cell lines, as can be seen by the IC<sub>50</sub> values. The IC<sub>50</sub> values of <b>13c</b> were 200 and 250 nM for MCF-7 and MDA-MB-231, respectively. The best inhibition (IC<sub>50</sub> = 100 nM) was obtained with <b>13c</b> on MDA-MB-468, the cell line harboring a PTEN mutation and thus an overactivation of the PI3K pathway.</div><div class="NLM_p">To ensure that <b>13b</b> and <b>13c</b> do inhibit PI3Kα and mTOR inside the cells, we checked by Western blotting the activity of the two major kinases of the pathway, Akt and mTORC1 (one of the two protein complexes containing mTOR), after treatment with inhibitors at the IC<sub>50</sub> level (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of <b>13b</b> and <b>13c</b> on the AKT and mTORC1 activity in breast cancer cells by Western blotting.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">mTORC1 activity was evaluated by quantifying the phosphorylation level of its target, S6K1, in the MCF-7 and MDA-MB-231 cell lines. mTORC1 was well inhibited in the two cell lines with both inhibitors; the best reduction was observed with <b>13b</b>, which is the most active compound against mTOR.</div><div class="NLM_p">Akt activity was monitored by measuring its phosphorylation level on Thr308 and Ser473 in MDA-MB-468, the cell line expressing high levels of activated Akt. Both inhibitors reduced p-AKT Ser473 (the mTORC2 target, the other protein complex containing mTOR), while P-Akt Thr308 (the PDK1 target, a downstream kinase, in the PI3K pathway) was slightly reduced by <b>13b</b> only. These results are in accordance with the results of enzymatic assays which show a more potent efficiency for <b>13b</b> as compared to 1<b>3c</b> to inhibit PI3Kα and mTOR. A discrepancy was observed with proliferation assay results since <b>13c</b> appeared to be the most efficient to reduce cell proliferation. This could be explained by the poor sensitivity of the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay.</div><div class="NLM_p">As cytotoxicity may result from inhibition of proliferation and/or an increase in apoptosis, we studied the effects of <b>13b</b> and <b>13c</b> on the distribution in the cell cycle and on apoptosis of the three breast cancer cell lines by flow cytometry.</div><div class="NLM_p">The G2/M-phase was not affected. In MCF-7 and MDA-MB-468 cells, the S-phase was reduced while the G1-phase was increased compared to the controls, implying that both inhibitors blocked the cell cycle at the G1-phase (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Although the treatments changed the distribution of MDA-MB-231 cells in the same way as they did for MCF-7 and MDA-MB-468 cells, the changes were not statistically significant. This differential effect on the cell lines may be related to the level of PI3K pathway activation. Inhibitors are more efficient in cells harboring high levels of their target. Apoptosis was induced in MCF-7 by <b>13b</b> and <b>13c</b> inhibitors as seen in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>. It was also increased in MDA-MB-231 and MDA-MB-468 but not significantly (data not shown).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of the best inhibitors <b>13b</b> and <b>13c</b> on the growth of breast cancer cell lines: left, distribution in the cell cycle; right, rate of apoptosis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, the ureas <b>13b</b> and <b>13c</b> are the best candidates to reduce proliferation of all the cancer cell lines tested. In breast cancer cells, the inhibition of their targets PI3Kα and mTOR is associated with an arrest of cells in the G1-phase along with an induction of apoptosis.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A new class of 2,4-disubsituted pyrido[3,2-<i>d</i>]pyrimidines and 2,4-disubsituted pyrido[2,3-<i>d</i>]pyrimidines were prepared following a two-step synthesis involving an S<sub>N</sub>Ar and a Suzuki-type cross-coupling reaction from our original 2,4-dichloropyridopyrimidine precursor. Biological activities were measured for each novel compound on three PI3K isoforms. The best candidates were additionally evaluated on mTOR to identify their potential activity as dual PI3K/mTOR inhibitors. The new library reported in this paper led to the discovery of seven promising dual PI3Kα/mTOR inhibitors which exhibited in vitro IC<sub>50</sub> values of less than 100 nM on both kinases. Structure–activity relationships are fully depicted, and molecular modeling studies explain the interaction of active compounds in the PI3Kα ATP binding site. In cellulo studies demonstrated that in vitro PI3K and mTOR inhibitions are related to cancer cell survival; a strong cytotoxic effect was observed. Indeed, the two urea derivatives which are the best dual PI3K and mTOR inhibitors specifically affect the survival and proliferation of cancer cell lines below the micromolar level. Further tests of the two lead compounds on breast cancer cell lines demonstrated that they do act on their two targets (PI3K and mTOR) inside the cells and reduce their proliferation by blocking them in the G1-phase of their cell cycle and by inducing apoptosis. Having in hand two lead compounds which fully appear as pro-apoptotic drugs, further efforts are in progress to enhance their therapeutic efficacy as anticancer agents. A particular focus will be made on bioavailability evaluation and ADME-tox studies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Part</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74471" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74471" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Information</h3><div class="NLM_p"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Bruker DPX 250 or 400 MHz instrument using CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub>. The chemical shifts are reported in parts per million (δ scale), and all coupling constant (<i>J</i>) values are in hertz. The following abbreviations were used to explain the multiplicities: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), and dd (doublet of doublets). Melting points are uncorrected. IR absorption spectra were obtained on a Perkin-Elmer PARAGON 1000 PC, and the values are reported in inverse centimeters. HRMS spectra were recorded on a Bruker maXis mass spectrometer. Monitoring of the reactions was performed using silica gel TLC plates (silica Merck 60 F<sub>254</sub>). Spots were visualized by UV light at 254 and 356 nm. Column chromatography was performed using silica gel 60 (0.063–0.200 mm, Merck). Microwave irradiation was carried out in sealed 2–5 mL vessels placed in a Biotage Initiator system using a standard absorbance level (300 W maximum power). The temperatures were measured externally by an IR probe that determined the temperature on the surface of the vial and could be read directly from the instrument screen. The reaction time was measured from when the reaction mixture reached the stated temperature for temperature-controlled experiments. Pressure was measured by a noninvasive sensor integrated into the cavity lid.</div><div class="NLM_p last">The chromatographic purities of the final compounds were determined using an Agilent Technology 1260 Infinity HPLC system using a C18 column (Agilent ZORBAX Eclipse Plus, 3.5 μm, 4.6 mm × 100 mm) operating at 30 °C. Elution was carried out using acetonitrile containing 0.1% formic acid as mobile phase A and water containing 0.1% formic acid as mobile phase B. Elution conditions: at 0 min, 10% phase A + 90% phase B; at 5 min, 50% phase A + 50% phase B; at 7 min, 50% phase A + 50% phase B; at 7.1 min, 10% phase A + 90% phase B; at 20 min, 10% phase A + 90% phase B. The flow rate of the mobile phase was 0.9 mL/min, and the injection volume of the sample was 2 μL. Peaks were detected at 254 and 300 nm. The purities of all the tested compounds were found to be >95% unless otherwise stated.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Procedure A for Amination at C-4 of the Pyridopyrimidine by S<sub>N</sub>Ar</h3><div class="NLM_p last">A solution of <b>1</b> or <b>10</b> (200 mg, 1.0 mmol, 1.0 equiv) in dry THF (20 mL) was cooled to 0 °C under an inert atmosphere. A solution of amine (1.05 equiv) and triethylamine (0.14 mL, 1.05 mmol, 1.05 equiv) in dry THF (5 mL) was added slowly. The mixture was stirred at room temperature for 12 h. The solvent was removed under reduced pressure. The crude product was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (30 mL), and the organic layer was washed with a saturated solution of NaHCO<sub>3</sub> (2 × 10 mL). The organic layer was dried over MgSO<sub>4</sub> and filtered. The solvent was removed under reduced pressure. The crude product was purified by flash chromatography.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedure B for the Suzuki Cross-Coupling Reaction</h3><div class="NLM_p last">To a solution of <b>2</b> or <b>11</b> (1.0 equiv) in 1,2-dimethoxyethane was added boronic acid or potassium aryltrifluoroborate (1.5 equiv). An aqueous solution (1 M) of potassium carbonate (3.0 equiv) was then injected, and the mixture was degassed by argon bubbling for 15 min. Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv) was added, and the mixture was heated to 150 °C for 1 h under microwave irradiation. After cooling, the solvent was removed in vacuo. The crude product was purified by flash chromatography.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure C for the Reduction of Nitro Derivatives</h3><div class="NLM_p last">To a solution of the nitro derivative (1 equiv) in ethanol was added tin(II) chloride dihydrate (6.0 equiv). The mixture was refluxed for 12 h. The solvent was removed under reduced pressure followed by the addition of a solution of NaOH (1 M, 100 mL). The crude material was extracted with EtOAc (3 × 60 mL), and the organic layers were washed with water (20 mL). The combined organic layers were dried over MgSO<sub>4</sub> and filtered. The solvent was removed under reduced pressure. The crude product was obtained without purification by flash chromatography.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure D for the Synthesis of Urea Derivatives</h3><div class="NLM_p last">A solution of triphosgene (65 mg, 0.22 mmol, 1.0 equiv) in dry THF (10 mL) was cooled to −78 °C. A solution of <b>4h</b> or <b>4i</b> (3.0 equiv) and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA; 0.17 mL, 1.04 mmol, 4.8 equiv) in dry THF (5 mL) was added dropwise. The mixture was stirred at −78 °C for 5 min and then warmed to room temperature for 40 min. A solution of amine (3.0 equiv) and DIPEA (85 μL, 0.52 mmol, 2.4 equiv) in dry THF (5 mL) was added dropwise. The solution was stirred at room temperature for 24 h. The reaction was stopped with a saturated solution of NaHCO<sub>3</sub> (10 mL). The crude material was extracted with EtOAc (3 × 50 mL). The combined organic layers were dried over MgSO<sub>4</sub> and filtered. The solvent was removed under reduced pressure to afford the final product.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure E for the Cleavage of the MOM Protecting Group</h3><div class="NLM_p last">Into a solution of MOM-protected compound (1.0 equiv) in dioxane was injected a solution of HCl in dioxane, 4.0 M (6.0 equiv). The mixture was stirred at room temperature until completion monitored by TLC. The solvent was then removed by filtration and the product washed with diethyl ether.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-Chloro-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>2a</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure A using <b>1</b> and morpholine. Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 98/2) yielded <b>2a</b> as a white solid (223 mg, 89%). Mp: 174–176 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.87 (t, <i>J</i> = 5.0 Hz, 4H), 4.57 (br s, 4H), 7.59 (dd, <i>J</i> = 4.2 Hz, <i>J</i> = 8.5 Hz, 1H) 8.02 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.5 Hz, 1H), 8.67 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.2 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>11</sub>ClN<sub>4</sub>O [M + H]<sup>+</sup> 251.0621, found 251.0700.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-Chloro-4-thiomorpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>2b</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure A using <b>1</b> and thiomorpholine. Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 9/1) yielded <b>2b</b> as a yellow solid (201 mg, 75%). Mp: 166–168 °C. NMR <sup>1</sup>H (400 MHz, CDCl<sub>3</sub>): δ 2.80 (t, <i>J</i> = 8.0 Hz, 4H), 4.71 (br s, 4H), 7.54 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.00 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.5 Hz, 1H), 8.63 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.1 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>11</sub>ClN<sub>4</sub>S [M + H]<sup>+</sup> 267.0393, found 267.0469.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-Chloro-4-(1,1-dioxothiomorpholino)pyrido[3,2-<i>d</i>]pyrimidine (<b>2c</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure A using <b>1</b> and thiomorpholine 1,1-dioxide. Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 98/2) yielded <b>2c</b> as a white solid (174 mg, 58%). Mp: 250 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.40 (s, 4H), 4.82 (br s, 4H), 7.87 (dd, <i>J</i> = 4.2 Hz, <i>J</i> = 8.5 Hz, 1H), 8.14 (d, <i>J</i> = 8.5 Hz, 1H), 8.84 (d, <i>J</i> = 4.2 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>11</sub>ClN<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 299.0291, found 299.0372.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-Chloro-4-(4-methylpiperazin-1-yl)pyrido[3,2-<i>d</i>]pyrimidine (<b>2d</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure A using <b>1</b> and 1-methylpiperazine. Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 99/1) yielded <b>2d</b> as a yellow solid (224 mg, 85%). Mp: 111–113 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.35 (s, 3H), 2.59 (br s, 4H), 4.55 (br s, 4H), 7.58 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.00 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.5 Hz, 1H), 8.67 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.1 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>14</sub>ClN<sub>5</sub> [M + H]<sup>+</sup> 264.0938, found 264.1021.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-Chloro-4-(4,4-difluoropiperidin-1-yl)pyrido[3,2-<i>d</i>]pyrimidine (<b>2e</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure A using <b>1</b> and 4,4-difluoropiperidine. Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 99/1) yielded <b>2e</b> as a yellow solid (228 mg, 80%). Mp: 136–138 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.18 (m, 4H), 4.62 (br s, 4H), 7.63 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.05 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.5 Hz, 1H), 8.71 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.1 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>11</sub>ClF<sub>2</sub>N<sub>4</sub> [M + H]<sup>+</sup> 285.0640, found 285.0725.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-Chloro-4-((3-pyridylmethyl)amino)pyrido[3,2-<i>d</i>]pyrimidine (<b>2f</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure A using <b>1</b> and 3-picolylamine. Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 99/1) yielded <b>2f</b> as a white solid (0.152 mg, 61%). Mp: 154–156 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 4.73 (d, <i>J</i> = 6.4 Hz, 2H), 7.35 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 4.8 Hz, 1H), 7.87 (m, 2H), 8.07 (dd, <i>J</i> = 8.5 Hz, <i>J</i> = 1.4 Hz, 1H), 8.49 (m, 1H), 8.62 (s, 1H), 8.82 (dd, <i>J</i> = 4.2 Hz, <i>J</i> = 1.3 Hz, 1H), 9.67 (t, <i>J</i> = 6.3 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>15</sub>ClN<sub>4</sub>O [M + H]<sup>+</sup> 272.0621, found 279.0636.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-Chloro-4-((2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholino)pyrido[3,2-<i>d</i>]pyrimidine (<b>2g</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure A using <b>1</b> and (2<i>R</i>,6<i>R</i>)-2,6-dimethylmorpholine. Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 15/85) yielded <b>2g</b> as a white solid (243 mg, 87%). Mp: 158–160 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.28 (s, 3H), 1.31 (s, 3H), 2.88 (m, 2H), 3.78 (dqd, <i>J</i> = 2.4 Hz, <i>J</i> = 6.2 Hz, <i>J</i> = 12.5 Hz, 2H), 5.35 (s, 1H), 6.19 (s, 1H), 7.59 (dd, <i>J</i> = 4.2 Hz, <i>J</i> = 8.5 Hz, 1H), 8.02 (dd, <i>J</i> = 4.2 Hz, <i>J</i> = 8.5 Hz, 1H), 8.69 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.2 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>15</sub>ClN<sub>4</sub>O [M + H]<sup>+</sup> 279.0934, found 279.1008.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-(3-Hydroxyphenyl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>3a</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol) and 3-hydroxyphenylboronic acid (132 mg, 0.958 mmol). Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 8/2) yielded <b>3a</b> as a white solid (173 mg, 76%). Mp: 236–238 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.81 (m, 4H), 4.51 (br s, 4H), 6.89 (m, 1H), 7.29 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 8.3 Hz, 1H), 7.80 (m, 1H), 7.89 (m, 2H), 8.17 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.3 Hz, 1H), 8.77 (d, <i>J</i> = 7.8 Hz, 1H), 9.54 (m, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 309.1273, found 309.1364. Purity: >96% by HPLC, <i>t</i><sub>R</sub> = 6.47 min.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-(3-Hydroxyphenyl)-4-thiomorpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>3b</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2b</b> (180 mg, 0.675 mmol) and 3-hydroxyphenylboronic acid (124 mg, 0.810 mmol). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 96/4) yielded <b>3b</b> as a white solid (167 mg, 76%). Mp: 238–240 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 2.85 (br s, 4H), 4.75 (br s, 4H), 6.90 (m, 1H), 7.28 (t, <i>J</i> = 7.5 Hz, 1H), 7.78 (dd, <i>J</i> = 5.0 Hz, <i>J</i> = 10.0 Hz, 1H), 7.88 (m, 2H), 8.17 (dd, <i>J</i> = 2.5 Hz, <i>J</i> = 10.0 Hz, 1H), 8.76 (dd, <i>J</i> = 2.5 Hz, <i>J</i> = 5.0 Hz, 1H), 9.55 (s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>16</sub>N<sub>4</sub>OS [M + H]<sup>+</sup> 325.1045, found 325.1113. Purity: >97% by HPLC, <i>t</i><sub>R</sub> = 7.75 min.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-(3-Hydroxyphenyl)-4-(1,1-dioxothiomorpholino)pyrido[3,2-<i>d</i>]pyrimidine (<b>3c</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2c</b> (160 mg, 0.536 mmol) and 3-hydroxyphenylboronic acid (89 mg, 0.643 mmol). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 98/2) yielded <b>3c</b> as a white solid (162 mg, 85%). Mp: 219–221 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.41 (br s, 4H), 4.90 (br s, 4H), 6.90 (d, <i>J</i> = 8.0 Hz, 1H), 7.31 (t, <i>J</i> = 8.0 Hz, 1H), 7.86 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 7.91 (m, 2H), 8.22 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.5 Hz, 1H), 8.81 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 4.1 Hz, 1H), 9.58 (s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>16</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 357.0943, found 357.1018. Purity: >97% by HPLC, <i>t</i><sub>R</sub> = 7.37 min.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-(3-Hydroxyphenyl)-4-(4-methylpiperazin-1-yl)pyrido[3,2-<i>d</i>]pyrimidine (<b>3d</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2d</b> (200 mg, 0.758 mmol) and 3-hydroxyphenylboronic acid (126 mg, 0.910 mmol). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 99/1) yielded <b>3d</b> as a yellow solid (211 mg, 87%). Mp: 174–176 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.60 (s, 3H), 2.96 (br s, 4H), 4.90 (br s, 4H), 7.15 (d, <i>J</i> = 8.0 Hz, 1H), 7.35 (br, 1H), 7.53 (t, <i>J</i> = 8.0 Hz, 1H), 7.79 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.13 (m, 1H), 8.24 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.5 Hz, 1H), 8.34 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 4.1 Hz, 1H), 8.88 (m, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 322.1590, found 322.1682 Purity: >96% by HPLC, <i>t</i><sub>R</sub> = 4.82 min.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-(4,4-Difluoropiperidin-1-yl)-2-(3-hydroxyphenyl)pyrido[3,2-<i>d</i>]pyrimidine (<b>3e</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2e</b> (200 mg, 0.703 mmol) and 3-hydroxyphenylboronic acid (116 mg, 0.844 mmol). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 99/1) yielded <b>3e</b> as a yellow solid (147 mg, 61%). Mp: 175 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.20 (m, 4H), 4.65 (s, 4H), 5.91 (br s, OH), 6.96 (d, <i>J</i> = 7.8 Hz, 1H), 7.35 (t, <i>J</i> = 7.8 Hz, 1H), 7.62 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 7.99 (s, 1H), 8.04 (d, <i>J</i> = 7.8 Hz, 1H), 8.21 (dd, <i>J</i> = 2.6 Hz, <i>J</i> = 8.5 Hz, 1H), 8.70 (dd, <i>J</i> = 2.6 Hz, <i>J</i> = 4.1 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>16</sub>F<sub>2</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 343.1292, found 343.1364. Purity: >96% by HPLC, <i>t</i><sub>R</sub> = 8.47 min.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-((2<i>R</i>,6<i>R</i>)-2,6-Dimethylmorpholino)-2-(3-hydroxyphenyl)pyrido[3,2-<i>d</i>]pyrimidine (<b>3g</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2g</b> (200 mg, 0.718 mmol) and 3-hydroxyphenylboronic acid (119 mg, 0.861 mmol). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 98/2) yielded <b>3g</b> as a white solid (205 mg, 85%). Mp: 219 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.28 (s, 3H), 1.30 (s, 3H), 2.91 (dd, <i>J</i> = 10.9 Hz, <i>J</i> = 12.9 Hz, 2H), 3.83 (m, 2H), 5.70 (m, 2H), 6.35 (m, 1H), 6.90 (m, 1H), 7.27 (t, <i>J</i> = 7.9 Hz, 1H), 7.51 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 7.93 (d, <i>J</i> = 7.8 Hz, 1H), 7.98 (s, 1H), 8.17 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.5 Hz, 1H), 8.63 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 4.1 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 337.1586, found 337.1661. Purity: >96% by HPLC, <i>t</i><sub>R</sub> = 7.50 min.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-(2-Hydroxyphenyl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>4a</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol) and 2-hydroxyphenylboronic acid (132 mg, 0.958 mmol). Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 7/3) yielded <b>4a</b> as a yellow solid (215 mg, 87%). Mp: 173–175 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.94 (t, <i>J</i> = 5.0 Hz, 4H), 4.63 (br s, 4H), 6.90 (dd, <i>J</i> = 7.2 Hz, <i>J</i> = 8.0 Hz, 1H), 7.02 (d, <i>J</i> = 8.0 Hz, 1H), 7.37 (t, <i>J</i> = 7.2 Hz, 1H), 7.61 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 4.4 Hz, 1H), 8.06 (d, <i>J</i> = 8.0 Hz, 1H), 8.41 (dd, <i>J</i> = 2.5 Hz, <i>J</i> = 10.0 Hz, 1H), 8.66 (dd, <i>J</i> = 2.5 Hz, <i>J</i> = 5.0 Hz, 1H), 14.3 (s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 309.1273, found 309.1363. Purity: >98% by HPLC, <i>t</i><sub>R</sub> = 11.84 min.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-(4-Hydroxyphenyl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>4b</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol) and 4-hydroxyphenylboronic acid (132 mg, 0.958 mmol). Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 7/3) yielded <b>4b</b> as a white solid (182 mg, 74%). Mp: 252–254 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.81 (t, <i>J</i> = 5.2 Hz, 4H), 4.48 (br s, 4H), 6.80 (m, 2H), 7.74 (m, 1H), 8.25 (m, 1H), 8.28 (m, 2H), 8.70 (m, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 309.1273, found 309.1352. Purity: >98% by HPLC, <i>t</i><sub>R</sub> = 6.25 min.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-(3-Methoxyphenyl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>4c</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol) and 3-methoxyphenylboronic acid (146 mg, 0.957 mmol). Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 2/8) yielded <b>4c</b> as a white solid (219 mg, 85%). Mp: 118–120 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.93 (s, 4H), 3.95 (s, 3H), 4.60 (br s, 4H), 7.03 (dd, <i>J</i> = 2.6 Hz, <i>J</i> = 8.1 Hz, 1H), 7.40 (t<i>J</i> = 7.9 Hz,, 1H), 7.61 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.08 (dd, <i>J</i> = 5.1 Hz, <i>J</i> = 13.3 Hz, 2H), 8.19 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.5 Hz, 1H), 8.68 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.1 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 323.1616, found 323.1504. Purity: >97% by HPLC, <i>t</i><sub>R</sub> = 7.97 min.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(4-Methoxyphenyl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>4d</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol) and 4-methoxyphenylboronic acid (146 mg, 0.958 mmol). Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 7/3) yielded <b>4d</b> as a white solid (196 mg, 76%). Mp: 178–180 °C<sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.88 (s, 3H), 3.92 (t, <i>J</i> = 5.0 Hz, 4H), 4.58 (m, 4H), 6.99 (d, <i>J</i> = 9.0 Hz, 2H), 7.58 (dd, <i>J</i> = 4.2 Hz, <i>J</i> = 8.5 Hz, 1H), 8.14 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.5 Hz, 1H), 8.45 (d, <i>J</i> = 9.0 Hz, 2H), 8.63 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.2 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 323.1616, found 323.1504. Purity: >97% by HPLC, <i>t</i><sub>R</sub> = 7.13 min.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-(3-(Hydroxymethyl)phenyl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>4e</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol) and 3-(hydroxymethyl)phenylboronic acid (146 mg, 0.958 mmol). Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 8/2) yielded <b>4e</b> as a yellow solid (226 mg, 88%). Mp: 119–121 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.92 (t, <i>J</i> = 6.0 Hz, 4H), 4.59 (br s, 4H), 4.78 (s, 2H), 7.45 (m, 2H), 7.60 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 8.0 Hz, 1H), 7.65 (m, 1H), 8.17 (m, 1H), 8.38 (dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.0 Hz, 1H), 8.45 (m, 1H), 8.66 (dd, <i>J</i> = 2.0 Hz, <i>J</i> = 4.0 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 323.1430, found 323.1498. Purity: >97% by HPLC, <i>t</i><sub>R</sub> = 6.17 min.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-(4-(Hydroxymethyl)phenyl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>4f</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol) and 4-(hydroxymethyl)phenylboronic acid (146 mg, 0.958 mmol). Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 8/2) yielded <b>4f</b> as a white solid (183 mg, 71%). Mp: 221–223 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.93 (m, 4H), 4.60 (br s, 4H), 4.77 (s, 2H), 7.46 (d, <i>J</i> = 8.1 Hz, 2H), 7.60 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.18 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.5 Hz, 1H), 8.47 (d, <i>J</i> = 8.2 Hz, 2H), 8.67 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.1 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 323.1430, found 323.1512. Purity: >99% by HPLC, <i>t</i><sub>R</sub> = 6.10 min.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-(3-Aminophenyl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>4g</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol, 1.0 equiv) and 3-nitrophenylboronic acid (161 mg, 0.958 mmol, 1.2 equiv). Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 85/15) yielded the nitro derivative as a yellow solid (191 mg, 71%). Mp: 193–195 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.84 (m, 4H), 4.56 (br s, 4H), 7.83 (m, 2H), 8.27 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 8.5 Hz, 1H), 8.36 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 8.5 Hz, 1H), 8.81 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 4.0 Hz, 1H), 8.85 (d, <i>J</i> = 7.8 Hz, 1H), 9.16 (s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>15</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 338.1175, found 338.1250. Then the reduction of the nitro group was carried out as described for general procedure C using the nitro derivative (180 mg, 0.534 mmol, 1.0 equiv). The crude product was obtained without purification by flash chromatography to afford <b>4g</b> as a white solid (131 mg, 80%). Mp: 182–184 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.82 (m, 4H), 4.51 (br s, 4H), 5.45 (br, 2H), 6.70 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 7.8 Hz, 1H), 7.13 (t, <i>J</i> = 7.8 Hz, 1H), 7.63 (d, <i>J</i> = 7.7 Hz, 1H), 7.72 (s, 1H), 7.77 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.15 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 8.5 Hz, 1H), 8.74 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 4.0 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>17</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 308.1433, found 308.1507. Purity: >99% by HPLC, <i>t</i><sub>R</sub> = 5.97 min.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-(4-Aminophenyl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine <b>4h</b></h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol, 1.0 equiv) and 4-nitrophenylboronic acid (161 mg, 0.958 mmol, 1.2 equiv). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/petroleum ether, 8/2) yielded the nitro derivative as a yellow solid (234 mg, 87%). Mp: 211–213 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.82 (m, 4H), 4.63 (br s, 4H), 7.66 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.20 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.5 Hz, 1H), 8.32 (d, <i>J</i> = 8.9 Hz, 2H), 8.66 (d, <i>J</i> = 8.0 Hz, 2H), 8.73 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.1 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>15</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 338.1175, found 338.1257. Then the reduction of the nitro group was carried out as described for general procedure C using the nitro derivative (600 mg, 1.78 mmol, 1.0 equiv) The crude product was obtained without purification by flash chromatography to afford <b>4h</b> as a white solid (443 mg, 80%). Mp: 221–223 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.62 (br, 2H), 3.93 (m, 4H), 4.56 (br s, 4H), 6.75 (d, <i>J</i> = 8.7 Hz, 2H), 7.56 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.12 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.5 Hz, 1H), 8.33 (d, <i>J</i> = 8.7 Hz, 2H), 8.61 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.1 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>17</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 308.1433, found 308.1509. Purity: >96% by HPLC, <i>t</i><sub>R</sub> = 6.29 min.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-Morpholino-2-(3-pyridyl)pyrido[3,2-<i>d</i>]pyrimidine (<b>4i</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol) and 3-pyridineboronic acid (118 mg, 0.958 mmol). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 99/1) yielded <b>4i</b> as a yellow solid (178 mg, 76%). Mp: 159–161 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.92 (t, <i>J</i> = 6.0 Hz, 4H), 4.63 (br s, 4H), 7.61–7.89 (m, 4H), 8.20 (dd, <i>J</i> = 1.75 Hz, <i>J</i> = 8.5 Hz, 1H), 8.31 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 6.25 Hz, 1H), 8.73 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 6.25 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>15</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 294.1277, found 294.1359. Purity: >95% by HPLC, <i>t</i><sub>R</sub> = 6.48 min.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-(1<i>H-</i>Indazol-6-yl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>4j</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol) and potassium 1<i>H</i>-indazole-6-trifluoroborate (155 mg, 0.958 mmol). Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 8/2) yielded <b>4j</b> as a white solid (119 mg, 45%). Mp: 236–238 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.97 (s, 4H), 4.56 (br s, 4H), 7.55 (d, <i>J</i> = 8.1 Hz, 2H), 7.53 (m, 1H), 8.20 (d, <i>J</i> = 8.8 Hz, 2H), 8.62 (d, <i>J</i> = 8.1 Hz, 2H), 8.67 (m, 1H), 8.97 (s, 1H), 10.31 (bd, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>16</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 333.1386, found 333.1451. Purity: >98% by HPLC, <i>t</i><sub>R</sub> = 6.26 min.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-(1<i>H-</i>Indazol-4-yl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>4k</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol) and potassium 1<i>H</i>-indazole-4-trifluoroborate (191 mg, 0.957 mmol). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 98/2) yielded <b>4k</b> as a white solid (129 mg, 49%). Mp: 212–214 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.77–3.91 (m, 4H), 4.54 (br s, 4H), 7.50 (t, <i>J</i> = 7.8 Hz, 1H), 7.71 (d, <i>J</i> = 8.2 Hz, 1H), 7.84 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.29 (d, <i>J</i> = 7.2 Hz, 1H), 8.35 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.5 Hz, 1H), 8.80 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 4.1 Hz, 1H), 9.01 (s, 1H), 13.22 (s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>16</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 333.1458, found 333.1460. Purity: >99% by HPLC, <i>t</i><sub>R</sub> = 6.80 min.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-(2-Aminopyridyl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>4l</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol) and potassium 2-aminopyridine-5-trifluoroborate (211 mg, 0.958 mmol). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 96/4) yielded <b>4l</b> as a yellow solid (71 mg, 23%). Mp: 242–244 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.92 (m, 4H), 4.61 (br s, 4H), 4.73 (br s, 2H), 6.57 (dd, <i>J</i> = 8.6 Hz, <i>J</i> = 0.8 Hz, 1H), 7.57 (dd, <i>J</i> = 8.5 Hz, <i>J</i> = 4.1 Hz, 1H), 8.10 (dd, <i>J</i> = 8.5 Hz, <i>J</i> = 1.7 Hz, 1H), 8.53 (dd, <i>J</i> = 8.6 Hz, <i>J</i> = 2.3 Hz, 1H), 8.63 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 1.7 Hz, 1H), 9.19 (dd, <i>J</i> = 2.3 Hz, <i>J</i> = 0.7 Hz, 1H) . HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>16</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 309.1458, found 309.1460. Purity: >97% by HPLC, <i>t</i><sub>R</sub> = 5.76 min.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-(2-Aminopyrimidinyl)-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>4m</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>2a</b> (200 mg, 0.798 mmol) and potassium 2-aminopyrimidine-5- trifluoroborate (212 mg, 0.958 mmol). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 96/4) yielded <b>4m</b> as a white solid (178 mg, 72%). Mp: 260 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.92 (m, 4H), 4.58 (br s, 4H), 5.30 (m, 2H), 7.59 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 8.5 Hz, 1H), 8.11 (d, <i>J</i> = 4.0 Hz, <i>J</i> = 8.5 Hz, 1H), 8.65 (d, <i>J</i> = 4.0 Hz, 1H), 9.33 (s, 2H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>15</sub>N<sub>7</sub>O [M + H]<sup>+</sup> 310.1338, found 310.1403. Purity: >98% by HPLC, <i>t</i><sub>R</sub> = 5.75 min.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4-Morpholino-2-(2-(acetylamino)pyrimidinyl)pyrido[3,2-<i>d</i>]pyrimidine (<b>5</b>)</h3><div class="NLM_p last">To a solution of <b>4m</b> (125 mg, 0.404 mmol, 1.0 equiv) in dimethylformamide (DMF; 2 mL) was added acetic anhydride (0.38 mL, 4.04 mmol, 10.0 equiv). The mixture was heated at 120 °C for 30 min under microwave irradiation. After cooling, the crude material was then diluted in water (30 mL) and extracted with EtOAc (5 mL). The combined organic layers were washed with water (2 × 30 mL) and dried over MgSO<sub>4</sub>. The solvent was removed in vacuo, and purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 98/2) yielded <b>5</b> as a white solid (40 mg, 28%). Mp: 260–262 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.56 (d, <i>J</i> = 4.7 Hz, 3H), 3.92 (d, <i>J</i> = 3.9 Hz, 4H), 4.60 (br s, 4H), 7.63 (m, 1H), 8.15 (s, 1H), 8.52 (s, 1H), 8.69 (s, 1H), 9.57 (d, <i>J</i> = 5.2 Hz, 2H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>17</sub>N<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup> 352.1444, found 352.1505. Purity: >99% by HPLC, <i>t</i><sub>R</sub> = 6.69 min.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 4-Morpholino-2-(2-(diacetylamino)pyrimidinyl))pyrido[3,2-<i>d</i>]pyrimidine <b>6</b></h3><div class="NLM_p last">Compound <b>6</b> was isolated during the transformation of <b>4n</b> into <b>5</b> (vide supra) during the purification by flash chromatography on silica gel as a white solid (70 mg, 44%). Mp: 225–227 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.34 (s, 6H), 3.93 (m, 4H), 4.64 (br s, 4H), 7.68 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.20 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.5 Hz, 1H), 8.75 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.0 Hz, 1H), 9.79 (s, 2H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>7</sub>O<sub>3</sub> [M + H]<sup>+</sup> 394.1549, found 394.1618. Purity: >98% by HPLC, <i>t</i><sub>R</sub> = 9.26 min.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-Chloro-4-(3-(methoxymethoxy)phenyl)pyrido[3,2-<i>d</i>]pyrimidine (<b>7</b>)</h3><div class="NLM_p last">To a solution of <b>1</b> (300 mg, 1.5 mmol, 1.0 equiv) in dry toluene were added potassium 3-(methoxymethoxy)phenyltrifluoroborate (256 mg, 1.58 mmol, 1.05 equiv), potassium carbonate (311 mg, 2.25 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (87 mg, 0.08 mmol, 0.05 equiv). The mixture was stirred at 100 °C for 2 h. The solvent was then removed under reduced pressure, and the crude material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (30 mL). The organic layer was washed with water (2 × 10 mL). The combined organic layers were dried over MgSO<sub>4</sub>. Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 8/2) yielded <b>7</b> as a yellow solid (204 mg, 45%). Mp: 189–191 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.56 (s, 3H), 5.28 (s, 2H), 6.98 (dd, <i>J</i> = 1.7 Hz, <i>J =</i> 7.2 Hz, 1H), 7.43 (t, <i>J</i> = 7.8 Hz, 1H), 7.56 (dd, <i>J</i> = 4.2 Hz, <i>J</i> = 8.7 Hz, 1H), 7.78 (d, <i>J</i> = 7.8 Hz, 2H), 7.96 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.7 Hz, 1H), 8.63 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 4.2 Hz, 1H). HRMS (EI-MS): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>12</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 302.1352, found 302.1358.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-(3-Hydroxyphenyl)-2-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>9</b>)</h3><div class="NLM_p last">To a solution of <b>7</b> (150 mg, 0.497 mmol, 1.0 equiv) in dry THF were added successively morpholine (70 μL, 0.746 mmol, 1.5 equiv) and triethylamine (103 μL, 0.746 mmol, 1.5 equiv). The mixture was refluxed for 12 h. The solvent was removed under reduced pressure, and the crude material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (30 mL). The organic layer was washed with water (2 × 10 mL). The combined organic layers were dried over MgSO<sub>4</sub>. Purification by flash chromatography on silica gel (petroleum ether/EtOAc, 8/2) yielded the protected <b>8</b> as a yellow solid (120 mg, 68%). Direct deprotection of the methoxymethoxy function was directly carried out as described ifor general procedure E (using EtOH as the solvent) to afford <b>9</b> as a yellow solid (63 mg, 60%). Mp: 162–164 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.86 (m, 4H), 4.04 (m, 4H), 6.41 (s, 1H), 7.01 (dd, <i>J</i> = 1.7 Hz, <i>J =</i> 7.2 Hz, 1H), 7.43 (t, <i>J</i> = 8.1 Hz, 1H), 7.56 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.6 Hz, 1H), 7.78 (d, <i>J</i> = 7.8 Hz, 2H), 7.96 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.7 Hz, 1H), 8.63 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 4.1 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 309.1352, found 309.1358. Purity: >99% by HPLC, <i>t</i><sub>R</sub> = 8.59 min.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-(3-Hydroxyphenyl)-4-morpholinopyrido[2,3-<i>d</i>]pyrimidine (<b>12a</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>11</b> (160 mg, 0.638 mmol) and 3-hydroxyphenylboronic acid (89 mg, 0.643 mmol). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 99/1) yielded <b>12a</b> as a white solid (118 mg, 60%). Mp: > 260 °C. <sup>1</sup>H NMR (250 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.83 (d, <i>J</i> = 4.5 Hz, 4H), 3.89 (d, <i>J</i> = 4.4 Hz, 4H), 6.93 (s, 1H), 7.31 (d, <i>J</i> = 8.0 Hz, 1H), 7.47 (dd, <i>J</i> = 4.3 Hz, <i>J</i> = 8.3 Hz, 1H), 7.94 (d, <i>J</i> = 7.6 Hz, 2H), 8.47 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.3 Hz, 1H), 9.01 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.2 Hz, 1H), 9.59 (s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 309.1273, found 309.1364. Purity: >97% by HPLC, <i>t</i><sub>R</sub> = 5.82 min.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-(3-(Hydroxymethyl)phenyl)-4-morpholinopyrido[2,3-<i>d</i>]pyrimidine (<b>12b</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>11</b> (200 mg, 0.798 mmol) and 3-(hydroxymethyl)phenylboronic acid (89 mg, 0.643 mmol). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 98/2) yielded <b>12b</b> as a white solid (167 mg, 65%). Mp: > 260 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.87–3.78 (m, 4H), 3.97–3.87 (m, 4H), 4.62 (d, <i>J</i> = 3.4 Hz, 2H), 5.32 (s, 1H), 7.47 (dd, <i>J</i> = 3.8 Hz, <i>J</i> = 7.2 Hz, 3H), 8.37 (s, 1H), 8.51–8.45 (m, 2H), 9.02 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.2 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 323.1508, found 323.1514. Purity: >95% by HPLC, <i>t</i><sub>R</sub> = 5.62 min.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-(2-Aminopyrimidinyl)-4-morpholinopyrido[2,3-<i>d</i>]pyrimidine (<b>12c</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure B using <b>11</b> (200 mg, 0.798 mmol) and potassium 2-aminopyrimidine-5- trifluoroborate (89 mg, 0.643 mmol). Purification by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 98/2) yielded <b>12c</b> as a white solid (170 mg, 69%). Mp: > 260 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.81 (m, 4H), 3.89 (m, 4H), 7.24 (s, 2H), 7.42 (dd, <i>J</i> = 4.3 Hz, <i>J</i> = 8.2 Hz, 1H), 8.43 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.2 Hz, 1H), 8.99–8.93 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.3 Hz, 1H), 9.20 (s, 2H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>15</sub>N<sub>7</sub>O [M + H]<sup>+</sup> 310.1416, found 310.1423. Purity: >99% by HPLC, <i>t</i><sub>R</sub> = 4.87 min.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-(4-(1-Methyl-3-phenylurea))-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>13a</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure D using <b>4h</b> (200 mg, 0.651 mmol) and methylamine (22 μL, 0.651 mmol). The crude product was obtained without purification by flash chromatography to afford <b>13a</b> as a yellow solid (50 mg, 21%). Mp: 223–225 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>CO): δ 2.83 (br s, 3H), 3.87 (m, 4H), 4.57 (br s, 4H), 5.68 (br s, 1H), 7.47 (d, <i>J</i> = 8.8 Hz, 2H), 7.58 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.00 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.5 Hz, 1H), 8.14 (br s, 1H), 8.30 (d, <i>J</i> = 8.8 Hz, 2H), 8.57 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.1 Hz, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 365.1648, found 365.1717. Purity: >96% by HPLC, <i>t</i><sub>R</sub> = 6.19 min.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 2-(4-(1-(3-(Hydroxymethyl)phenyl)-3-phenylurea))-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>13b</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure D using <b>4h</b> (100 mg, 0.325 mmol) and (3-aminophenyl)methanol (40 mg, 0.325 mmol). The crude product was obtained without purification by flash chromatography to afford <b>13b</b> as a brown solid (59 mg, 40%). Mp: 244–246 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.83 (m, 4H), 4.49 (br s, 6H), 5.19 (br s, 1H), 6.94 (d, <i>J</i> = 6.2 Hz, 1H), 7.24 (s, 1H), 7.34 (d, <i>J</i> = 7.1 Hz, 1H), 7.46 (s, 1H), 7.60 (d, <i>J</i> = 7.8 Hz, 2H), 7.79 (s, 1H), 8.16 (d, <i>J</i> = 8.1 Hz, 1H), 8.39 (d, <i>J</i> = 7.7 Hz, 2H), 8.73 (br s, 2H), 8.92 (s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 457.1477, found 457.1985. Purity: >95% by HPLC, <i>t</i><sub>R</sub> = 6.98 min.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 2-(4-(1-(4-(Hydroxymethyl)phenyl)-3-phenylurea))-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>13c</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure D using <b>4h</b> (65 mg, 0.211 mmol) and (4-aminophenyl)methanol (26 mg, 0.211 mmol). The crude product was obtained without purification by flash chromatography to afford <b>13c</b> as a yellow solid (85 mg, 89%). Mp: 220–222 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.34 (s, 2H), 3.83 (m, 4H), 4.51 (br s, 4H), 5.2 (br s, 1H)7.22 (d, <i>J</i> = 8.5 Hz, 2H), 7.45 (d, <i>J</i> = 8.5 Hz, 2H), 7.61 (d, <i>J</i> = 8.8 Hz, 2H), 7.78 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.15 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.5 Hz, 1H), 8.37 (d, <i>J</i> = 8.8 Hz, 2H), 8.73 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 4.1 Hz, 1H), 9.22 (s, 1H), 9.45 (s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 457.1477, found 457.1995. Purity: >96% by HPLC, <i>t</i><sub>R</sub> = 6.86 min.</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2-(4-(1-(3-Hydroxyphenyl)-3-phenylurea))-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>13d</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure D using <b>4h</b> (90 mg, 0.293 mmol) and 3-aminophenol (32 mg, 0.293 mmol). The crude product was obtained without purification by flash chromatography to afford <b>13d</b> as a brown solid (58 mg, 45%). Mp: 221–223 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.83 (d, <i>J</i> = 4.6 Hz, 4H), 4.51 (br s, 4H), 6.39 (dd, <i>J</i> = 2.1 Hz, <i>J</i> = 8.0 Hz, 1H), 6.81 (d, <i>J</i> = 7.7 Hz, 1H), 7.06 (m, 2H), 7.58 (d, <i>J</i> = 8.7 Hz, 2H), 7.78 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.16 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.5 Hz, 1H), 8.39 (d, <i>J</i> = 8.7 Hz, 2H), 8.63 (s, 1H), 8.73 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.0 Hz, 1H), 8.88 (s, 1H), 9.34 (s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 443.1753, found 443.1827. Purity: >95% by HPLC, <i>t</i><sub>R</sub> = 7.09 min.</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-(4-(1-(4-Hydroxyphenyl)-3-phenylurea))-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>13e</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure D using <b>4h</b> (120 mg, 0.390 mmol) and 3-aminophenol (43 mg, 0.390 mmol). The crude product was obtained without purification by flash chromatography to afford <b>13e</b> as a brown solid (100 mg, 58%). Mp: 239–241 °C. <sup>1</sup>H NMR (250 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.82 (m, 4H), 4.51 (br s, 4H), 6.70 (m, 2H), 7.24 (m, 2H), 7.57 (d, <i>J</i> = 8.8 Hz, 2H), 7.77 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.15 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 8.5 Hz, 1H), 8.38 (m, 3H), 8.72 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 4.1 Hz, 1H), 8.82 (s, 1H), 9.09 (s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 443.1753, found 443.1826. Purity: >96% by HPLC, <i>t</i><sub>R</sub> = 6.88 min.</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 4-Morpholino-2-(4-(1-(4-pyridinyl)-3-phenylurea))pyrido[3,2-<i>d</i>] pyrimidine (<b>13f</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure D using <b>4h</b> (110 mg, 0.358 mmol) and 3-aminopyridine (34 mg, 0.358 mmol). The crude product was obtained without purification by flash chromatography to afford <b>13f</b> as a white solid (109 mg, 71%). Mp: > 260 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.84 (s, 4H), 4.53 (br s, 4H), 7.48 (d, <i>J</i> = 5.0 Hz, 1H), 7.65 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 8.0 Hz, 2H), 7.79 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 8.4 Hz, 1H), 7.97 (m, 1H), 8.19 (d, <i>J</i> = 8.4 Hz, 1H), 8.38 (m, 3H), 8.80–8.71 (m, 2H), 9.73 (br s, 1H), 10.1 (br s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>21</sub>N<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup> 428.1757, found 428.1828. Purity: >96% by HPLC, <i>t</i><sub>R</sub> = 5.67 min.</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-Morpholino-2-(4-(1-(3-pyridinyl)-3-phenylurea))pyrido[3,2-<i>d</i>]pyrimidine (<b>13g</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure D using <b>4h</b> (115 mg, 0.374 mmol) and 3-aminopyridine (35 mg, 0.374 mmol). The crude product was obtained without purification by flash chromatography to afford <b>13g</b> as a white solid (110 mg, 69%). Mp: 249–251 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.97–3.65 (m, 4H), 4.51 (br s, 4H), 7.33 (d, <i>J</i> = 4.7 Hz, 1H), 7.62 (d, <i>J</i> = 8.6 Hz, 2H), 7.78 (m, 1H), 7.97 (d, <i>J</i> = 7.4 Hz, 1H), 8.25–8.10 (m, 2H), 8.38 (d, <i>J</i> = 8.7 Hz, 2H), 8.65 (d, <i>J</i> = 1.7 Hz, 1H), 8.73 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 4.0 Hz, 1H), 9.61 (s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>21</sub>N<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup> 428.1757, found 428.1831. Purity: >95% by HPLC, <i>t</i><sub>R</sub> = 5.77 min.</div></div><div id="sec4_1_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-(3-(1-(3-(Hydroxymethyl)phenyl)-3-phenylurea))-4-morpholinopyrido[3,2-<i>d</i>]pyrimidine (<b>13h</b>)</h3><div class="NLM_p last">The reaction was carried out as described for general procedure D using <b>4g</b> (65 mg, 0.22 mmol) and (3-aminophenyl)methanol (80 mg, 0.22 mmol). The crude product was obtained without purification by flash chromatography to afford <b>13h</b> as a yellow solid (48 mg, 47%). Mp: 230 °C. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO): δ 3.83 (m, 4H), 4.42 (d, <i>J</i> = 5.6 Hz, 2H), 4.53 (br s, 4H), 5.05 (t, <i>J</i> = 5.6 Hz, 1H), 7.23 (d, <i>J</i> = 8.5 Hz, 2H), 7.42 (d, <i>J</i> = 8.5 Hz, 2H), 7.71 (d, <i>J</i> = 7.8 Hz, 1H), 7.81 (dd, <i>J</i> = 4.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.06 (d, <i>J</i> = 7.8 Hz, 1H), 8.20 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 8.5 Hz, 1H), 8.43 (s, 1H), 8.60 (s, 1H) 8.77 (m, 1H), 8.85 (s, 1H). HRMS (EI/MS): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 457.1910, found 457.1988. Purity: >95% by HPLC, <i>t</i><sub>R</sub> = 7.05 min.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Molecular Modeling</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Hardware and Software</h4><div class="NLM_p last">All molecular modeling studies were performed with Schrodinger Molecular Modeling Suite 2010.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Maestro was the interface piloting the diverse modules. Glide<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> was used to dock ligands. Calculations were run on a Linux station: Intel Core  i7 CPU 950 at 3.07 GHz.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Structure Preparation</h4><div class="NLM_p last">The three structures of PI3Kα apo or in complex with wortmannin were retrieved from the Protein Data Bank.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Subunit A of each structure, corresponding to the catalytic subunit, was conserved. Structures were aligned and superimposed on their backbone using the Protein Structure Alignment tool of Schrodinger Molecular Modeling Suite 2010. Bond orders and connections of wortmannin were manually corrected, and the ligand was transposed in the two apo structures. Next all three complexes were prepared using the Protein Preparation Wizard workflow of Schrodinger Molecular Modeling Suite 2010. The proteins were subsequently preprocessed (hydrogen atoms added, incomplete residues filled), and an exhaustive sampling was done regarding hydrogen bond assignment. Finally, the hydrogen atoms of the complexes were refined by a minimization stage with a constraint to converge to a structure with an RMSD of 0.3 Å (OPLS2005 force field) to remove steric clashes. The seven cocrystallized inhibitors used as references were extracted from the structures <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2X6K">2X6K</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LS8">3LS8</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L13">3L13</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L16">3L16</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L17">3L17</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS">3DBS</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a>. On the basis of the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a> structure of PI3Kγ, the lateral chain of Lys802 in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HHM">3HHM</a> was moved by manually modifying the dihedral angles of the residue. The resulting protein model was finally refined by a minimization stage with a constraint to converge to a structure with an RMSD of 0.3 Å (OPLS2005 force field). All docked ligands were built within Marvin.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Three-dimensional structures were generated using Corina.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Next 3D structures were submitted to the LigPrep module of Schrodinger Molecular Modeling Suite 2010. All ionization states (via the Ionizer module) and tautomers were taken into account at pH 7.0 ± 2.0. The resulting structures were used as the starting point for all docking simulations.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Docking Parameters</h4><div class="NLM_p last">The receptor grids were generated using wortmannin as the centroid of the enclosing box, allowing the docking of ligands with a length of 21 Å. Docking calculations were performed with the standard precision of Glide. Ligand flexibility was taken into account, and the option of ring conformation sampling was activated. For each ligand, postdocking minimization was performed on 100 poses, and the 10 best poses were kept and analyzed.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Biological Assays</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> In Vitro Kinase Assay on PI3K</h4><div class="NLM_p">The activity of mTOR was evaluated using a purified protein (ref PV4753 from Invitrogen). The TR-FRET mTOR kinase LANCE Ultra assay kit (Perkin-Elmer) is a fluorescence-based immunoassay for the detection of the phosphorylation of a synthetic peptide, 4EBP1f, a substrate of mTOR. It takes place in 384-well plates and can be divided into two phases: a kinase reaction phase and a phosphorylated peptide detection phase.</div><div class="NLM_p">In the kinase reaction phase, the following components were mixed in the same well: 5 μL of a solution containing 20 μM ATP and 2 μM PIP2 diluted in kinase assay buffer (50 mM HEPES, pH 7.5, 100 mM NaCl, 0.03% CHAPS, 1 mM EGTA, 3 mM MgCl<sub>2</sub>, 2 mM DTT), 2.5 μL of kinase at the optimal concentration (222 ng/mL) diluted in kinase assay buffer, and 2.5 μL of serial dilutions of inhibitors diluted in 4% DMSO and kinase assay buffer. For each inhibitor concentration, the assay was run in triplicate. The reaction was then incubated for 60 min at room temperature.</div><div class="NLM_p">For the ADP detection phase, 5 μL of a detection solution containing europium-labeled anti-ADP antibody (6 nM), Alexa Fluor 647-labeled ADP tracer (12 nM), and EDTA (30 mM, to stop the kinase reaction) diluted in TR-FRET dilution buffer (provided by the manufacturer) was added to the assay well. After 30 min of incubation at room temperature, the 384-well plates were read in a Victor V plate reader configured for HTRF (Perkin-Elmer). Excitation was performed at 340 nm, and emission was measured at 665 and 615 nm. The inhibition curve was then plotted as emission ratio 665 nm/615 nm versus inhibitor concentration.</div><div class="NLM_p last">To calculate substrate conversion values (conversion (%) of ATP in ADP) from the raw TR-FRET emission ratios, an ATP-ADP titration curve was performed with a total nucleotide concentration of 10 μM. The resulting TR-FRET emission ratio was plotted against the conversion of ATP to ADP. The data of this curve were fitted to a three-parameter hyperbolic model with the following equation obtained from the GraphPad Prism software:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/jm-2013-01138v_m001.gif" alt="" /></img></span>The conversion corresponding to each TR-FRET ratio was calculated using the following equation:<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/jm-2013-01138v_m002.gif" alt="" /></img></span>The conversion was then plotted versus the concentration of inhibitor. The amount of inhibitor required to elicit a 50% change in the % conversion of ATP into ADP (the EC50) was then determined. This EC<sub>50</sub> corresponds to the IC<sub>50</sub> value of the inhibitor.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> In Vitro Kinase Assay on mTOR</h4><div class="NLM_p">The activity of mTOR was evaluated using a purified protein (ref PV4753 from Invitrogen). The TR-FRET mTOR kinase LANCE Ultra assay kit (Perkin-Elmer) is a fluorescence-based immunoassay for the detection of the phosphorylation of a synthetic peptide from 4EBP1, a substrate of mTOR. It takes place in 384-well plates and can be divided into two phases: a kinase reaction phase and a phosphorylated peptide detection phase.</div><div class="NLM_p">In the kinase reaction phase, the following components were mixed in the same well: 5 μL of a solution containing 10 μM ATP and 50 nM peptide (covalently linked to an acceptor fluorophore, ULight) diluted in kinase assay buffer (50 nM HEPES, pH 7.5, 0.1% Tween 20, 1 mM EGTA, 10 mM MgCl<sub>2</sub>, 3 mM MnCl<sub>2</sub>, 2 mM DTT), 2.5 mL of kinase at the optimal concentration (3 ng/μL) diluted in kinase assay buffer, and 5 μL of serial dilutions of inhibitors diluted in 4% DMSO and kinase assay buffer. For each inhibitor concentration, the assay was run in triplicate. The reaction was then incubated for 2 h in a solution containing 32 mM EDTA.</div><div class="NLM_p last">For the detection phase, 5 μL of a detection solution containing europium-labeled antiphosphopeptide antibody (2 nM final concentration) diluted in dilution buffer (provided by the manufacturer) was added to the assay well. After 1 h of incubation at room temperature, the 384-well plates were read in a Victor V plate reader configured for HTRF (Perkin-Elmer). Excitation of europium was performed at 340 nm, and emission of UV light was measured at 665 nm. The inhibition curve was then plotted as the intensity of emission at 665 nm versus the logarithm of the inhibitor concentration.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Kinase Assays</h4><div class="NLM_p">For most assays, kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an <i>Escherichia coli</i> host derived from the BL21 strain. <i>E. coli</i> were grown to the log phase and infected with T7 phage from a frozen stock (multiplicity of infection 0.4) and incubated with shaking at 32 °C until lysis (90–150 min). The lysates were centrifuged (6000<i>g</i>) and filtered (0.2 μm) to remove cell debris. The remaining kinases were produced in HEK-293 cells and subsequently tagged with DNA for qPCR detection. Streptavidin-coated magnetic beads were treated with biotinylated small-molecule ligands for 30 min at room temperature to generate affinity resins for kinase assays. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand and to reduce nonspecific phage binding. Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17× PBS, 0.05% Tween 20, 6 mM DTT).Test compounds were prepared as 40× stocks in 100% DMSO and directly diluted into the assay. All reactions were performed in polypropylene 384-well plates in a final volume of 0.04 mL. The assay plates were incubated at room temperature with shaking for 1 h, and the affinity beads were washed with wash buffer (1× PBS, 0.05% Tween 20). The beads were then resuspended in elution buffer (1× PBS, 0.05% Tween 20, 0.5 μM nonbiotinylated affinity ligand) and incubated at room temperature with shaking for 30 min. The kinase concentration in the eluates was measured by qPCR.</div><div class="NLM_p last">The compound(s) were screened at the concentration(s) requested, and the results for primary screen binding interactions are reported as “ctrl (%)”, where lower numbers indicate stronger hits in the matrix:<span class="NLM_disp-formula" id="ueq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/jm-2013-01138v_m003.gif" alt="" /></img></span></div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Cell Culture and Survival Assay</h4><div class="NLM_p last">Skin diploid fibroblast cells were provided by BIOPREDIC International Co. (Rennes, France). HuH7, CaCo-2, and HaCaT cell lines were obtained from the ECACC collection. Cells were grown according to ECACC recommendations. The toxicity test of the compounds on these cells was as follows: A total of 4 × 10<sup>3</sup> cells/well were seeded in 96-well plates. Twenty-four hours after cell seeding, the cells were exposed to increasing concentrations of the compounds (0.1, 0.3, 0.9, 2.7, 8.3, and 25 μM). After 48 h of treatment, the cells were washed in PBS and fixed in cooled 90% ethanol/5% acetic acid for 20 min. Then the nuclei were stained with Hoechst 3342 (Sigma). Image acquisition and analysis were performed using a Cellomics ArrayScan VTI/HCS reader (Thermo Scientific).</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Breast Cancer Cell Proliferation (MTT Assay)</h4><div class="NLM_p last">Cells were seeded at 1.5 × 10<sup>4</sup> cells/cm<sup>2</sup> in 24-well plates. After 24 h, the cells were grown for 72 h with inhibitors used over a 10<sup>–9</sup> to 10 μM concentration range. Cell proliferation was assessed with the MTT assay. Briefly, the cells were incubated with 400 μL of MTT (0.5 mg/mL in culture medium) for 1 h at 37 ◦C. The medium was then aspirated. Formazan crystals were dissolved with 400 μL dimethyl sulfoxide for 5 min. The absorbance of each well was read at 570 nm in a Spectramax 190 spectrophotometer (Molecular Devices Corp., Sunnyvale, CA). The assay was performed in three wells per condition. Absorbance is expressed as a percentage of the control (vehicle).</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Cell Cycle Analysis</h4><div class="NLM_p last">Cells were grown in the presence of inhibitors for 24 h. Breast cancer cells were treated with the Coulter DNA-Prep reagents kit (Beckman Coulter, France) as previously described.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Flow cytometry analyses were performed using a Coulter Epics Elite ESP flow cytometer (Beckman Coulter). Cell cycle distribution was analyzed with the Multicycle-AV software (Phoenix Flow Systems, San Diego, CA).</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Quantification of Apoptotic Cells</h4><div class="NLM_p last">Cells were grown in the presence of inhibitors for 48 h. Apoptosis was assessed by flow cytometry with a method adapted to adherent cells, which is based on the selective thermal denaturation of apoptotic DNA and detection of denatured DNA with a monoclonal antibody against single-stranded DNA (anti-ssDNA Mab, F7–26, from AbCys, Paris, France). The cells were treated as previously described.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Data were analyzed with the Expo32 software (Beckman Coulter, France).</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Western Blot Analysis</h4><div class="NLM_p last">Cells were grown in the presence of inhibitors for 48 h. Cellular lysates (PBS/5% SDS lysis buffer containing protease inhibitors and phosphatase inhibitors) were subjected to SDS–polyacrylamide (10%) gel electrophoresis and transferred onto nitrocellulose membranes. Immunoblotting was done using rabbit monoclonal antibodies (Cell Signaling Technology, Ozyme, France) against Akt phosphorylated on Thr 308 (ref 4056) or Ser 473 (ref 4060) and total Akt (ref 4685) and against S6K1 phosphorylated on Thr 389 (ref 9234) and total S6K1 (ref 2708). Detection was performed with the enhanced chemiluminescence reagent (ECL Western blotting detection reagents, Interchim, France). Bands were quantitated using the Multi Gauge software (Fujifilm).</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Statistical Analysis</h4><div class="NLM_p last">Statistical analysis was performed using the GraphPad Prism software. Data are presented as the mean ± SD from at least three independent experiments, and differences are considered significant when <i>P</i> < 0.05 as determined by the nonparametric unpaired Student <i>t</i> test.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77"><a href="/doi/suppl/10.1021/jm401138v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43483" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43483" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Additional characterizations for compounds <b>2</b>–<b>13</b>, <sup>1</sup>H and <sup>13</sup> C NMR spectra for compounds <b>2</b>–<b>13</b>, and standard deviations for IC<sub>50</sub> (Table S1). This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401138v/suppl_file/jm401138v_si_001.pdf">jm401138v_si_001.pdf (5.53 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401138v/suppl_file/jm401138v_si_003.pdf">jm401138v_si_003.pdf (11.66 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Crystal structure PDB IDs for docking model construction used in this paper: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HHM">3HHM</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IEB">3IEB</a>.</p><div class="testing" data-doi="10.1021/jm401138v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36808" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36808" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvain Routier</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, Rue de Chartres, BP 6759, 45067 OrléansCedex
2, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1162687d6770787f3f637e646578746351647f78673c7e637d74707f623f7763"><span class="__cf_email__" data-cfemail="a5d6dcc9d3c4cccb8bd7cad0d1ccc0d7e5d0cbccd388cad7c9c0c4cbd68bc3d7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thibault Saurat</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, Rue de Chartres, BP 6759, 45067 OrléansCedex
2, France</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
de Biophysique Moléculaire, CNRS Orléans, Rue Charles Sadron, 45071 Orléans, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frédéric Buron</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, Rue de Chartres, BP 6759, 45067 OrléansCedex
2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nuno Rodrigues</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, Rue de Chartres, BP 6759, 45067 OrléansCedex
2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marie-Ludivine de Tauzia</span> - <span class="hlFld-Affiliation affiliation">Centre
de Biophysique Moléculaire, CNRS Orléans, Rue Charles Sadron, 45071 Orléans, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lionel Colliandre</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, Rue de Chartres, BP 6759, 45067 OrléansCedex
2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stéphane Bourg</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, Rue de Chartres, BP 6759, 45067 OrléansCedex
2, France</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
de Biophysique Moléculaire, CNRS Orléans, Rue Charles Sadron, 45071 Orléans, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal Bonnet</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, Rue de Chartres, BP 6759, 45067 OrléansCedex
2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gérald Guillaumet</span> - <span class="hlFld-Affiliation affiliation">Institut
de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, Rue de Chartres, BP 6759, 45067 OrléansCedex
2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohamed Akssira</span> - <span class="hlFld-Affiliation affiliation">Équipe
de Chimie Bioorganique & Analytique, URAC 22, Université Hassan II Mohammedia-Casablanca, BP 146, 28800 Mohammedia, Morocco</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne Corlu</span> - <span class="hlFld-Affiliation affiliation">Hôpital
de Pontchaillou, Université de Rennes
1, INSERM, UMR-991, 65033 Rennes Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christiane Guillouzo</span> - <span class="hlFld-Affiliation affiliation">Hôpital
de Pontchaillou, Université de Rennes
1, INSERM, UMR-991, 65033 Rennes Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pauline Berthier</span> - <span class="hlFld-Affiliation affiliation">Faculté
de Médecine, Centre Hospitalier Universitaire
(CHU) Tours,  INSERM U1069, 10 Boulevard Tonnellé, 37032 Tours Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascale Rio</span> - <span class="hlFld-Affiliation affiliation">Faculté
de Médecine, Centre Hospitalier Universitaire
(CHU) Tours,  INSERM U1069, 10 Boulevard Tonnellé, 37032 Tours Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marie-Lise Jourdan</span> - <span class="hlFld-Affiliation affiliation">Faculté
de Médecine, Centre Hospitalier Universitaire
(CHU) Tours,  INSERM U1069, 10 Boulevard Tonnellé, 37032 Tours Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hélène Bénédetti</span> - <span class="hlFld-Affiliation affiliation">Centre
de Biophysique Moléculaire, CNRS Orléans, Rue Charles Sadron, 45071 Orléans, France</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1636e5857-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76017" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76017" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Ligue contre le Cancer (Comités des Deux Sèvres, du Finistère, de l’Ille et Vilaine, du Loir-et-Cher, de Loire Atlantique, du Loiret, de la Vienne), the Cancéropôle Grand Ouest, and the Région Centre (CrikMapAkt program) for their financial support. The ICOA synthesis team thanks Dr. A. Chartier and N. Percina for the analytical methods to determine the purity of each compound. We thank Dr. L. Meijer, Dr. S. Ruchaud, Dr. O. Lozach, and Dr. S. Bach (CNRS Roscoff) for CDK, DYRK1A, CK1, and GSK3 kinase evaluations. Additionally, we thank Dr. Le Guével and Dr. M. Ravache from the technical ImPACcell platform support (Biogenouest and Biosit).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i80" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i80"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> Abbreviations Used</h2><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar</p></td></tr><tr><td class="NLM_term">μM</td><td class="NLM_def"><p class="first last">micromolar</p></td></tr><tr><td class="NLM_term">μL</td><td class="NLM_def"><p class="first last">microliter</p></td></tr><tr><td class="NLM_term">vs</td><td class="NLM_def"><p class="first last">versus</p></td></tr><tr><td class="NLM_term">ATR</td><td class="NLM_def"><p class="first last">attenuated total reflection</p></td></tr><tr><td class="NLM_term">mg</td><td class="NLM_def"><p class="first last">milligram</p></td></tr><tr><td class="NLM_term">satd</td><td class="NLM_def"><p class="first last">saturated</p></td></tr><tr><td class="NLM_term">IS</td><td class="NLM_def"><p class="first last">ion spray</p></td></tr><tr><td class="NLM_term">RTKs</td><td class="NLM_def"><p class="first last">several receptor tyrosine kinases</p></td></tr><tr><td class="NLM_term">GPCRs</td><td class="NLM_def"><p class="first last">G-protein-coupled receptors</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">PIP2</td><td class="NLM_def"><p class="first last">phosphatidylinositol 4,5-diphosphate</p></td></tr><tr><td class="NLM_term">PIP3</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3,4,5-triphosphate</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">IRS-1</td><td class="NLM_def"><p class="first last">insulin receptor substrate 1</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">microwave</p></td></tr><tr><td class="NLM_term">Ac<sub>2</sub>O</td><td class="NLM_def"><p class="first last">acetic anhydride</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">rflx</td><td class="NLM_def"><p class="first last">reflux</p></td></tr><tr><td class="NLM_term">MOM</td><td class="NLM_def"><p class="first last">methyl methyl ether</p></td></tr><tr><td class="NLM_term">DYRK</td><td class="NLM_def"><p class="first last">dual-specificity tyrosine-phosphorylation-regulated kinase</p></td></tr><tr><td class="NLM_term">CK</td><td class="NLM_def"><p class="first last">cyclin kinase</p></td></tr><tr><td class="NLM_term">GSK</td><td class="NLM_def"><p class="first last">glycogen synthase kinase</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">The phosphoinositide 3-kinase pathway</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1126%2Fscience.296.5573.1655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=12040186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1655-1657&author=L.+C.+Cantley&title=The+phosphoinositide+3-kinase+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphoinositide 3-kinase pathway</span></div><div class="casAuthors">Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5573</span>),
    <span class="NLM_cas:pages">1655-1657</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 8 refs.  Phosphorylated lipids are produced at cellular membranes during signaling events and contribute to the recruitment and activation of various signaling components.  The role of phosphoinositide 3-kinase (PI3K), which catalyzes the prodn. of phosphatidylinositol 3,4,5-trisphosphate, in cell survival pathways; the regulation of gene expression and cell metab.; and cytoskeletal rearrangements are highlighted.  The PI3K pathway is implicated in human diseases including diabetes and cancer, and understanding the intricacies of this pathway may provide new avenues for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9pxSplxmS1rVg90H21EOLACvtfcHk0lhaGdMs5F23bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D&md5=110c8a351448aed6ab938b9ccf90a655</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1126%2Fscience.296.5573.1655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.296.5573.1655%26sid%3Dliteratum%253Aachs%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520phosphoinositide%25203-kinase%2520pathway%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D1655%26epage%3D1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1038%2Fnrg1879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=16847462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFCnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=606-619&author=J.+A.+Engelmanauthor=J.+Luoauthor=L.+C.+Cantley&title=The+evolution+of+phosphatidylinositol+3-kinases+as+regulators+of+growth+and+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism</span></div><div class="casAuthors">Engelman, Jeffrey A.; Luo, Ji; Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">606-619</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphatidylinositol 3-kinases (PI3Ks) evolved from a single enzyme that regulates vesicle trafficking in unicellular eukaryotes into a family of enzymes that regulate cellular metab. and growth in multicellular organisms.  In this review, we examine how the PI3K pathway has evolved to control these fundamental processes, and how this pathway is in turn regulated by intricate feedback and crosstalk mechanisms.  In light of the recent advances in our understanding of the function of PI3Ks in the pathogenesis of diabetes and cancer, we discuss the exciting therapeutic opportunities for targeting this pathway to treat these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphucxYJIwcQLVg90H21EOLACvtfcHk0lhaGdMs5F23bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFCnu7Y%253D&md5=cd9eb85158710db6b33336af4e0a8cfe</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnrg1879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg1879%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520evolution%2520of%2520phosphatidylinositol%25203-kinases%2520as%2520regulators%2520of%2520growth%2520and%2520metabolism%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2006%26volume%3D7%26spage%3D606%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Meier, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radding, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingaraj, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. C.</span><span> </span><span class="NLM_article-title">Cloning, expression, purification, and characterization of the human class Ia phosphoinositide 3-kinase isoforms</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.pep.2003.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=15135396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsl2msrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2004&pages=218-224&author=T.+I.+Meierauthor=J.+A.+Cookauthor=J.+E.+Thomasauthor=J.+A.+Raddingauthor=C.+Hornauthor=T.+Lingarajauthor=M.+C.+Smith&title=Cloning%2C+expression%2C+purification%2C+and+characterization+of+the+human+class+Ia+phosphoinositide+3-kinase+isoforms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms</span></div><div class="casAuthors">Meier, Timothy I.; Cook, James A.; Thomas, James E.; Radding, Jeffrey A.; Horn, Candice; Lingaraj, Trupti; Smith, Michele C.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">218-224</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The Class I phosphoinositide 3-kinases (PI3Ks) are lipid kinases that phosphorylate the 3-hydroxyl group of the inositol ring of phosphatidylinositides.  Although closely related, exptl. evidence suggests that the four Class I PI3Ks may be functionally distinct.  To further study their unique biochem. properties, the three human Class Ia PI3K (α, β, and δ) p110 catalytic domains were cloned and co-expressed with the p85α regulatory domain in Sf9 cells.  None of the p110 subunits were successfully expressed in the absence of p85α.  Successful expression and purifn. of each p85α/p110 protein required using an excess of the p110 vector over the p85 vector during co-infection of Sf9 cells.  Proteins were purified as the p85α/p110 complex by nickel affinity chromatog. through an N-terminal His-tag on the p110 subunit using an imidazole gradient.  The purifn. yields were high using the optimized ratio of p85/p110 vector and small culture vols., with 24 mg/L cell culture media for p85α/p110α, 17.5 mg/L for p85α/p110δ, and 3.5 mg/L for p85α/p110β.  The identity of each purified isoform was confirmed by mass spectral anal. and immunoblotting.  The activities of the three p85α/p110 proteins and the Class Ib p110γ catalytic domain were investigated using phosphatidylinositol 4,5-bisphosphate (PIP2) as the substrate in a PIP2/phosphatidylserine (PS) liposome.  All four enzymes exhibited reaction velocities that were dependent on the surface concn. of PIP2.  The surface concns. that gave maximal activity for each human isoform with 0.5 mM PIP2 were 2.5 mol% PIP2 for p110γ, 7.5 mol% for p85α/p110β, and 10 mol% PIP2 for p85α/p110α and p85α/p110δ.  The specific activity of p85α/p110α was three to five times higher than that of the other human isoforms.  These kinetic differences may contribute to the unique roles of these isoforms in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8gaKRYiaAH7Vg90H21EOLACvtfcHk0lhaGdMs5F23bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsl2msrs%253D&md5=167564a41fdf98822b5bb2ee854d8421</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2003.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2003.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DMeier%26aufirst%3DT.%2BI.%26aulast%3DCook%26aufirst%3DJ.%2BA.%26aulast%3DThomas%26aufirst%3DJ.%2BE.%26aulast%3DRadding%26aufirst%3DJ.%2BA.%26aulast%3DHorn%26aufirst%3DC.%26aulast%3DLingaraj%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DM.%2BC.%26atitle%3DCloning%252C%2520expression%252C%2520purification%252C%2520and%2520characterization%2520of%2520the%2520human%2520class%2520Ia%2520phosphoinositide%25203-kinase%2520isoforms%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2004%26volume%3D35%26spage%3D218%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Ali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rückle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span> </span><span class="NLM_article-title">Isoform-specific functions of phosphoinositide 3-kinases: p110δ but not p110γ promotes optimal allergic responses in vivo</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">2538</span><span class="NLM_x">–</span> <span class="NLM_lpage">2544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=2538-2544&author=K.+Aliauthor=M.+Campsauthor=W.+P.+Pearceauthor=H.+Jiauthor=T.+R%C3%BCckleauthor=N.+Kuehnauthor=C.+Pasqualiauthor=C.+Chabertauthor=C.+Rommelauthor=B.+Vanhaesebroeck&title=Isoform-specific+functions+of+phosphoinositide+3-kinases%3A+p110%CE%B4+but+not+p110%CE%B3+promotes+optimal+allergic+responses+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DK.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DPearce%26aufirst%3DW.%2BP.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DKuehn%26aufirst%3DN.%26aulast%3DPasquali%26aufirst%3DC.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26atitle%3DIsoform-specific%2520functions%2520of%2520phosphoinositide%25203-kinases%253A%2520p110%25CE%25B4%2520but%2520not%2520p110%25CE%25B3%2520promotes%2520optimal%2520allergic%2520responses%2520in%2520vivo%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D2538%26epage%3D2544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilancio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilfillan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkaczyk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giddings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskett, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okkenhaug, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span> </span><span class="NLM_article-title">Essential role for the p110δ phosphoinositide 3-kinase in the allergic response</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">431</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1011</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=2004&pages=1007-1011&author=K.+Aliauthor=A.+Bilancioauthor=M.+Thomasauthor=W.+Pearceauthor=A.+M.+Gilfillanauthor=C.+Tkaczykauthor=N.+Kuehnauthor=A.+Grayauthor=J.+Giddingsauthor=E.+Peskettauthor=R.+Foxauthor=I.+Bruceauthor=C.+Walkerauthor=C.+Sawyerauthor=K.+Okkenhaugauthor=P.+Finanauthor=B.+Vanhaesebroeck&title=Essential+role+for+the+p110%CE%B4+phosphoinositide+3-kinase+in+the+allergic+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DK.%26aulast%3DBilancio%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DPearce%26aufirst%3DW.%26aulast%3DGilfillan%26aufirst%3DA.%2BM.%26aulast%3DTkaczyk%26aufirst%3DC.%26aulast%3DKuehn%26aufirst%3DN.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DGiddings%26aufirst%3DJ.%26aulast%3DPeskett%26aufirst%3DE.%26aulast%3DFox%26aufirst%3DR.%26aulast%3DBruce%26aufirst%3DI.%26aulast%3DWalker%26aufirst%3DC.%26aulast%3DSawyer%26aufirst%3DC.%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26atitle%3DEssential%2520role%2520for%2520the%2520p110%25CE%25B4%2520phosphoinositide%25203-kinase%2520in%2520the%2520allergic%2520response%26jtitle%3DNature%26date%3D2004%26volume%3D431%26spage%3D1007%26epage%3D1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenwaelder, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goncalves, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesbitt, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dopheide, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturgeon, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabaharan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniele, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saylik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughan, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, H. H.</span><span> </span><span class="NLM_article-title">PI3-kinase p110β: a new target for antithrombotic therapy</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1038%2Fnm1232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=15834429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=507-514&author=S.+P.+Jacksonauthor=S.+M.+Schoenwaelderauthor=I.+Goncalvesauthor=W.+S.+Nesbittauthor=C.+L.+Yapauthor=C.+E.+Wrightauthor=V.+Kencheauthor=K.+E.+Andersonauthor=S.+M.+Dopheideauthor=Y.+Yuanauthor=S.+A.+Sturgeonauthor=H.+Prabaharanauthor=P.+E.+Thompsonauthor=G.+D.+Smithauthor=P.+R.+Shepherdauthor=N.+Danieleauthor=S.+Kulkarniauthor=B.+Abbottauthor=D.+Saylikauthor=C.+Jonesauthor=L.+Luauthor=S.+Giulianoauthor=S.+C.+Hughanauthor=J.+A.+Angusauthor=A.+D.+Robertsonauthor=H.+H.+Salem&title=PI3-kinase+p110%CE%B2%3A+a+new+target+for+antithrombotic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PI 3-kinase p110β: a new target for antithrombotic therapy</span></div><div class="casAuthors">Jackson, Shaun P.; Schoenwaelder, Simone M.; Goncalves, Isaac; Nesbitt, Warwick S.; Yap, Cindy L.; Wright, Christine E.; Kenche, Vijaya; Anderson, Karen E.; Dopheide, Sacha M.; Yuan, Yuping; Sturgeon, Sharelle A.; Prabaharan, Hishani; Thompson, Philip E.; Smith, Gregg D.; Shepherd, Peter R.; Daniele, Nathalie; Kulkarni, Suhasini; Abbott, Belinda; Saylik, Dilek; Jones, Catherine; Lu, Lucy; Giuliano, Simon; Hughan, Sascha C.; Angus, James A.; Robertson, Alan D.; Salem, Hatem H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-514</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Platelet activation at sites of vascular injury is essential for the arrest of bleeding; however, excessive platelet accumulation at regions of atherosclerotic plaque rupture can result in the development of arterial thrombi, pptg. diseases such as acute myocardial infarction and ischemic stroke.  Rheol. disturbances (high shear stress) have an important role in promoting arterial thrombosis by enhancing the adhesive and signaling function of platelet integrin αIIbβ3 (GPIIb-IIIa).  In this study we have defined a key role for the Type Ia phosphoinositide 3-kinase (PI3K) p110β isoform in regulating the formation and stability of integrin αIIbβ3 adhesion bonds, necessary for shear activation of platelets.  Isoform-selective PI3K p110β inhibitors have been developed which prevent formation of stable integrin αIIbβ3 adhesion contacts, leading to defective platelet thrombus formation.  In vivo, these inhibitors eliminate occlusive thrombus formation but do not prolong bleeding time.  These studies define PI3K p110β as an important new target for antithrombotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYYnYolzsDrrVg90H21EOLACvtfcHk0lhun8C1WNdN3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOlsrk%253D&md5=c8dc7ba1955e86104ae913d39f22674b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnm1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1232%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DSchoenwaelder%26aufirst%3DS.%2BM.%26aulast%3DGoncalves%26aufirst%3DI.%26aulast%3DNesbitt%26aufirst%3DW.%2BS.%26aulast%3DYap%26aufirst%3DC.%2BL.%26aulast%3DWright%26aufirst%3DC.%2BE.%26aulast%3DKenche%26aufirst%3DV.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DDopheide%26aufirst%3DS.%2BM.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DSturgeon%26aufirst%3DS.%2BA.%26aulast%3DPrabaharan%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DSmith%26aufirst%3DG.%2BD.%26aulast%3DShepherd%26aufirst%3DP.%2BR.%26aulast%3DDaniele%26aufirst%3DN.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DAbbott%26aufirst%3DB.%26aulast%3DSaylik%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DGiuliano%26aufirst%3DS.%26aulast%3DHughan%26aufirst%3DS.%2BC.%26aulast%3DAngus%26aufirst%3DJ.%2BA.%26aulast%3DRobertson%26aufirst%3DA.%2BD.%26aulast%3DSalem%26aufirst%3DH.%2BH.%26atitle%3DPI3-kinase%2520p110%25CE%25B2%253A%2520a%2520new%2520target%2520for%2520antithrombotic%2520therapy%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D507%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katanaev, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garlanda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzolino, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silengo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sozzani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantovani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altruda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span> </span><span class="NLM_article-title">Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=1049-1053&author=E.+Hirschauthor=V.+L.+Katanaevauthor=C.+Garlandaauthor=O.+Azzolinoauthor=L.+Pirolaauthor=L.+Silengoauthor=S.+Sozzaniauthor=A.+Mantovaniauthor=F.+Altrudaauthor=M.+P.+Wymann&title=Central+role+for+G+protein-coupled+phosphoinositide+3-kinase+%CE%B3+in+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DKatanaev%26aufirst%3DV.%2BL.%26aulast%3DGarlanda%26aufirst%3DC.%26aulast%3DAzzolino%26aufirst%3DO.%26aulast%3DPirola%26aufirst%3DL.%26aulast%3DSilengo%26aufirst%3DL.%26aulast%3DSozzani%26aufirst%3DS.%26aulast%3DMantovani%26aufirst%3DA.%26aulast%3DAltruda%26aufirst%3DF.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DCentral%2520role%2520for%2520G%2520protein-coupled%2520phosphoinositide%25203-kinase%2520%25CE%25B3%2520in%2520inflammation%26jtitle%3DScience%26date%3D2000%26volume%3D287%26spage%3D1049%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Campbell, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choong, D. Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciavarella, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooi, C. S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristiano, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, W. A.</span><span> </span><span class="NLM_article-title">Mutation of the PIK3CA gene in ovarian and breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">7678</span><span class="NLM_x">–</span> <span class="NLM_lpage">7681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7678-7681&author=I.+G.+Campbellauthor=S.+E.+Russellauthor=D.+Y.+H.+Choongauthor=K.+G.+Montgomeryauthor=M.+L.+Ciavarellaauthor=C.+S.+F.+Hooiauthor=B.+E.+Cristianoauthor=R.+B.+Pearsonauthor=W.+A.+Phillips&title=Mutation+of+the+PIK3CA+gene+in+ovarian+and+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DI.%2BG.%26aulast%3DRussell%26aufirst%3DS.%2BE.%26aulast%3DChoong%26aufirst%3DD.%2BY.%2BH.%26aulast%3DMontgomery%26aufirst%3DK.%2BG.%26aulast%3DCiavarella%26aufirst%3DM.%2BL.%26aulast%3DHooi%26aufirst%3DC.%2BS.%2BF.%26aulast%3DCristiano%26aufirst%3DB.%2BE.%26aulast%3DPearson%26aufirst%3DR.%2BB.%26aulast%3DPhillips%26aufirst%3DW.%2BA.%26atitle%3DMutation%2520of%2520the%2520PIK3CA%2520gene%2520in%2520ovarian%2520and%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7678%26epage%3D7681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P. K.</span><span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=802-807&author=S.+Kangauthor=A.+G.+Baderauthor=P.+K.+Vogt&title=Phosphatidylinositol+3-kinase+mutations+identified+in+human+cancer+are+oncogenic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DS.%26aulast%3DBader%26aufirst%3DA.%2BG.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DPhosphatidylinositol%25203-kinase%2520mutations%2520identified%2520in%2520human%2520cancer%2520are%2520oncogenic%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D802%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">High frequency of mutations of the PIK3CA gene in human cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1126%2Fscience.1096502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=15016963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=554&author=Y.+Samuelsauthor=Z.+Wangauthor=A.+Bardelliauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=H.+Yanauthor=A.+Gazdarauthor=S.+M.+Powellauthor=G.+J.+Rigginsauthor=J.+K.+V.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=High+frequency+of+mutations+of+the+PIK3CA+gene+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Brevia: High frequency of mutations of the PIK3Ca gene in human cancers</span></div><div class="casAuthors">Samuels, Yardena; Wang, Zhenghe; Bardelli, Alberto; Silliman, Natalie; Ptak, Janine; Szabo, Steve; Yan, Hai; Gazdar, Adi; Powell, Steven M.; Riggins, Gregory J.; Willson, James K. V.; Markowitz, Sanford; Kinzler, Kenneth W.; Vogelstein, Bert; Velculescu, Victor E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5670</span>),
    <span class="NLM_cas:pages">554</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr74Tv7Oo80NbVg90H21EOLACvtfcHk0lgPgLXYzaJ9JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVGmsbk%253D&md5=be8d63bf0c909971c3b7a5f475ce8fab</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1096502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1096502%26sid%3Dliteratum%253Aachs%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DS.%2BM.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%2BV.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DHigh%2520frequency%2520of%2520mutations%2520of%2520the%2520PIK3CA%2520gene%2520in%2520human%2520cancers%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Yuan, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">PI3K pathway alterations in cancer: variations on a theme</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5497</span><span class="NLM_x">–</span> <span class="NLM_lpage">5510</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5497-5510&author=T.+L.+Yuanauthor=L.+C.+Cantley&title=PI3K+pathway+alterations+in+cancer%3A+variations+on+a+theme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DT.%2BL.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DPI3K%2520pathway%2520alterations%2520in%2520cancer%253A%2520variations%2520on%2520a%2520theme%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5497%26epage%3D5510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Manning, B. D.</span><span> </span><span class="NLM_article-title">Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2004&pages=399-403&author=B.+D.+Manning&title=Balancing+Akt+with+S6K%3A+implications+for+both+metabolic+diseases+and+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26atitle%3DBalancing%2520Akt%2520with%2520S6K%253A%2520implications%2520for%2520both%2520metabolic%2520diseases%2520and%2520tumorigenesis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2004%26volume%3D167%26spage%3D399%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span> </span><span class="NLM_article-title">Targeting the phosphoinositide 3-kinase pathway in cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=19644473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-644&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Targeting+the+phosphoinositide+3-kinase+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0liR_QDepkY7Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520phosphoinositide%25203-kinase%2520pathway%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D627%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Jiang, B.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.-Z.</span><span> </span><span class="NLM_article-title">Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.drup.2008.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=18440854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlGhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=63-76&author=B.-H.+Jiangauthor=L.-Z.+Liu&title=Role+of+mTOR+in+anticancer+drug+resistance%3A+perspectives+for+improved+drug+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment</span></div><div class="casAuthors">Jiang, Bing-Hua; Liu, Ling-Zhi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">63-76</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR) pathway plays a central role in regulating protein synthesis, ribosomal protein translation, and cap-dependent translation.  Deregulations in mTOR signaling are frequently assocd. with tumorigenesis, angiogenesis, tumor growth and metastasis.  This review highlights the role of the mTOR in anticancer drug resistance.  We discuss the network of signaling pathways in which the mTOR kinase is involved, including the structure and activation of the mTOR complex and the pathways upstream and downstream of mTOR as well as other mol. interactions of mTOR.  Major upstream signaling components in control of mTOR activity are PI3K/PTEN/AKT and Ras/Raf/MEK/ERK pathways.  We discuss the central role of mTOR in mediating the translation of mRNAs of proteins related to cell cycle progression, those involved in cell survival such as c-myc, hypoxia inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF), cyclin A, cyclin dependent kinases (cdk1/2), cdk inhibitors (p21Cip1 and p27Kip1), retinoblastoma (Rb) protein, and RNA polymerases I and III.  We then discuss the potential therapeutic opportunities for using mTOR inhibitors rapamycin, CCI-779, RAD001, and AP-23573 in cancer therapy as single agents or in combinations to reverse drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLkKe2ZBODqrVg90H21EOLACvtfcHk0liR_QDepkY7Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlGhsL8%253D&md5=091e8e0620e6ae0a909138b6bf87d4dd</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2008.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2008.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DB.-H.%26aulast%3DLiu%26aufirst%3DL.-Z.%26atitle%3DRole%2520of%2520mTOR%2520in%2520anticancer%2520drug%2520resistance%253A%2520perspectives%2520for%2520improved%2520drug%2520treatment%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2008%26volume%3D11%26spage%3D63%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chalhoub, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span> </span><span class="NLM_article-title">PTEN and the PI3-kinase pathway in cancer</span> <span class="citation_source-journal">Annu. Rev. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1146%2Fannurev.pathol.4.110807.092311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=18767981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1aiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=127-150&author=N.+Chalhoubauthor=S.+J.+Baker&title=PTEN+and+the+PI3-kinase+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN and the PI3-kinase pathway in cancer</span></div><div class="casAuthors">Chalhoub, Nader; Baker, Suzanne J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-150</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  PI3-kinase and PTEN are major pos. and neg. regulators, resp., of the PI3-kinase pathway, which regulates growth, survival, and proliferation.  These key signaling components are two of the most frequently mutated proteins in human cancers, resulting in unregulated activation of PI3K signaling and providing irrefutable genetic evidence of the central role of this pathway in tumorigenesis.  PTEN regulates PI3K signaling by dephosphorylating the lipid signaling intermediate PIP3, but PTEN may have addnl. phosphatase-independent activities, as well as other functions in the nucleus.  In this review, we highlight current work showing cancer-relevant complexities in the regulation of PTEN and PI3K activity, potential novel functions for PTEN, and feedback regulation within the pathway.  The significance and complexity of PI3K signaling make it an important but challenging therapeutic target for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYL7OEFJS0L7Vg90H21EOLACvtfcHk0liR_QDepkY7Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1aiu78%253D&md5=3a85209dd4803ce16557d4cdafc51613</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pathol.4.110807.092311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pathol.4.110807.092311%26sid%3Dliteratum%253Aachs%26aulast%3DChalhoub%26aufirst%3DN.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26atitle%3DPTEN%2520and%2520the%2520PI3-kinase%2520pathway%2520in%2520cancer%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%26date%3D2009%26volume%3D4%26spage%3D127%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">O’Reilly, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Q.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1500</span><span class="NLM_x">–</span> <span class="NLM_lpage">1508</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1500-1508&author=K.+E.+O%E2%80%99Reillyauthor=F.+Rojoauthor=Q.-B.+Sheauthor=D.+Solitauthor=G.+B.+Millsauthor=D.+Smithauthor=H.+Laneauthor=F.+Hofmannauthor=D.+J.+Hicklinauthor=D.+L.+Ludwigauthor=J.+Baselgaauthor=N.+Rosen&title=mTOR+inhibition+induces+upstream+receptor+tyrosine+kinase+signaling+and+activates+Akt"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DK.%2BE.%26aulast%3DRojo%26aufirst%3DF.%26aulast%3DShe%26aufirst%3DQ.-B.%26aulast%3DSolit%26aufirst%3DD.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DLane%26aufirst%3DH.%26aulast%3DHofmann%26aufirst%3DF.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DLudwig%26aufirst%3DD.%2BL.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DmTOR%2520inhibition%2520induces%2520upstream%2520receptor%2520tyrosine%2520kinase%2520signaling%2520and%2520activates%2520Akt%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D1500%26epage%3D1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Peng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5575</span><span class="NLM_x">–</span> <span class="NLM_lpage">5584</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1128%2FMCB.22.15.5575-5584.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=12101249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlGnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=5575-5584&author=T.+Pengauthor=T.+R.+Golubauthor=D.+M.+Sabatini&title=The+immunosuppressant+rapamycin+mimics+a+starvation-like+signal+distinct+from+amino+acid+and+glucose+deprivation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation</span></div><div class="casAuthors">Peng, Tao; Golub, Todd R.; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5575-5584</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">RAFT1/FRAP/mTOR is a key regulator of cell growth and division and the mammalian target of rapamycin, an immunosuppressive and anticancer drug.  Rapamycin deprivation and nutrient deprivation have similar effects on the activity of S6 kinase 1 (S6K1) and 4E-BP1, two downstream effectors of RAFT1, but the relationship between nutrient- and rapamycin-sensitive pathways is unknown.  Using transcriptional profiling, we show that, in human BJAB B-lymphoma cells and murine CTLL-2 T lymphocytes, rapamycin treatment affects the expression of many genes involved in nutrient and protein metab.  The rapamycin-induced transcriptional profile is distinct from those induced by glucose, glutamine, or leucine deprivation but is most similar to that induced by amino acid deprivation.  In particular, rapamycin treatment and amino acid deprivation up-regulate genes involved in nutrient catabolism and energy prodn. and down-regulate genes participating in lipid and nucleotide synthesis and in protein synthesis, turnover, and folding.  Surprisingly, however, rapamycin had effects opposite from those of amino acid starvation on the expression of a large group of genes involved in the synthesis, transport, and use of amino acids.  Supported by measurements of nutrient use, the data suggest that RAFT1 is an energy and nutrient sensor and that rapamycin mimics a signal generated by the starvation of amino acids but that the signal is unlikely to be the absence of amino acids themselves.  These observations underscore the importance of metab. in controlling lymphocyte proliferation and offer a novel explanation for immunosuppression by rapamycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6e8qWqNJ4-7Vg90H21EOLACvtfcHk0ljIza6plaWD1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlGnt7g%253D&md5=e6efd63b037090ed2273e071d6ed01cd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.15.5575-5584.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.15.5575-5584.2002%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DT.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DThe%2520immunosuppressant%2520rapamycin%2520mimics%2520a%2520starvation-like%2520signal%2520distinct%2520from%2520amino%2520acid%2520and%2520glucose%2520deprivation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26spage%3D5575%26epage%3D5584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Shaw, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">Ras, PI3K and mTOR signalling controls tumour cell growth</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2006&pages=424-430&author=R.+J.+Shawauthor=L.+C.+Cantley&title=Ras%2C+PI3K+and+mTOR+signalling+controls+tumour+cell+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DR.%2BJ.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DRas%252C%2520PI3K%2520and%2520mTOR%2520signalling%2520controls%2520tumour%2520cell%2520growth%26jtitle%3DNature%26date%3D2006%26volume%3D441%26spage%3D424%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Cleary, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer</span> <span class="citation_source-journal">Curr. Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1007%2Fs11912-010-0091-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=20425592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Cjsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=87-94&author=J.+M.+Clearyauthor=G.+I.+Shapiro&title=Development+of+phosphoinositide-3+kinase+pathway+inhibitors+for+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer</span></div><div class="casAuthors">Cleary, James M.; Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Oncology Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-94</span>CODEN:
                <span class="NLM_cas:coden">CORUAT</span>;
        ISSN:<span class="NLM_cas:issn">1534-6269</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide-3 kinase (PI3K) pathway plays a crit. role in cancer cell growth and survival.  PI3K is activated in human cancers by elevated receptor tyrosine kinase activity, RAS mutation, as well as by mutation, amplification, and deletion of genes encoding components of the pathway.  Addnl., PI3K pathway activation plays an important role in acquired resistance to both chemotherapy and targeted agents.  The essential role of PI3K in human cancer has led to the development of PI3K pathway inhibitors that have shown promise in preclin. models and have entered phase I clin. trials.  This article reviews preclin. and clin. data on members of this novel drug class, as well as data justifying the combination of PI3K inhibitors with other anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon-44aT68pebVg90H21EOLACvtfcHk0lgzmScy1ZHk-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Cjsb%252FN&md5=647bf5a5f1d7b05a3ce4d6361913fb19</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs11912-010-0091-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11912-010-0091-6%26sid%3Dliteratum%253Aachs%26aulast%3DCleary%26aufirst%3DJ.%2BM.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DDevelopment%2520of%2520phosphoinositide-3%2520kinase%2520pathway%2520inhibitors%2520for%2520advanced%2520cancer%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2010%26volume%3D12%26spage%3D87%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span> </span><span class="NLM_article-title">Drug discovery approaches targeting the PI3K/Akt pathway in cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5511</span><span class="NLM_x">–</span> <span class="NLM_lpage">5526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5511-5526&author=C.+Garcia-Echeverriaauthor=W.+R.+Sellers&title=Drug+discovery+approaches+targeting+the+PI3K%2FAkt+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26atitle%3DDrug%2520discovery%2520approaches%2520targeting%2520the%2520PI3K%252FAkt%2520pathway%2520in%2520cancer%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5511%26epage%3D5526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mahadevan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiorean, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Hoff, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stejskal-Barnett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younger, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rensvold, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordova, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garlich, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durden, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, R. K.</span><span> </span><span class="NLM_article-title">Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3319</span><span class="NLM_x">–</span> <span class="NLM_lpage">3327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=3319-3327&author=D.+Mahadevanauthor=E.+G.+Chioreanauthor=W.+B.+Harrisauthor=D.+D.+Von+Hoffauthor=A.+Stejskal-Barnettauthor=W.+Qiauthor=S.+P.+Anthonyauthor=A.+E.+Youngerauthor=D.+M.+Rensvoldauthor=F.+Cordovaauthor=C.+F.+Sheltonauthor=M.+D.+Beckerauthor=J.+R.+Garlichauthor=D.+L.+Durdenauthor=R.+K.+Ramanathan&title=Phase+I+pharmacokinetic+and+pharmacodynamic+study+of+the+pan-PI3K%2FmTORC+vascular+targeted+pro-drug+SF1126+in+patients+with+advanced+solid+tumours+and+B-cell+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahadevan%26aufirst%3DD.%26aulast%3DChiorean%26aufirst%3DE.%2BG.%26aulast%3DHarris%26aufirst%3DW.%2BB.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DStejskal-Barnett%26aufirst%3DA.%26aulast%3DQi%26aufirst%3DW.%26aulast%3DAnthony%26aufirst%3DS.%2BP.%26aulast%3DYounger%26aufirst%3DA.%2BE.%26aulast%3DRensvold%26aufirst%3DD.%2BM.%26aulast%3DCordova%26aufirst%3DF.%26aulast%3DShelton%26aufirst%3DC.%2BF.%26aulast%3DBecker%26aufirst%3DM.%2BD.%26aulast%3DGarlich%26aufirst%3DJ.%2BR.%26aulast%3DDurden%26aufirst%3DD.%2BL.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26atitle%3DPhase%2520I%2520pharmacokinetic%2520and%2520pharmacodynamic%2520study%2520of%2520the%2520pan-PI3K%252FmTORC%2520vascular%2520targeted%2520pro-drug%2520SF1126%2520in%2520patients%2520with%2520advanced%2520solid%2520tumours%2520and%2520B-cell%2520malignancies%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2012%26volume%3D48%26spage%3D3319%26epage%3D3327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chang, K.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, B.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.-Y.</span><span> </span><span class="NLM_article-title">Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7116</span><span class="NLM_x">–</span> <span class="NLM_lpage">7126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1158%2F1078-0432.CCR-11-0796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=21976531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKht7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=7116-7126&author=K.-Y.+Changauthor=S.-Y.+Tsaiauthor=C.-M.+Wuauthor=C.-J.+Yenauthor=B.-F.+Chuangauthor=J.-Y.+Chang&title=Novel+phosphoinositide+3-kinase%2FmTOR+dual+inhibitor%2C+NVP-BGT226%2C+displays+potent+growth-inhibitory+activity+against+human+head+and+neck+cancer+cells+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Phosphoinositide 3-Kinase/mTOR Dual Inhibitor, NVP-BGT226, Displays Potent Growth-Inhibitory Activity against Human Head and Neck Cancer Cells In Vitro and In Vivo</span></div><div class="casAuthors">Chang, Kwang-Yu; Tsai, Shan-Yin; Wu, Ching-Ming; Yen, Chia-Jui; Chuang, Bin-Fay; Chang, Jang-Yang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7116-7126</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Dysregulation of the phosphoinositide 3-kinase (PI3K)/AKT/mTOR signaling pathway frequently accounts for the tumorigenesis in head and neck cancer.  To develop a new treatment, we investigated the effect of a novel dual PI3K/mTOR inhibitor, NVP-BGT226 (BGT226), in head and neck cancer cells.  Exptl. Design: The in vitro antitumor effect of BGT226 was detd. in various cancer cell lines.  Animal models were also applied to examine drug potency.  The inhibitory ability of BGT226 on the PI3K/AKT/mTOR signaling pathway was analyzed.  RESULTS: The growth inhibition assay revealed that BGT226 was active against all tested cancer cell lines.  Cross-resistance was not obsd. in the cisplatin-resistant cell line.  The activation of the AKT/mTOR signal cascade was suppressed by BGT226 in a concn.- and time-dependent manner.  Flow cytometric anal. revealed an accumulation of cells in the G0-G1 phase with concomitant loss in the S-phase.  Results of the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay and the anal. of caspase 3/7 and PARP indicated that BGT226 induced cancer cell death through an apoptosis-independent pathway.  BGT226 induced autophagy as indicated by the aggregation and upregulation of the microtubule-assocd. protein light chain 3B-II, and p62 degrdn.  Gene silencing of Beclin1 or cotreatment of the autophagosome inhibitor, 3-methyladenine, inhibited the BGT226-induced autophagy and led to the retrieval of colony survival.  In a xenografted animal model, BGT226 significantly delayed tumor growth in a dose-dependent manner, along with suppressed cytoplasmic expression of p-p70 S6 kinase and the presence of autophagosome formation.  CONCLUSIONS: These data indicate that BGT226 is a potential drug in the treatment of head and neck cancer.  Clin Cancer Res; 17(22); 7116-26.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCgjQvdZ3pn7Vg90H21EOLACvtfcHk0liGyhw2-42gkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKht7nP&md5=20163ec3099aa3c33eac1eed54a3e1b1</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-0796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-0796%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DK.-Y.%26aulast%3DTsai%26aufirst%3DS.-Y.%26aulast%3DWu%26aufirst%3DC.-M.%26aulast%3DYen%26aufirst%3DC.-J.%26aulast%3DChuang%26aufirst%3DB.-F.%26aulast%3DChang%26aufirst%3DJ.-Y.%26atitle%3DNovel%2520phosphoinositide%25203-kinase%252FmTOR%2520dual%2520inhibitor%252C%2520NVP-BGT226%252C%2520displays%2520potent%2520growth-inhibitory%2520activity%2520against%2520human%2520head%2520and%2520neck%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D7116%26epage%3D7126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cleary, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer</span> <span class="citation_source-journal">Curr. Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1007%2Fs11912-010-0091-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=20425592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Cjsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=87-94&author=J.+M.+Clearyauthor=G.+I.+Shapiro&title=Development+of+phosphoinositide-3+kinase+pathway+inhibitors+for+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer</span></div><div class="casAuthors">Cleary, James M.; Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Oncology Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-94</span>CODEN:
                <span class="NLM_cas:coden">CORUAT</span>;
        ISSN:<span class="NLM_cas:issn">1534-6269</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide-3 kinase (PI3K) pathway plays a crit. role in cancer cell growth and survival.  PI3K is activated in human cancers by elevated receptor tyrosine kinase activity, RAS mutation, as well as by mutation, amplification, and deletion of genes encoding components of the pathway.  Addnl., PI3K pathway activation plays an important role in acquired resistance to both chemotherapy and targeted agents.  The essential role of PI3K in human cancer has led to the development of PI3K pathway inhibitors that have shown promise in preclin. models and have entered phase I clin. trials.  This article reviews preclin. and clin. data on members of this novel drug class, as well as data justifying the combination of PI3K inhibitors with other anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon-44aT68pebVg90H21EOLACvtfcHk0liGyhw2-42gkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Cjsb%252FN&md5=647bf5a5f1d7b05a3ce4d6361913fb19</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1007%2Fs11912-010-0091-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11912-010-0091-6%26sid%3Dliteratum%253Aachs%26aulast%3DCleary%26aufirst%3DJ.%2BM.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DDevelopment%2520of%2520phosphoinositide-3%2520kinase%2520pathway%2520inhibitors%2520for%2520advanced%2520cancer%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2010%26volume%3D12%26spage%3D87%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ihle, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span> </span><span class="NLM_article-title">Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1158%2F1535-7163.MCT-08-0801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=19139107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFSntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1-9&author=N.+T.+Ihleauthor=G.+Powis&title=Take+your+PIK%3A+phosphatidylinositol+3-kinase+inhibitors+race+through+the+clinic+and+toward+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19dR"><div class="casContent"><span class="casTitleNuber">19d</span><div class="casTitle"><span class="NLM_cas:atitle">Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy</span></div><div class="casAuthors">Ihle, Nathan T.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is currently one of the most exciting drug targets in oncol.  However, only a short time ago, the paradigm existed that drugs targeted to the four PI3K class I isoforms would be too toxic for use in cancer therapy due to effects on physiol. signaling.  Since that time, studies have delineated the roles of these four isoforms in nonpathol. signaling as well as their roles in cancer.  An extensive effort has gone into developing agents that inhibit one or more PI3K isoforms, as well as closely related proteins implicated in cancer.  These agents have proved to be tolerable and therapeutically beneficial in animal studies, and a no. are in clin. testing.  The agents, their properties, and their mol. targets are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtwozBC-h437Vg90H21EOLACvtfcHk0lg2gE-m7Bb_Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFSntA%253D%253D&md5=4bc339da7fdd1dc74e13eadf76ae53ce</span></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0801%26sid%3Dliteratum%253Aachs%26aulast%3DIhle%26aufirst%3DN.%2BT.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DTake%2520your%2520PIK%253A%2520phosphatidylinositol%25203-kinase%2520inhibitors%2520race%2520through%2520the%2520clinic%2520and%2520toward%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Marone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cmiljanovic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span> </span><span class="NLM_article-title">Targeting phosphoinositide 3-kinase: moving towards therapy</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1784</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1784&publication_year=2008&pages=159-185&author=R.+Maroneauthor=V.+Cmiljanovicauthor=B.+Gieseauthor=M.+P.+Wymann&title=Targeting+phosphoinositide+3-kinase%3A+moving+towards+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarone%26aufirst%3DR.%26aulast%3DCmiljanovic%26aufirst%3DV.%26aulast%3DGiese%26aufirst%3DB.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DTargeting%2520phosphoinositide%25203-kinase%253A%2520moving%2520towards%2520therapy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1784%26spage%3D159%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Yap, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19f&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.coph.2008.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19f&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=18721898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19f&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=393-412&author=T.+A.+Yapauthor=M.+D.+Garrettauthor=M.+I.+Waltonauthor=F.+Raynaudauthor=J.+S.+De+Bonoauthor=P.+Workman&title=Targeting+the+PI3K-AKT-mTOR+pathway%3A+progress%2C+pitfalls%2C+and+promises"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19fR"><div class="casContent"><span class="casTitleNuber">19f</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises</span></div><div class="casAuthors">Yap, Timothy A.; Garrett, Michelle D.; Walton, Mike I.; Raynaud, Florence; de Bono, Johann S.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">393-412</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The strategy of drugging the cancer kinome' has led to the successful development and regulatory approval of several novel mol. targeted agents.  The spotlight is now shifting to the phosphatidylinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway as a key potential target.  This review details the role of the pathway in oncogenesis and the rationale for inhibiting its vital components.  The focus will be on the progress made in the development of novel therapies for cancer treatment, with emphasis placed on agents that have entered clin. development.  Strategies involving horizontal and vertical blockade of the pathway, as well as the use of biomarkers to select appropriate patients and to provide proof of target modulation will also be highlighted.  Finally, we discuss the issues and limitations involved with targeting the PI3K-AKT-mTOR pathway, and predict what the future may hold for these novel anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmwezNSKUfbVg90H21EOLACvtfcHk0ljqfHPsfYbPbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E&md5=b6a4f3c01a6776977d61cde8222d7201</span></div><a href="/servlet/linkout?suffix=cit19f&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DDe%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520PI3K-AKT-mTOR%2520pathway%253A%2520progress%252C%2520pitfalls%252C%2520and%2520promises%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D393%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Eichhorn, P. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gili, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaltriti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nijkamp, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beijersbergen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seoane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">9221</span><span class="NLM_x">–</span> <span class="NLM_lpage">9230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=9221-9230&author=P.+J.+A.+Eichhornauthor=M.+Giliauthor=M.+Scaltritiauthor=V.+Serraauthor=M.+Guzmanauthor=W.+Nijkampauthor=R.+L.+Beijersbergenauthor=V.+Valeroauthor=J.+Seoaneauthor=R.+Bernardsauthor=J.+Baselga&title=Phosphatidylinositol+3-kinase+hyperactivation+results+in+lapatinib+resistance+that+is+reversed+by+the+mTOR%2Fphosphatidylinositol+3-kinase+inhibitor+NVP-BEZ235"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEichhorn%26aufirst%3DP.%2BJ.%2BA.%26aulast%3DGili%26aufirst%3DM.%26aulast%3DScaltriti%26aufirst%3DM.%26aulast%3DSerra%26aufirst%3DV.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3DNijkamp%26aufirst%3DW.%26aulast%3DBeijersbergen%26aufirst%3DR.%2BL.%26aulast%3DValero%26aufirst%3DV.%26aulast%3DSeoane%26aufirst%3DJ.%26aulast%3DBernards%26aufirst%3DR.%26aulast%3DBaselga%26aufirst%3DJ.%26atitle%3DPhosphatidylinositol%25203-kinase%2520hyperactivation%2520results%2520in%2520lapatinib%2520resistance%2520that%2520is%2520reversed%2520by%2520the%2520mTOR%252Fphosphatidylinositol%25203-kinase%2520inhibitor%2520NVP-BEZ235%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D9221%26epage%3D9230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Maira, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chène, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pover, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Echeverría, C.</span><span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19h&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19h&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19h&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&author=S.-M.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Ch%C3%A8neauthor=A.+D.+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garc%C3%ADa-Echeverr%C3%ADa&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19hR"><div class="casContent"><span class="casTitleNuber">19h</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0lje8uQKMGrrpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit19h&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.-M.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DCh%25C3%25A8ne%26aufirst%3DP.%26aulast%3DPover%26aufirst%3DA.%2BD.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarc%25C3%25ADa-Echeverr%25C3%25ADa%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Howes, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2505</span><span class="NLM_x">–</span> <span class="NLM_lpage">2514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19i&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1158%2F1535-7163.MCT-06-0698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19i&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=17766839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19i&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCgur7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=2505-2514&author=A.+L.+Howesauthor=G.+G.+Chiangauthor=E.+S.+Langauthor=C.+B.+Hoauthor=G.+Powisauthor=K.+Vuoriauthor=R.+T.+Abraham&title=The+phosphatidylinositol+3-kinase+inhibitor%2C+PX-866%2C+is+a+potent+inhibitor+of+cancer+cell+motility+and+growth+in+three-dimensional+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19iR"><div class="casContent"><span class="casTitleNuber">19i</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures</span></div><div class="casAuthors">Howes, Amy L.; Chiang, Gary G.; Lang, Elizabeth S.; Ho, Caroline B.; Powis, Garth; Vuori, Kristiina; Abraham, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2505-2514</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K) pathway is activated in many human tumors and mediates processes such as cell proliferation, survival, adhesion, and motility.  The natural product, wortmannin, has been widely used to study the functional consequences of PI3K inhibition in both normal and transformed cells in culture but is not a suitable cancer chemotherapeutic agent due to stability and toxicity issues.  PX-866, an improved wortmannin analog, displays significant antitumor activity in xenograft models.  Here, we directly compare PX-866 and wortmannin in human cancer cell lines cultured in monolayer or as three-dimensional spheroids.  Both PI3K inhibitors failed to inhibit monolayer cell growth at concns. up to 100 nmol/L but strongly suppressed spheroid growth at low nanomolar concns., with PX-866 showing greater potency than wortmannin.  Relative to wortmannin, PX-866 treatment results in a more sustained loss of Akt phosphorylation, suggesting that the increased potency of PX-866 is related to a more durable inhibition of PI3K signaling.  PX-866 and wortmannin both inhibit spheroid growth without causing cytotoxicity, similar to known cytostatic agents, such as rapamycin.  PX-866 also inhibits cancer cell motility at subnanomolar concns.  These findings suggest that the antitumor activities of PX-866 stem from prolonged inhibition of the PI3K pathway and inhibition of cell motility.  In addn., we propose that the use of three-dimensional tumor models is more predictive of in vivo growth inhibition by PI3K inhibitors in cancer cell lines lacking phosphatase and tensin homolog activity or expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopwYCvvi3YnrVg90H21EOLACvtfcHk0liuHOam07fqhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCgur7E&md5=2e04aade456fc6dca5e6aea10ef198c6</span></div><a href="/servlet/linkout?suffix=cit19i&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0698%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DA.%2BL.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DLang%26aufirst%3DE.%2BS.%26aulast%3DHo%26aufirst%3DC.%2BB.%26aulast%3DPowis%26aufirst%3DG.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DThe%2520phosphatidylinositol%25203-kinase%2520inhibitor%252C%2520PX-866%252C%2520is%2520a%2520potent%2520inhibitor%2520of%2520cancer%2520cell%2520motility%2520and%2520growth%2520in%2520three-dimensional%2520cultures%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D2505%26epage%3D2514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19j"><span><span class="NLM_label">(j) </span> Phase I Trial of Oral PX-866. <a href="http://www.clinicaltrials.gov/ct2/show/NCT00726583?term=PX866&amp;rank=5" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT00726583?term=PX866&rank=5</a> (accessed <span class="NLM_access-date">January 2014</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Phase+I+Trial+of+Oral+PX-866.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT00726583%3Fterm%3DPX866%26rank%3D5+%28accessed+January+2014%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">mTOR mediated anti-cancer drug discovery</span> <span class="citation_source-journal">Drug Discovery Today: Ther. Strategies</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.ddstr.2009.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=20622997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosFGnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=47-55&author=Q.+Liuauthor=C.+Thoreenauthor=J.+Wangauthor=D.+Sabatiniauthor=N.+S.+Gray&title=mTOR+mediated+anti-cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR mediated anti-cancer drug discovery</span></div><div class="casAuthors">Liu, Qingsong; Thoreen, Carson; Wang, Jinhua; Sabatini, David; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Therapeutic Strategies</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">47-55</span>CODEN:
                <span class="NLM_cas:coden">DDTTC6</span>;
        ISSN:<span class="NLM_cas:issn">1740-6773</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine kinase and the founding member of a signaling pathway that regulates many fundamental features of cell growth and division.  In cells, mTOR acts as the catalytic subunit of two functionally distinct complexes, called mTOR Complex 1 (mTORC1) and mTOR Complex 2 (mTORC2).  Together, these complexes coordinate a variety of processes that include protein translation, autophagy, proliferation, survival and metab. in response to nutrient, energy and growth factor signals.  Consistent with its role as a growth-promoting pathway, numerous studies have found that mTOR signaling is hyper-activated in a broad spectrum of human cancers.  In particular, mTORC2 is considered a primary effector of the phosphatidylinositol-3-kinase (PI3K) signaling pathway, which is mutated in a majority of human cancers, in part through its ability to phosphorylate and regulate the proto-oncogene Akt/PKB.  Many biol. functions of mTOR have been pharmacol. explored using the natural product rapamycin, an allosteric inhibitor that has been reviewed extensively elsewhere.  This review will focus specifically on the development of small mol. ATP-competitive inhibitors of mTOR and their prospects as a targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo708zVFEp5VLVg90H21EOLACvtfcHk0liuHOam07fqhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosFGnur8%253D&md5=93364d568c3a23dd0fcf0c3980841e7e</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2Fj.ddstr.2009.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddstr.2009.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DThoreen%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSabatini%26aufirst%3DD.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DmTOR%2520mediated%2520anti-cancer%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Ther.%2520Strategies%26date%3D2009%26volume%3D6%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazif, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aizenstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span> </span><span class="NLM_article-title">Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1038%2Fnchembio.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=18849971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=691-699&author=B.+Apselauthor=J.+A.+Blairauthor=B.+Gonzalezauthor=T.+M.+Nazifauthor=M.+E.+Feldmanauthor=B.+Aizensteinauthor=R.+Hoffmanauthor=R.+L.+Williamsauthor=K.+M.+Shokatauthor=Z.+A.+Knight&title=Targeted+polypharmacology%3A+discovery+of+dual+inhibitors+of+tyrosine+and+phosphoinositide+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases</span></div><div class="casAuthors">Apsel, Beth; Blair, Jimmy A.; Gonzalez, Beatriz; Nazif, Tamim M.; Feldman, Morri E.; Aizenstein, Brian; Hoffman, Randy; Williams, Roger L.; Shokat, Kevan M.; Knight, Zachary A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">691-699</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. success of multitargeted kinase inhibitors has stimulated efforts to identify promiscuous drugs with optimal selectivity profiles.  It remains unclear to what extent such drugs can be rationally designed, particularly for combinations of targets that are structurally divergent.  Here we report the systematic discovery of mols. that potently inhibit both tyrosine kinases and phosphatidylinositol-3-OH kinases, two protein families that are among the most intensely pursued cancer drug targets.  Through iterative chem. synthesis, X-ray crystallog. and kinome-level biochem. profiling, we identified compds. that inhibit a spectrum of new target combinations in these two families.  Crystal structures revealed that the dual selectivity of these mols. is controlled by a hydrophobic pocket conserved in both enzyme classes and accessible through a rotatable bond in the drug skeleton.  We show that compd. I blocks the proliferation of tumor cells by direct inhibition of oncogenic tyrosine kinases and phosphatidylinositol-3-OH kinases.  These mols. demonstrate the feasibility of accessing a chem. space that intersects two families of oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7xlegha5YF7Vg90H21EOLACvtfcHk0lgQNq2inSXtjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7bF&md5=4da10a973f6895f92a644ca82ca5cdcd</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.117%26sid%3Dliteratum%253Aachs%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DBlair%26aufirst%3DJ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DNazif%26aufirst%3DT.%2BM.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DAizenstein%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26atitle%3DTargeted%2520polypharmacology%253A%2520discovery%2520of%2520dual%2520inhibitors%2520of%2520tyrosine%2520and%2520phosphoinositide%2520kinases%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D691%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, K. K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagrodia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greasley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knighton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafidi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span> </span><span class="NLM_article-title">Quinazolines with intra-molecular hydrogen bonding scaffold (iMHBS) as PI3K/mTOR dual inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1270-1274&author=K.+K.+C.+Liuauthor=X.+Huangauthor=S.+Bagrodiaauthor=J.+H.+Chenauthor=S.+Greasleyauthor=H.+Chengauthor=S.+Sunauthor=D.+Knightonauthor=C.+Rodgersauthor=K.+Rafidiauthor=A.+Zouauthor=J.+Xiaoauthor=S.+Yan&title=Quinazolines+with+intra-molecular+hydrogen+bonding+scaffold+%28iMHBS%29+as+PI3K%2FmTOR+dual+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BK.%2BC.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBagrodia%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DKnighton%26aufirst%3DD.%26aulast%3DRodgers%26aufirst%3DC.%26aulast%3DRafidi%26aufirst%3DK.%26aulast%3DZou%26aufirst%3DA.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DS.%26atitle%3DQuinazolines%2520with%2520intra-molecular%2520hydrogen%2520bonding%2520scaffold%2520%2528iMHBS%2529%2520as%2520PI3K%252FmTOR%2520dual%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1270%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, K. K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagrodia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greasley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knighton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninkovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafidi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, C. M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, A.</span><span> </span><span class="NLM_article-title">4-Methylpteridinones as orally active and selective PI3K/mTOR dual inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6096</span><span class="NLM_x">–</span> <span class="NLM_lpage">6099</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6096-6099&author=K.+K.-C.+Liuauthor=S.+Bagrodiaauthor=S.+Baileyauthor=H.+Chengauthor=H.+Chenauthor=L.+Gaoauthor=S.+Greasleyauthor=J.+E.+Hoffmanauthor=Q.+Huauthor=T.+O.+Johnsonauthor=D.+Knightonauthor=Z.+Liuauthor=M.+A.+Marxauthor=M.+D.+Nambuauthor=S.+Ninkovicauthor=B.+Pascualauthor=K.+Rafidiauthor=C.+M.-L.+Rodgersauthor=G.+L.+Smithauthor=S.+Sunauthor=H.+Wangauthor=A.+Yangauthor=J.+Yuanauthor=A.+Zou&title=4-Methylpteridinones+as+orally+active+and+selective+PI3K%2FmTOR+dual+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BK.-C.%26aulast%3DBagrodia%26aufirst%3DS.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DHoffman%26aufirst%3DJ.%2BE.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DKnighton%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMarx%26aufirst%3DM.%2BA.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DPascual%26aufirst%3DB.%26aulast%3DRafidi%26aufirst%3DK.%26aulast%3DRodgers%26aufirst%3DC.%2BM.-L.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DA.%26atitle%3D4-Methylpteridinones%2520as%2520orally%2520active%2520and%2520selective%2520PI3K%252FmTOR%2520dual%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6096%26epage%3D6099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagrodia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knighton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninkovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span> </span><span class="NLM_article-title">Discovery of the highly potent PI3K/mTOR dual inhibitor PF-04691502 through structure based drug design</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=139&author=H.+Chengauthor=S.+Bagrodiaauthor=S.+Baileyauthor=M.+Edwardsauthor=J.+Hoffmanauthor=Q.+Huauthor=R.+Kaniaauthor=D.+R.+Knightonauthor=M.+A.+Marxauthor=S.+Ninkovicauthor=S.+Sunauthor=E.+Zhang&title=Discovery+of+the+highly+potent+PI3K%2FmTOR+dual+inhibitor+PF-04691502+through+structure+based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DBagrodia%26aufirst%3DS.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DKania%26aufirst%3DR.%26aulast%3DKnighton%26aufirst%3DD.%2BR.%26aulast%3DMarx%26aufirst%3DM.%2BA.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520the%2520highly%2520potent%2520PI3K%252FmTOR%2520dual%2520inhibitor%2520PF-04691502%2520through%2520structure%2520based%2520drug%2520design%26jtitle%3DMedChemComm%26date%3D2010%26volume%3D1%26spage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donatelli, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgers, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarpong, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garver, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gontarek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershner, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherk, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegrzyn, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span> </span><span class="NLM_article-title">Discovery of GSK2126458, a highly potent inhibitor of PI3K and the mammalian target of rapamycin</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml900028r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=39-43&author=S.+D.+Knightauthor=N.+D.+Adamsauthor=J.+L.+Burgessauthor=A.+M.+Chaudhariauthor=M.+G.+Darcyauthor=C.+A.+Donatelliauthor=J.+I.+Luengoauthor=K.+A.+Newlanderauthor=C.+A.+Parrishauthor=L.+H.+Ridgersauthor=M.+A.+Sarpongauthor=S.+J.+Schmidtauthor=G.+S.+Van+Allerauthor=J.+D.+Carsonauthor=M.+A.+Diamondauthor=P.+A.+Elkinsauthor=C.+M.+Gardinerauthor=E.+Garverauthor=S.+A.+Gilbertauthor=R.+R.+Gontarekauthor=J.+R.+Jacksonauthor=K.+L.+Kershnerauthor=L.+Luoauthor=K.+Rahaauthor=C.+S.+Sherkauthor=C.-M.+Sungauthor=D.+Suttonauthor=P.+J.+Tumminoauthor=R.+J.+Wegrzynauthor=K.+R.+Augerauthor=D.+Dhanak&title=Discovery+of+GSK2126458%2C+a+highly+potent+inhibitor+of+PI3K+and+the+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span></div><div class="casAuthors">Knight, Steven D.; Adams, Nicholas D.; Burgess, Joelle L.; Chaudhari, Amita M.; Darcy, Michael G.; Donatelli, Carla A.; Luengo, Juan I.; Newlander, Ken A.; Parrish, Cynthia A.; Ridgers, Lance H.; Sarpong, Martha A.; Schmidt, Stanley J.; Van Aller, Glenn S.; Carson, Jeffrey D.; Diamond, Melody A.; Elkins, Patricia A.; Gardiner, Christine M.; Garver, Eric; Gilbert, Seth A.; Gontarek, Richard R.; Jackson, Jeffrey R.; Kershner, Kevin L.; Luo, Lusong; Raha, Kaushik; Sherk, Christian S.; Sung, Chiu-Mei; Sutton, David; Tummino, Peter J.; Wegrzyn, Ronald J.; Auger, Kurt R.; Dhanak, Dashyant</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-43</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase α (PI3Kα) is a crit. regulator of cell growth and transformation, and its signaling pathway is the most commonly mutated pathway in human cancers.  The mammalian target of rapamycin (mTOR), a class IV PI3K protein kinase, is also a central regulator of cell growth, and mTOR inhibitors are believed to augment the antiproliferative efficacy of PI3K/AKT pathway inhibition. 2,4-Difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide (GSK2126458, 1 (I)) has been identified as a highly potent, orally bioavailable inhibitor of PI3Kα and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.  Compd. 1 is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBH6_ywCnjCrVg90H21EOLACvtfcHk0ljezZg7aViE2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D&md5=72fcca85702dba95529ac03281e0bdbc</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fml900028r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900028r%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DChaudhari%26aufirst%3DA.%2BM.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DDonatelli%26aufirst%3DC.%2BA.%26aulast%3DLuengo%26aufirst%3DJ.%2BI.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DParrish%26aufirst%3DC.%2BA.%26aulast%3DRidgers%26aufirst%3DL.%2BH.%26aulast%3DSarpong%26aufirst%3DM.%2BA.%26aulast%3DSchmidt%26aufirst%3DS.%2BJ.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DDiamond%26aufirst%3DM.%2BA.%26aulast%3DElkins%26aufirst%3DP.%2BA.%26aulast%3DGardiner%26aufirst%3DC.%2BM.%26aulast%3DGarver%26aufirst%3DE.%26aulast%3DGilbert%26aufirst%3DS.%2BA.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DKershner%26aufirst%3DK.%2BL.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DRaha%26aufirst%3DK.%26aulast%3DSherk%26aufirst%3DC.%2BS.%26aulast%3DSung%26aufirst%3DC.-M.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DWegrzyn%26aufirst%3DR.%2BJ.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520GSK2126458%252C%2520a%2520highly%2520potent%2520inhibitor%2520of%2520PI3K%2520and%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D39%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wen, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omuro, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nghiemphu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norden, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendreau, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T.</span><span> </span><span class="NLM_article-title">Abstract B265: a phase 1 safety and pharmacokinetic study of XL765 (SAR245409), a novel PI3K/TORC1/TORC2 inhibitor, in combination with temozolomide (TMZ) in patients (pts) with malignant glioma</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">B265</span><span class="NLM_x">–</span> <span class="NLM_lpage">B265</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=B265-B265&author=P.+Y.+Wenauthor=A.+M.+Omuroauthor=T.+T.+Batchelorauthor=A.+Laiauthor=I.+K.+Mellinghoffauthor=L.+Nghiemphuauthor=A.+Nordenauthor=S.+B.+Gendreauauthor=A.+D.+Lairdauthor=L.+Nguyenauthor=T.+Cloughesy&title=Abstract+B265%3A+a+phase+1+safety+and+pharmacokinetic+study+of+XL765+%28SAR245409%29%2C+a+novel+PI3K%2FTORC1%2FTORC2+inhibitor%2C+in+combination+with+temozolomide+%28TMZ%29+in+patients+%28pts%29+with+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DOmuro%26aufirst%3DA.%2BM.%26aulast%3DBatchelor%26aufirst%3DT.%2BT.%26aulast%3DLai%26aufirst%3DA.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DNghiemphu%26aufirst%3DL.%26aulast%3DNorden%26aufirst%3DA.%26aulast%3DGendreau%26aufirst%3DS.%2BB.%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DCloughesy%26aufirst%3DT.%26atitle%3DAbstract%2520B265%253A%2520a%2520phase%25201%2520safety%2520and%2520pharmacokinetic%2520study%2520of%2520XL765%2520%2528SAR245409%2529%252C%2520a%2520novel%2520PI3K%252FTORC1%252FTORC2%2520inhibitor%252C%2520in%2520combination%2520with%2520temozolomide%2520%2528TMZ%2529%2520in%2520patients%2520%2528pts%2529%2520with%2520malignant%2520glioma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3DB265%26epage%3DB265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tikad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akssira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léger, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">Efficient synthesis of 2-substituted pyrido[3,2-<i>d</i>]pyrimidines involving S<sub>N</sub>Ar and palladium-catalyzed cross-coupling reactions</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">2379</span><span class="NLM_x">–</span> <span class="NLM_lpage">2284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFGktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=2379-2284&author=A.+Tikadauthor=S.+Routierauthor=M.+Akssiraauthor=J.-M.+L%C3%A9gerauthor=C.+Jarryauthor=G.+Guillaumet&title=Efficient+synthesis+of+2-substituted+pyrido%5B3%2C2-d%5Dpyrimidines+involving+SNAr+and+palladium-catalyzed+cross-coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis of 2-substituted pyrido[3,2-d]pyrimidines involving SNAr and palladium-catalyzed cross-coupling reactions</span></div><div class="casAuthors">Tikad, Abdellatif; Routier, Sylvain; Akssira, Mohamed; Leger, Jean-Michel; Jarry, Christian; Guillaumet, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2379-2384</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The efficient and original synthesis of various 2-substituted pyrido[3,2-d]pyrimidines is reported.  Starting from 2,4-dichloropyrido[3,2-d]pyrimidine, a regioselective pallado-dehalogenation led to 2-chloropyrido[3,2-d]pyrimidine, which was used in SNAr and Pd-catalyzed cross-couplings to afford highly functionalized products in very good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZQMyOn1tMCrVg90H21EOLACvtfcHk0liycGLX6-oAcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFGktb0%253D&md5=910cbd8df6e5ea4bf664933eade87044</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTikad%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DAkssira%26aufirst%3DM.%26aulast%3DL%25C3%25A9ger%26aufirst%3DJ.-M.%26aulast%3DJarry%26aufirst%3DC.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DEfficient%2520synthesis%2520of%25202-substituted%2520pyrido%255B3%252C2-d%255Dpyrimidines%2520involving%2520SNAr%2520and%2520palladium-catalyzed%2520cross-coupling%2520reactions%26jtitle%3DSynthesis%26date%3D2009%26spage%3D2379%26epage%3D2284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tikad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akssira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">Efficient one-pot synthesis of 2,4-di(het)aryl and 2,4-diamino pyrido[3,2-<i>d</i>]pyrimidines involving regioselective S<sub>N</sub>Ar and palladium-catalyzed reactions</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">5113</span><span class="NLM_x">–</span> <span class="NLM_lpage">5118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=5113-5118&author=A.+Tikadauthor=S.+Routierauthor=M.+Akssiraauthor=G.+Guillaumet&title=Efficient+one-pot+synthesis+of+2%2C4-di%28het%29aryl+and+2%2C4-diamino+pyrido%5B3%2C2-d%5Dpyrimidines+involving+regioselective+SNAr+and+palladium-catalyzed+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTikad%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DAkssira%26aufirst%3DM.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DEfficient%2520one-pot%2520synthesis%2520of%25202%252C4-di%2528het%2529aryl%2520and%25202%252C4-diamino%2520pyrido%255B3%252C2-d%255Dpyrimidines%2520involving%2520regioselective%2520SNAr%2520and%2520palladium-catalyzed%2520reactions%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D5113%26epage%3D5118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tikad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akssira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">New efficient route to dissymmetric 2,4-di(het)aryl-pyrido[3,2-<i>d</i>]pyrimidines via regioselective cross-coupling reactions</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">4673</span><span class="NLM_x">–</span> <span class="NLM_lpage">4676</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol7014434" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=4673-4676&author=A.+Tikadauthor=S.+Routierauthor=M.+Akssiraauthor=J.-M.+Legerauthor=C.+Jarryauthor=G.+Guillaumet&title=New+efficient+route+to+dissymmetric+2%2C4-di%28het%29aryl-pyrido%5B3%2C2-d%5Dpyrimidines+via+regioselective+cross-coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1021%2Fol7014434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol7014434%26sid%3Dliteratum%253Aachs%26aulast%3DTikad%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DAkssira%26aufirst%3DM.%26aulast%3DLeger%26aufirst%3DJ.-M.%26aulast%3DJarry%26aufirst%3DC.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DNew%2520efficient%2520route%2520to%2520dissymmetric%25202%252C4-di%2528het%2529aryl-pyrido%255B3%252C2-d%255Dpyrimidines%2520via%2520regioselective%2520cross-coupling%2520reactions%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D4673%26epage%3D4676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Tikad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akssira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">Efficient access to novel mono- and disubstituted pyrido[3,2-<i>d</i>]pyrimidines</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">1938</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=1938-1942&author=A.+Tikadauthor=S.+Routierauthor=M.+Akssiraauthor=J.-M.+Legerauthor=C.+Jarryauthor=G.+Guillaumet&title=Efficient+access+to+novel+mono-+and+disubstituted+pyrido%5B3%2C2-d%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTikad%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DAkssira%26aufirst%3DM.%26aulast%3DLeger%26aufirst%3DJ.-M.%26aulast%3DJarry%26aufirst%3DC.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DEfficient%2520access%2520to%2520novel%2520mono-%2520and%2520disubstituted%2520pyrido%255B3%252C2-d%255Dpyrimidines%26jtitle%3DSynlett%26date%3D2006%26spage%3D1938%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritomo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110α inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6847</span><span class="NLM_x">–</span> <span class="NLM_lpage">6858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6847-6858&author=M.+Hayakawaauthor=H.+Kaizawaauthor=H.+Moritomoauthor=T.+Koizumiauthor=T.+Ohishiauthor=M.+Okadaauthor=M.+Ohtaauthor=S.+Tsukamotoauthor=P.+Parkerauthor=P.+Workmanauthor=M.+Waterfield&title=Synthesis+and+biological+evaluation+of+4-morpholino-2-phenylquinazolines+and+related+derivatives+as+novel+PI3+kinase+p110%CE%B1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DMoritomo%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWaterfield%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204-morpholino-2-phenylquinazolines%2520and%2520related%2520derivatives%2520as%2520novel%2520PI3%2520kinase%2520p110%25CE%25B1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6847%26epage%3D6858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hayakawa, M.; Kaizawa, H.; Moritomo, H.; Kawaguchi, K.; Koizumi, T.; Yamano, M.; Matsuda, K.; Okada, M.; Ohta, M.</span><span> </span><span class="NLM_article-title">Preparation of condensed heteroaryl derivatives as phosphatidylinositol 3-kinase inhibitors and anticancer agents</span>. PCT Int. Appl. WO 2001083456 A1 20011108,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=M.+Hayakawa&author=H.+Kaizawa&author=H.+Moritomo&author=K.+Kawaguchi&author=T.+Koizumi&author=M.+Yamano&author=K.+Matsuda&author=M.+Okada&author=M.+Ohta&title=Preparation+of+condensed+heteroaryl+derivatives+as+phosphatidylinositol+3-kinase+inhibitors+and+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520condensed%2520heteroaryl%2520derivatives%2520as%2520phosphatidylinositol%25203-kinase%2520inhibitors%2520and%2520anticancer%2520agents%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisconte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chantry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondru, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadin, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reif, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safina, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staben, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seward, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waszkowycz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, B.</span><span> </span><span class="NLM_article-title">Potent and selective inhibitors of PI3Kδ: obtaining isoform selectivity from the affinity pocket and tryptophan shelf</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4296</span><span class="NLM_x">–</span> <span class="NLM_lpage">4302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.bmcl.2012.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=22672799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVegur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4296-4302&author=D.+P.+Sutherlinauthor=S.+Bakerauthor=A.+Bisconteauthor=P.+M.+Blaneyauthor=A.+Brownauthor=B.+K.+Chanauthor=D.+Chantryauthor=G.+Castanedoauthor=P.+DePledgeauthor=P.+Goldsmithauthor=D.+M.+Goldsteinauthor=T.+Hancoxauthor=J.+Kaurauthor=D.+Knowlesauthor=R.+Kondruauthor=J.+Lesnickauthor=M.+C.+Lucasauthor=C.+Lewisauthor=J.+Murrayauthor=A.+J.+Nadinauthor=J.+Nonomiyaauthor=J.+Pangauthor=N.+Peggauthor=S.+Priceauthor=K.+Reifauthor=B.+S.+Safinaauthor=L.+Salphatiauthor=S.+Stabenauthor=E.+M.+Sewardauthor=S.+Shuttleworthauthor=S.+Sohalauthor=Z.+K.+Sweeneyauthor=M.+Ultschauthor=B.+Waszkowyczauthor=B.+Wei&title=Potent+and+selective+inhibitors+of+PI3K%CE%B4%3A+obtaining+isoform+selectivity+from+the+affinity+pocket+and+tryptophan+shelf"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective inhibitors of PI3Kδ: Obtaining isoform selectivity from the affinity pocket and tryptophan shelf</span></div><div class="casAuthors">Sutherlin, Daniel P.; Baker, Stewart; Bisconte, Angelina; Blaney, Paul M.; Brown, Anthony; Chan, Bryan K.; Chantry, David; Castanedo, Georgette; DePledge, Paul; Goldsmith, Paul; Goldstein, David M.; Hancox, Timothy; Kaur, Jasmit; Knowles, David; Kondru, Rama; Lesnick, John; Lucas, Matthew C.; Lewis, Cristina; Murray, Jeremy; Nadin, Alan J.; Nonomiya, Jim; Pang, Jodie; Pegg, Neil; Price, Steve; Reif, Karin; Safina, Brian S.; Salphati, Laurent; Staben, Steven; Seward, Eileen M.; Shuttleworth, Stephen; Sohal, Sukhjit; Sweeney, Zachary K.; Ultsch, Mark; Waszkowycz, Bohdan; Wei, Binqing</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4296-4302</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A potent inhibitor of PI3Kδ that is ≥200 fold selective for the remaining three Class I PI3K isoforms and addnl. kinases is described.  The hypothesis for selectivity is illustrated through structure activity relationships and crystal structures of compds. bound to a K802T mutant of PI3Kγ.  Pharmacokinetic data in rats and mice support the use of 3 as a useful tool compd. to use for in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaSfg4K5zqbLVg90H21EOLACvtfcHk0ljAsxEg1FSSBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVegur0%253D&md5=d15c7cd8ce626cc5e9a13ac355557ce8</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DBaker%26aufirst%3DS.%26aulast%3DBisconte%26aufirst%3DA.%26aulast%3DBlaney%26aufirst%3DP.%2BM.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChantry%26aufirst%3DD.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DDePledge%26aufirst%3DP.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DHancox%26aufirst%3DT.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKnowles%26aufirst%3DD.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNadin%26aufirst%3DA.%2BJ.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPegg%26aufirst%3DN.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DReif%26aufirst%3DK.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DStaben%26aufirst%3DS.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DShuttleworth%26aufirst%3DS.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DWei%26aufirst%3DB.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520PI3K%25CE%25B4%253A%2520obtaining%2520isoform%2520selectivity%2520from%2520the%2520affinity%2520pocket%2520and%2520tryptophan%2520shelf%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4296%26epage%3D4302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Vlahos, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. F.</span><span> </span><span class="NLM_article-title">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=8106507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=5241-5248&author=C.+J.+Vlahosauthor=W.+F.+Matterauthor=K.+Y.+Huiauthor=R.+F.+Brown&title=A+specific+inhibitor+of+phosphatidylinositol+3-kinase%2C+2-%284-morpholinyl%29-8-phenyl-4H-1-benzopyran-4-one+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)</span></div><div class="casAuthors">Vlahos, Chris J.; Matter, William F.; Hui, Kwan Y.; Brown, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5241-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Phosphatidylinositol (PtIns) 3-kinase is an enzyme implicated in growth factor signal transduction by assocg. with receptor and nonreceptor tyrosine kinases, including the platelet-derived growth factor receptor.  Inhibitors of PtdIns 3-kinase could potentially give a better understanding of the function and regulatory mechanisms of the enzyme.  Quercetin, a naturally occurring bioflavonoid, was previously shown to inhibit PtdIns 3-kinase with an IC50 of 1.3 μg/mL (3.8 μM); inhibition appeared to be directed at the ATP-binding site of the kinase.  Analogs of quercetin were investigated as PtdIns 3-kinase inhibitors, with the most potent ones exhibiting IC50 values in the range of 1.7-8.4 μg/mL.  In contrast, genistein, a potent tyrosine kinase inhibitor of the isoflavone class, did not inhibit PtdIns 3-kinase significantly (IC50 > 30 μg/mL).  Since quercetin has also been shown to inhibit other PtdIns and protein kinases, other chromones were evaluated as inhibitors of PtdIns 3-kinase without affecting PtdIns 4-kinase or selected protein kinases.  One such compd., 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (also known as 2-(4-morpholinyl)-8-phenylchromone, LY294002), completely and specifically abolished PtdIns 3-kinase activity (IC50 = 0.43 μg/mL; 1.40 μM) but did not inhibit PtdIns 4-kinase or tested protein and lipid kinases.  Analogs of LY294002 demonstrated a very selective structure-activity relationship, with slight changes in structure causing marked decreases in inhibition.  LY294002 was shown to completely abolish PtdIns 3-kinase activity in fMet-Leu-Phe-stimulated human neutrophils, as well as inhibit proliferation of smooth muscle cells in cultured rabbit aortic segments.  Since PtdIns 3-kinase appears to be centrally involved with growth factor signal transduction, the development of specific inhibitors against the kinase may be beneficial in the treatment of proliferative diseases as well as in elucidating the biol. role of the kinase in cellular proliferation and growth factor response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Ii0f457BC7Vg90H21EOLACvtfcHk0ljAsxEg1FSSBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D&md5=2635c03af206ce35d55b899f92921477</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlahos%26aufirst%3DC.%2BJ.%26aulast%3DMatter%26aufirst%3DW.%2BF.%26aulast%3DHui%26aufirst%3DK.%2BY.%26aulast%3DBrown%26aufirst%3DR.%2BF.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520phosphatidylinositol%25203-kinase%252C%25202-%25284-morpholinyl%2529-8-phenyl-4H-1-benzopyran-4-one%2520%2528LY294002%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D5241%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Pomel, V.; Gaillard, P.; Desforges, G.; Quattropani, A.; Montagne, C.</span><span> </span><span class="NLM_article-title">Preparation of 4-morpholino-pyrido[3,2-d]pyrimidine compounds as PI3K inhibitors for therapeutic applications</span>. PCT Int. Appl. WO 2010037765 A2 20100408,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=V.+Pomel&author=P.+Gaillard&author=G.+Desforges&author=A.+Quattropani&author=C.+Montagne&title=Preparation+of+4-morpholino-pyrido%5B3%2C2-d%5Dpyrimidine+compounds+as+PI3K+inhibitors+for+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPomel%26aufirst%3DV.%26atitle%3DPreparation%2520of%25204-morpholino-pyrido%255B3%252C2-d%255Dpyrimidine%2520compounds%2520as%2520PI3K%2520inhibitors%2520for%2520therapeutic%2520applications%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Castanedo, G.; Chan, B.; Lucas, M.; Safina, B.; Sutherlin, D.; Sweeney, Z.</span><span> </span><span class="NLM_article-title">Preparation of pyrido[3,2-d]pyrimidine as PI3kδ inhibitors</span>. PCT Int. Appl. WO 2011101429 A1 20110825,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Castanedo&author=B.+Chan&author=M.+Lucas&author=B.+Safina&author=D.+Sutherlin&author=Z.+Sweeney&title=Preparation+of+pyrido%5B3%2C2-d%5Dpyrimidine+as+PI3k%CE%B4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%26atitle%3DPreparation%2520of%2520pyrido%255B3%252C2-d%255Dpyrimidine%2520as%2520PI3k%25CE%25B4%2520inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0lidLMJr9fzO7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.-Y.</span><span> </span><span class="NLM_article-title">Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901284w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1086-1097&author=D.+P.+Sutherlinauthor=D.+Sampathauthor=M.+Berryauthor=G.+Castanedoauthor=Z.+Changauthor=I.+Chuckowreeauthor=J.+Dotsonauthor=A.+Folkesauthor=L.+Friedmanauthor=R.+Goldsmithauthor=T.+Heffronauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=J.+Pangauthor=W.+W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=Q.+Tianauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=C.+Wiesmannauthor=S.+Wongauthor=B.-Y.+Zhu&title=Discovery+of+%28thienopyrimidin-2-yl%29aminopyrimidines+as+potent%2C+selective%2C+and+orally+available+pan-PI3-kinase+and+dual+pan-PI3-kinase%2FmTOR+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm901284w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901284w%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeffron%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DB.-Y.%26atitle%3DDiscovery%2520of%2520%2528thienopyrimidin-2-yl%2529aminopyrimidines%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520pan-PI3-kinase%2520and%2520dual%2520pan-PI3-kinase%252FmTOR%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1086%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lavecchia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berteina-Raboin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">Selective bifunctionalization of pyrido[2,3-<i>d</i>]pyrimidines in positions 2 and 4 by SN<sub>Ar</sub> and palladium-catalyzed coupling reactions</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5851</span><span class="NLM_x">–</span> <span class="NLM_lpage">5855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=5851-5855&author=G.+Lavecchiaauthor=S.+Berteina-Raboinauthor=G.+Guillaumet&title=Selective+bifunctionalization+of+pyrido%5B2%2C3-d%5Dpyrimidines+in+positions+2+and+4+by+SNAr+and+palladium-catalyzed+coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLavecchia%26aufirst%3DG.%26aulast%3DBerteina-Raboin%26aufirst%3DS.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DSelective%2520bifunctionalization%2520of%2520pyrido%255B2%252C3-d%255Dpyrimidines%2520in%2520positions%25202%2520and%25204%2520by%2520SNAr%2520and%2520palladium-catalyzed%2520coupling%2520reactions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D5851%26epage%3D5855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Riadi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massip, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">Convenient synthesis of 2,4-disubstituted pyrido[2,3-<i>d</i>]pyrimidines via regioselective palladium-catalyzed reactions</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">5018</span><span class="NLM_x">–</span> <span class="NLM_lpage">5024</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=5018-5024&author=Y.+Riadiauthor=S.+Massipauthor=J.+M.+Legerauthor=C.+Jarryauthor=S.+Lazarauthor=G.+Guillaumet&title=Convenient+synthesis+of+2%2C4-disubstituted+pyrido%5B2%2C3-d%5Dpyrimidines+via+regioselective+palladium-catalyzed+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiadi%26aufirst%3DY.%26aulast%3DMassip%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DJ.%2BM.%26aulast%3DJarry%26aufirst%3DC.%26aulast%3DLazar%26aufirst%3DS.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DConvenient%2520synthesis%2520of%25202%252C4-disubstituted%2520pyrido%255B2%252C3-d%255Dpyrimidines%2520via%2520regioselective%2520palladium-catalyzed%2520reactions%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D5018%26epage%3D5024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Neagoie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedrenne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buron, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mérour, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldeyrou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansiaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span> </span><span class="NLM_article-title">Synthesis of chromeno[3,4-<i>b</i>]indoles as lamellarin D analogues: a novel DYRK1A inhibitor class</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2012&pages=379-396&author=C.+Neagoieauthor=E.+Vedrenneauthor=F.+Buronauthor=J.-Y.+M%C3%A9rourauthor=S.+Roscaauthor=S.+Bourgauthor=O.+Lozachauthor=L.+Meijerauthor=B.+Baldeyrouauthor=A.+Lansiauxauthor=S.+Routier&title=Synthesis+of+chromeno%5B3%2C4-b%5Dindoles+as+lamellarin+D+analogues%3A+a+novel+DYRK1A+inhibitor+class"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeagoie%26aufirst%3DC.%26aulast%3DVedrenne%26aufirst%3DE.%26aulast%3DBuron%26aufirst%3DF.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DRosca%26aufirst%3DS.%26aulast%3DBourg%26aufirst%3DS.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBaldeyrou%26aufirst%3DB.%26aulast%3DLansiaux%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520chromeno%255B3%252C4-b%255Dindoles%2520as%2520lamellarin%2520D%2520analogues%253A%2520a%2520novel%2520DYRK1A%2520inhibitor%2520class%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D49%26spage%3D379%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefever, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Discovery of 4-morpholino-6-aryl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">8010</span><span class="NLM_x">–</span> <span class="NLM_lpage">8024</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9013828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=8010-8024&author=J.+C.+Verheijenauthor=D.+J.+Richardauthor=K.+Curranauthor=J.+Kaplanauthor=M.+Lefeverauthor=P.+Nowakauthor=D.+J.+Malwitzauthor=N.+Brooijmansauthor=L.+Toral-Barzaauthor=W.-G.+Zhangauthor=J.+Lucasauthor=I.+Hollanderauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=K.+Yuauthor=A.+Zask&title=Discovery+of+4-morpholino-6-aryl-1H-pyrazolo%5B3%2C4-d%5Dpyrimidines+as+highly+potent+and+selective+ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29%3A+optimization+of+the+6-aryl+substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1021%2Fjm9013828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9013828%26sid%3Dliteratum%253Aachs%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DLefever%26aufirst%3DM.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DDiscovery%2520of%25204-morpholino-6-aryl-1H-pyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520highly%2520potent%2520and%2520selective%2520ATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%253A%2520optimization%2520of%2520the%25206-aryl%2520substituent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D8010%26epage%3D8024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Smith, R.; Thompson, S.; Hosahalli, S.; Bejugam, M.; Nanduri, S.; Panigrahi, S.; Mahalingam, N.</span><span> </span><span class="NLM_article-title">Preparation of morpholinylheteroaryl-quinazolinylphenylcarbonylphenylurea derivatives and analogs for use as dual PI3K/mTOR inhibitors</span>. PCT Int. Appl. WO 2012058671 A1 20120503,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+Smith&author=S.+Thompson&author=S.+Hosahalli&author=M.+Bejugam&author=S.+Nanduri&author=S.+Panigrahi&author=N.+Mahalingam&title=Preparation+of+morpholinylheteroaryl-quinazolinylphenylcarbonylphenylurea+derivatives+and+analogs+for+use+as+dual+PI3K%2FmTOR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DR.%26atitle%3DPreparation%2520of%2520morpholinylheteroaryl-quinazolinylphenylcarbonylphenylurea%2520derivatives%2520and%2520analogs%2520for%2520use%2520as%2520dual%2520PI3K%252FmTOR%2520inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span>Biological Macromolecular Resource. <a href="http://www.rcsb.org/pdb/home/home.do" class="extLink">http://www.rcsb.org/pdb/home/home.do</a> (accessed <span class="NLM_access-date">January 2014</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Biological+Macromolecular+Resource.+http%3A%2F%2Fwww.rcsb.org%2Fpdb%2Fhome%2Fhome.do+%28accessed+January+2014%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Huang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Kittler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabelli, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amzel, L. M.</span><span> </span><span class="NLM_article-title">The structure of a human p110α/p85α complex elucidates the effects of oncogenic PI3Kα mutations</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1744</span><span class="NLM_x">–</span> <span class="NLM_lpage">1748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1744-1748&author=C.-H.+Huangauthor=D.+Mandelkerauthor=O.+Schmidt-Kittlerauthor=Y.+Samuelsauthor=V.+E.+Velculescuauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=S.+B.+Gabelliauthor=L.+M.+Amzel&title=The+structure+of+a+human+p110%CE%B1%2Fp85%CE%B1+complex+elucidates+the+effects+of+oncogenic+PI3K%CE%B1+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.-H.%26aulast%3DMandelker%26aufirst%3DD.%26aulast%3DSchmidt-Kittler%26aufirst%3DO.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DGabelli%26aufirst%3DS.%2BB.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DThe%2520structure%2520of%2520a%2520human%2520p110%25CE%25B1%252Fp85%25CE%25B1%2520complex%2520elucidates%2520the%2520effects%2520of%2520oncogenic%2520PI3K%25CE%25B1%2520mutations%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1744%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Mandelker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabelli, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Kittler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amzel, L. M.</span><span> </span><span class="NLM_article-title">A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">16996</span><span class="NLM_x">–</span> <span class="NLM_lpage">17001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=16996-17001&author=D.+Mandelkerauthor=S.+B.+Gabelliauthor=O.+Schmidt-Kittlerauthor=J.+Zhuauthor=I.+Cheongauthor=C.-H.+Huangauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=L.+M.+Amzel&title=A+frequent+kinase+domain+mutation+that+changes+the+interaction+between+PI3K%CE%B1+and+the+membrane"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandelker%26aufirst%3DD.%26aulast%3DGabelli%26aufirst%3DS.%2BB.%26aulast%3DSchmidt-Kittler%26aufirst%3DO.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DCheong%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DC.-H.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DA%2520frequent%2520kinase%2520domain%2520mutation%2520that%2520changes%2520the%2520interaction%2520between%2520PI3K%25CE%25B1%2520and%2520the%2520membrane%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D16996%26epage%3D17001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alaimo, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenski, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4749</span><span class="NLM_x">–</span> <span class="NLM_lpage">4759</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.bmc.2004.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=15358300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Oiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=4749-4759&author=Z.+A.+Knightauthor=G.+G.+Chiangauthor=P.+J.+Alaimoauthor=D.+M.+Kenskiauthor=C.+B.+Hoauthor=K.+Coanauthor=R.+T.+Abrahamauthor=K.+M.+Shokat&title=Isoform-specific+phosphoinositide+3-kinase+inhibitors+from+an+arylmorpholine+scaffold"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold</span></div><div class="casAuthors">Knight, Zachary A.; Chiang, Gary G.; Alaimo, Peter J.; Kenski, Denise M.; Ho, Caroline B.; Coan, Kristin; Abraham, Robert T.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4749-4759</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3-Ks) are an ubiquitous class of signaling enzymes that regulate diverse cellular processes including growth, differentiation, and motility.  Physiol. roles of PI3-Ks have traditionally been assigned using two pharmacol. inhibitors, LY294002 and wortmannin.  Although these compds. are broadly specific for the PI3-K family, they show little selectivity among family members, and the development of isoform-specific inhibitors of these enzymes has been long anticipated.  Herein, the prepn. of two classes of arylmorpholine PI3-K inhibitors and the characterization of their specificity against a comprehensive panel of targets within the PI3-K family are reported.  Multiplex inhibitors that potently inhibit distinct subsets of PI3-K isoforms, including the first selective inhibitor of p110β/p110δ (IC50 p110β = 0.13 μM, p110δ = 0.63 μM), were identified.  Trends that suggest certain PI3-K isoforms may be more sensitive to potent inhibition by arylmorpholines, thereby guiding future drug design based on this pharmacophore, were also identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvvlNyK2W7KLVg90H21EOLACvtfcHk0likfNfQUEmF-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Oiurc%253D&md5=46426eff73eb2fdf6cc6878081510005</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DAlaimo%26aufirst%3DP.%2BJ.%26aulast%3DKenski%26aufirst%3DD.%2BM.%26aulast%3DHo%26aufirst%3DC.%2BB.%26aulast%3DCoan%26aufirst%3DK.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DIsoform-specific%2520phosphoinositide%25203-kinase%2520inhibitors%2520from%2520an%2520arylmorpholine%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D4749%26epage%3D4759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5013</span><span class="NLM_x">–</span> <span class="NLM_lpage">5016</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900851f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5013-5016&author=A.+Zaskauthor=J.+C.+Verheijenauthor=K.+Curranauthor=J.+Kaplanauthor=D.+J.+Richardauthor=P.+Nowakauthor=D.+J.+Malwitzauthor=N.+Brooijmansauthor=J.+Bardauthor=K.+Svensonauthor=J.+Lucasauthor=L.+Toral-Barzaauthor=W.-G.+Zhangauthor=I.+Hollanderauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=K.+Yu&title=ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin%3A+design+and+synthesis+of+highly+potent+and+selective+pyrazolopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm900851f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900851f%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%253A%2520design%2520and%2520synthesis%2520of%2520highly%2520potent%2520and%2520selective%2520pyrazolopyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5013%26epage%3D5016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0ljGQCdR8RF6RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Nakabayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taketa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, J.</span><span> </span><span class="NLM_article-title">Growth of human hepatoma cells lines with differentiated functions in chemically defined medium</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3858</span><span class="NLM_x">–</span> <span class="NLM_lpage">3863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=6286115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADyaL38Xlt1ens78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1982&pages=3858-3863&author=H.+Nakabayashiauthor=K.+Taketaauthor=K.+Miyanoauthor=T.+Yamaneauthor=J.+Sato&title=Growth+of+human+hepatoma+cells+lines+with+differentiated+functions+in+chemically+defined+medium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Growth of human hepatoma cell lines with differentiated functions in chemically defined medium</span></div><div class="casAuthors">Nakabayashi, Hidekazu; Taketa, Kazuhisa; Miyano, Keiko; Yamane, Takashi; Sato, Jiro</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3858-63</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">A human hepatoma cell line, HuH-7, which was established from a hepatocellular carcinoma, replicated continuously in a chem. defined medium when the medium was supplemented with Na2SeO3.  The cells grew better in this medium than in serum-contg. medium without any adaptation period.  Other established human hepatoma and hepatoblastoma cell lines, HuH-6 cl-5, PLC/PRF/5, huH-1, and huH-4, also grew in the defined medium.  Although HLEC-1 cells failed to proliferate continuously with Na2SeO3 alone, they grew if a cell-free conditioned medium from HuH-7 cells was added to the medium.  These cell lines, except the HLEC-1 cell line, produced the following human plasma proteins: albumin, prealbumin, α1-antitrypsin, ceruloplasmin, fibrinogen, fibronectin, haptoglobin, hemopexin, β-lipoprotein, α2-macroglobulin, β2-microglobulin, transferrin, complement components 3 and 4, and α1-fetoprotein.  Beside plasma proteins, the media from HuH-7, HuH-6 cl-5, PLC/PRF/5, and huH-1 contained anticarcinoembryonic antigen-reactive proteins, and those from PLC/PRF/5, huH-1, and huH-4 medium contained hepatitis B surface antigen.  These proteins were detected during periods of serial cultivation over 9 mo under the above culture conditions.  The hepatoma cell lines grown in the fully defined synthetic medium may provide a new approach for investigating the growth and metab. of human hepatoma cells in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0TOrW0aPitLVg90H21EOLACvtfcHk0lh8xt_INlnAjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xlt1ens78%253D&md5=ea9da2cd2c0090618a3c2e5d924799e0</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakabayashi%26aufirst%3DH.%26aulast%3DTaketa%26aufirst%3DK.%26aulast%3DMiyano%26aufirst%3DK.%26aulast%3DYamane%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DJ.%26atitle%3DGrowth%2520of%2520human%2520hepatoma%2520cells%2520lines%2520with%2520differentiated%2520functions%2520in%2520chemically%2520defined%2520medium%26jtitle%3DCancer%2520Res.%26date%3D1982%26volume%3D42%26spage%3D3858%26epage%3D3863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Nakanishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto-Tamaoki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuyama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, E.</span><span> </span><span class="NLM_article-title">Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase</span> <span class="citation_source-journal">Clin. Exp. Metastasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1023%2FA%3A1006685218766" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=10763917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A280%3ADC%252BD3c3isV2rtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=507-514&author=K.+Nakanishiauthor=J.+Fujimotoauthor=T.+Uekiauthor=K.+Kishimotoauthor=T.+Hashimoto-Tamaokiauthor=J.+Furuyamaauthor=T.+Itohauthor=Y.+Sasakiauthor=E.+Okamoto&title=Hepatocyte+growth+factor+promotes+migration+of+human+hepatocellular+carcinoma+via+phosphatidylinositol+3-kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase</span></div><div class="casAuthors">Nakanishi K; Fujimoto J; Ueki T; Kishimoto K; Hashimoto-Tamaoki T; Furuyama J; Itoh T; Sasaki Y; Okamoto E</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & experimental metastasis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">507-14</span>
        ISSN:<span class="NLM_cas:issn">0262-0898</span>.
    </div><div class="casAbstract">Hepatocyte growth factor (HGF) is known to be a potent mitogen and motogen for epithelial cells.  Hepatocellular carcinoma (HCC) often metastasizes, and the c-Met/HGF receptor is highly expressed by HCC cells.  The aim of this study was to investigate the signaling pathways associated with the motogenic effect of HGF on HCC cells via c-Met.  HCC cell lines (Hep3B, HepG2, PLC, and Huh-7) and HCC cells harvested from patients were used for the Boyden chamber assay of chemotactic activity as well as for immunoprecipitation and immunoblotting studies.  HGF stimulated the motility of Hep3B, HepG2, and Huh-7 cells in a dose-dependent manner in association with tyrosine phosphorylation of c-Met and activation of phosphatidylinositol 3-kinase (PI3-K).  A tyrosine kinase inhibitor (genistein) and a PI3-K inhibitor (wortmannin) prevented the migration of HCC cells.  However, migration was not prevented by calphostin C, an inhibitor of protein kinase C (PKC), which is a downstream target of phospholipase Cgamma (PLCgamma).  HGF also stimulated the migration of HCC cells obtained from three patients, while wortmannin prevented the migration of these cells.  These results indicate that HGF stimulates the migration of HCC cells through the tyrosine phosphorylation of c-Met via activation of PI3-K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTNGwbZoo09dGxpATR2EQURfW6udTcc2ebJC27xOctylbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3isV2rtQ%253D%253D&md5=4c445617fdf72e7ddcf0daa2acdb9758</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006685218766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006685218766%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DK.%26aulast%3DFujimoto%26aufirst%3DJ.%26aulast%3DUeki%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DK.%26aulast%3DHashimoto-Tamaoki%26aufirst%3DT.%26aulast%3DFuruyama%26aufirst%3DJ.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DOkamoto%26aufirst%3DE.%26atitle%3DHepatocyte%2520growth%2520factor%2520promotes%2520migration%2520of%2520human%2520hepatocellular%2520carcinoma%2520via%2520phosphatidylinositol%25203-kinase%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D1999%26volume%3D17%26spage%3D507%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Gedaly, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hundley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daily, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, B. M.</span><span> </span><span class="NLM_article-title">PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4951</span><span class="NLM_x">–</span> <span class="NLM_lpage">4958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=21187475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVOktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=4951-4958&author=R.+Gedalyauthor=P.+Anguloauthor=J.+Hundleyauthor=M.+F.+Dailyauthor=C.+Chenauthor=A.+Kochauthor=B.+M.+Evers&title=PI-103+and+sorafenib+inhibit+hepatocellular+carcinoma+cell+proliferation+by+blocking+Ras%2FRaf%2FMAPK+and+PI3K%2FAKT%2FmTOR+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways</span></div><div class="casAuthors">Gedaly, Roberto; Angulo, Paul; Hundley, Jonathan; Daily, Michael F.; Chen, Changguo; Koch, Alvaro; Evers, B. Mark</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4951-4958</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Aberrant Ras/Raf/MAPK and PI3K/AKT/mTOR signaling pathways are found in hepatocellular carcinoma (HCC).  This study reports how sorafenib (a multi-kinase inhibitor) and PI-103 (a dual PI3K/mTOR inhibitor) alone and in combination inhibit the proliferation of the HCC cell line, Huh7.  Huh7 proliferation was assayed by 3H-thymidine incorporation and by MTT assay.  Western blot was used to detect phosphorylation of the key enzymes in the Ras/Raf and PI3K pathways.  Sorafenib and PI-103, as single agents inhibited Huh7 proliferation and epidermal growth factor (EGF)-stimulated Huh7 proliferation in a dose-dependent fashion; the combination of sorafenib and PI-103 produced synergistic effects.  EGF increased phosphorylation of MEK and ERK, key Ras/Raf downstream signaling proteins; this activation was inhibited by sorafenib.  However, sorafenib as a single agent increased AKT(Ser473) and mTOR phosphorylation.  EGF-stimulated activation of PI3K/AKT/mTOR pathway components was inhibited by PI-103.  PI-103 is a potent inhibitor of AKT(Ser473) phosphorylation; in contrast, rapamycin stimulated AKT(Ser473) phosphorylation.  It was found that PI-103, as a single agent, stimulated MEK and ERK phosphorylation.  However, the combination of sorafenib and PI-103 caused inhibition of all the tested kinases in the Ras/Raf and PI3K pathways.  The combination of sorafenib and PI-103 can significantly inhibit EGF-stimulated Huh7 proliferation by blocking both Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5ZuZBBqJpi7Vg90H21EOLACvtfcHk0lhYkrjLADzqWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVOktrg%253D&md5=496c0b84fc75aa250715fd89ac5107e7</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGedaly%26aufirst%3DR.%26aulast%3DAngulo%26aufirst%3DP.%26aulast%3DHundley%26aufirst%3DJ.%26aulast%3DDaily%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DA.%26aulast%3DEvers%26aufirst%3DB.%2BM.%26atitle%3DPI-103%2520and%2520sorafenib%2520inhibit%2520hepatocellular%2520carcinoma%2520cell%2520proliferation%2520by%2520blocking%2520Ras%252FRaf%252FMAPK%2520and%2520PI3K%252FAKT%252FmTOR%2520pathways%26jtitle%3DAnticancer%2520Res.%26date%3D2010%26volume%3D30%26spage%3D4951%26epage%3D4958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Ivison, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shobab, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kifayet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sly, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, T. S.</span><span> </span><span class="NLM_article-title">The p110α and p110β isoforms of class I phosphatidylinositol 3-kinase are involved in Toll-like receptor 5 signaling in epithelial cells</span> <span class="citation_source-journal">Mediators Inflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1155%2F2010%2F652098" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=1-12&author=S.+M.+Ivisonauthor=M.+A.+S.+Khanauthor=N.+R.+Grahamauthor=L.+A.+Shobabauthor=Y.+Yaoauthor=A.+Kifayetauthor=L.+M.+Slyauthor=T.+S.+Steiner&title=The+p110%CE%B1+and+p110%CE%B2+isoforms+of+class+I+phosphatidylinositol+3-kinase+are+involved+in+Toll-like+receptor+5+signaling+in+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1155%2F2010%2F652098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2010%252F652098%26sid%3Dliteratum%253Aachs%26aulast%3DIvison%26aufirst%3DS.%2BM.%26aulast%3DKhan%26aufirst%3DM.%2BA.%2BS.%26aulast%3DGraham%26aufirst%3DN.%2BR.%26aulast%3DShobab%26aufirst%3DL.%2BA.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DKifayet%26aufirst%3DA.%26aulast%3DSly%26aufirst%3DL.%2BM.%26aulast%3DSteiner%26aufirst%3DT.%2BS.%26atitle%3DThe%2520p110%25CE%25B1%2520and%2520p110%25CE%25B2%2520isoforms%2520of%2520class%2520I%2520phosphatidylinositol%25203-kinase%2520are%2520involved%2520in%2520Toll-like%2520receptor%25205%2520signaling%2520in%2520epithelial%2520cells%26jtitle%3DMediators%2520Inflammation%26date%3D2010%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Langlois, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernatchez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudreau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saucier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreault, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrier, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivard, N.</span><span> </span><span class="NLM_article-title">The PTEN phosphatase controls intestinal epithelial cell polarity and barrier function: role in colorectal cancer progression</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e15742</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e15742&author=M.-J.+Langloisauthor=S.+Bergeronauthor=G.+Bernatchezauthor=F.+Boudreauauthor=C.+Saucierauthor=N.+Perreaultauthor=J.+C.+Carrierauthor=N.+Rivard&title=The+PTEN+phosphatase+controls+intestinal+epithelial+cell+polarity+and+barrier+function%3A+role+in+colorectal+cancer+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLanglois%26aufirst%3DM.-J.%26aulast%3DBergeron%26aufirst%3DS.%26aulast%3DBernatchez%26aufirst%3DG.%26aulast%3DBoudreau%26aufirst%3DF.%26aulast%3DSaucier%26aufirst%3DC.%26aulast%3DPerreault%26aufirst%3DN.%26aulast%3DCarrier%26aufirst%3DJ.%2BC.%26aulast%3DRivard%26aufirst%3DN.%26atitle%3DThe%2520PTEN%2520phosphatase%2520controls%2520intestinal%2520epithelial%2520cell%2520polarity%2520and%2520barrier%2520function%253A%2520role%2520in%2520colorectal%2520cancer%2520progression%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De15742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Mordant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriot, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leteur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderaro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourhis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wislez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutsch, E.</span><span> </span><span class="NLM_article-title">Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (everolimus) in combination</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1158%2F1535-7163.MCT-09-1014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=20124452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslektb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=358-368&author=P.+Mordantauthor=Y.+Loriotauthor=C.+Leteurauthor=J.+Calderaroauthor=J.+Bourhisauthor=M.+Wislezauthor=J.-C.+Soriaauthor=E.+Deutsch&title=Dependence+on+phosphoinositide+3-kinase+and+RAS-RAF+pathways+drive+the+activity+of+RAF265%2C+a+novel+RAF%2FVEGFR2+inhibitor%2C+and+RAD001+%28everolimus%29+in+combination"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in Combination</span></div><div class="casAuthors">Mordant, Pierre; Loriot, Yohann; Leteur, Celine; Calderaro, Julien; Bourhis, Jean; Wislez, Marie; Soria, Jean-Charles; Deutsch, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">358-368</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activation of phosphatidylinositol-3-kinase (PI3K)-AKT and Kirsten rat sarcoma viral oncogene homolog (KRAS) can induce cellular immortalization, proliferation, and resistance to anticancer therapeutics such as epidermal growth factor receptor inhibitors or chemotherapy.  This study assessed the consequences of inhibiting these two pathways in tumor cells with activation of KRAS, PI3K-AKT, or both.  We investigated whether the combination of a novel RAF/vascular endothelial growth factor receptor inhibitor, RAF265, with a mammalian target of rapamycin (mTOR) inhibitor, RAD001 (everolimus), could lead to enhanced antitumoral effects in vitro and in vivo.  To address this question, we used cell lines with different status regarding KRAS, PIK3CA, and BRAF mutations, using immunoblotting to evaluate the inhibitors, and MTT and clonogenic assays for effects on cell viability and proliferation.  S.c. xenografts were used to assess the activity of the combination in vivo.  RAD001 inhibited mTOR downstream signaling in all cell lines, whereas RAF265 inhibited RAF downstream signaling only in BRAF mutant cells.  In vitro, addn. of RAF265 to RAD001 led to decreased AKT, S6, and Eukaryotic translation initiation factor 4E binding protein 1 phosphorylation in HCT116 cells.  In vitro and in vivo, RAD001 addn. enhanced the antitumoral effect of RAF265 in HCT116 and H460 cells (both KRAS mut, PIK3CA mut); in contrast, the combination of RAF265 and RAD001 yielded no addnl. activity in A549 and MDAMB231 cells.  The combination of RAF and mTOR inhibitors is effective for enhancing antitumoral effects in cells with deregulation of both RAS-RAF and PI3K, possibly through the cross-inhibition of 4E binding protein 1 and S6 protein.  Mol Cancer Ther; 9(2); 358-68.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBLcFcZujsVbVg90H21EOLACvtfcHk0lhYkrjLADzqWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslektb0%253D&md5=d8f99d5865a37b36583fab0ae937a548</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1014%26sid%3Dliteratum%253Aachs%26aulast%3DMordant%26aufirst%3DP.%26aulast%3DLoriot%26aufirst%3DY.%26aulast%3DLeteur%26aufirst%3DC.%26aulast%3DCalderaro%26aufirst%3DJ.%26aulast%3DBourhis%26aufirst%3DJ.%26aulast%3DWislez%26aufirst%3DM.%26aulast%3DSoria%26aufirst%3DJ.-C.%26aulast%3DDeutsch%26aufirst%3DE.%26atitle%3DDependence%2520on%2520phosphoinositide%25203-kinase%2520and%2520RAS-RAF%2520pathways%2520drive%2520the%2520activity%2520of%2520RAF265%252C%2520a%2520novel%2520RAF%252FVEGFR2%2520inhibitor%252C%2520and%2520RAD001%2520%2528everolimus%2529%2520in%2520combination%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D358%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Bénistant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapuis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, S.</span><span> </span><span class="NLM_article-title">A specific function for phosphatidylinositol 3-kinase α (p85α-p110α) in cell survival and for phosphatidylinositol 3-kinase β (p85α-p110β) in de novo DNA synthesis of human colon carcinoma cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5083</span><span class="NLM_x">–</span> <span class="NLM_lpage">5090</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=5083-5090&author=C.+B%C3%A9nistantauthor=H.+Chapuisauthor=S.+Roche&title=A+specific+function+for+phosphatidylinositol+3-kinase+%CE%B1+%28p85%CE%B1-p110%CE%B1%29+in+cell+survival+and+for+phosphatidylinositol+3-kinase+%CE%B2+%28p85%CE%B1-p110%CE%B2%29+in+de+novo+DNA+synthesis+of+human+colon+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9nistant%26aufirst%3DC.%26aulast%3DChapuis%26aufirst%3DH.%26aulast%3DRoche%26aufirst%3DS.%26atitle%3DA%2520specific%2520function%2520for%2520phosphatidylinositol%25203-kinase%2520%25CE%25B1%2520%2528p85%25CE%25B1-p110%25CE%25B1%2529%2520in%2520cell%2520survival%2520and%2520for%2520phosphatidylinositol%25203-kinase%2520%25CE%25B2%2520%2528p85%25CE%25B1-p110%25CE%25B2%2529%2520in%2520de%2520novo%2520DNA%2520synthesis%2520of%2520human%2520colon%2520carcinoma%2520cells%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D5083%26epage%3D5090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Calay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vind-Kezunovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poumay, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gniadecki, R.</span><span> </span><span class="NLM_article-title">Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1136</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2010&pages=1136-1145&author=D.+Calayauthor=D.+Vind-Kezunovicauthor=A.+Frankartauthor=S.+Lambertauthor=Y.+Poumayauthor=R.+Gniadecki&title=Inhibition+of+Akt+signaling+by+exclusion+from+lipid+rafts+in+normal+and+transformed+epidermal+keratinocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalay%26aufirst%3DD.%26aulast%3DVind-Kezunovic%26aufirst%3DD.%26aulast%3DFrankart%26aufirst%3DA.%26aulast%3DLambert%26aufirst%3DS.%26aulast%3DPoumay%26aufirst%3DY.%26aulast%3DGniadecki%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520Akt%2520signaling%2520by%2520exclusion%2520from%2520lipid%2520rafts%2520in%2520normal%2520and%2520transformed%2520epidermal%2520keratinocytes%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2010%26volume%3D130%26spage%3D1136%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Hollestelle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elstrodt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, J. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallemeijn, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutte, M.</span><span> </span><span class="NLM_article-title">Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1158%2F1541-7786.MCR-06-0263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=17314276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFWrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=195-201&author=A.+Hollestelleauthor=F.+Elstrodtauthor=J.+H.+A.+Nagelauthor=W.+W.+Kallemeijnauthor=M.+Schutte&title=Phosphatidylinositol-3-OH+kinase+or+RAS+pathway+mutations+in+human+breast+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines</span></div><div class="casAuthors">Hollestelle, Antoinette; Elstrodt, Fons; Nagel, Jord H. A.; Kallemeijn, Wouter W.; Schutte, Mieke</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-201</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Constitutive activation of the phosphatidylinositol-3-OH kinase (PI3K) and RAS signaling pathways are important events in tumor formation.  This is illustrated by the frequent genetic alteration of several key players from these pathways in a wide variety of human cancers.  Here, we report a detailed sequence anal. of the PTEN, PIK3CA, KRAS, HRAS, NRAS, and BRAF genes in a collection of 40 human breast cancer cell lines.  We identified a surprisingly large proportion of cell lines with mutations in the PI3K or RAS pathways (54% and 25%, resp.), with mutants for each of the six genes.  The PIK3CA, KRAS, and BRAF mutation spectra of the breast cancer cell lines were similar to those of colorectal cancers.  Unlike in colorectal cancers, however, mutational activation of the PI3K pathway was mutually exclusive with mutational activation of the RAS pathway in all but 1 of 30 mutant breast cancer cell lines (P = 0.001).  These results suggest that there is a fine distinction between the signaling activators and downstream effectors of the oncogenic PI3K and RAS pathways in breast epithelium and those in other tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkA_wgqc842bVg90H21EOLACvtfcHk0lht3RWwfb-1lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFWrtb8%253D&md5=b2149d14c32bd2c3c1e64b3852d5e817</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-06-0263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-06-0263%26sid%3Dliteratum%253Aachs%26aulast%3DHollestelle%26aufirst%3DA.%26aulast%3DElstrodt%26aufirst%3DF.%26aulast%3DNagel%26aufirst%3DJ.%2BH.%2BA.%26aulast%3DKallemeijn%26aufirst%3DW.%2BW.%26aulast%3DSchutte%26aufirst%3DM.%26atitle%3DPhosphatidylinositol-3-OH%2520kinase%2520or%2520RAS%2520pathway%2520mutations%2520in%2520human%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2007%26volume%3D5%26spage%3D195%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Clark, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streicher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, P. A.</span><span> </span><span class="NLM_article-title">Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=12479367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=707-717&author=A.+S.+Clarkauthor=K.+Westauthor=S.+Streicherauthor=P.+A.+Dennis&title=Constitutive+and+inducible+Akt+activity+promotes+resistance+to+chemotherapy%2C+trastuzumab%2C+or+tamoxifen+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells</span></div><div class="casAuthors">Clark, Amy S.; West, Kip; Streicher, Samantha; Dennis, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">707-717</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To evaluate the role of the phosphatidylinositol 3-kinase (Pl3K)/Akt pathway in breast cancer cell survival and therapeutic resistance, we analyzed a panel of six breast cancer cell lines that varied in erbB2 and estrogen receptor status.  Akt activity was constitutive in four cell lines and was assocd. with either PTEN mutations or erbB2 overexpression.  Akt promoted breast cancer cell survival because a Pl3K inhibitor, LY294002, or transient transfection of a dominant-neg. Akt mutant inhibited Akt activity and increased apoptosis.  When combined with therapies commonly used in breast cancer treatment, LY294002 potentiated apoptosis caused by doxorubicin, trastuzumab, paclitaxel, or etoposide.  Potentiation of apoptosis by LY294002 correlated with induction of Akt by doxorubicin or trastuzumab alone that occurred before the onset of apoptosis.  Similar results were obsd. with tamoxifen.  Combining LY294002 with tamoxifen in estrogen receptor-pos. cells greatly potentiated apoptosis, which was correlated with tamoxifen-induced Akt phosphorylation that preceded apoptosis.  To confirm that the effects of LY294002 on chemotherapy-induced apoptosis were attributable to inhibition of Akt, we transiently transfected breast cancer cells with dominant-neg. Akt and obsd. increased doxorubicin-induced apoptosis.  Conversely, stably transfecting cells with constitutively active Akt increased Akt activity and attenuated doxorubicin-induced apoptosis.  These studies show that endogenous Akt activity promotes breast cancer cell survival and therapeutic resistance, and that induction of Akt by chemotherapy, trastuzumab, or tamoxifen might be an early compensatory mechanism that could be exploited to increase the efficacy of these therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokFulbrsRhrLVg90H21EOLACvtfcHk0lglSrGL-lxBCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmtLk%253D&md5=8524c66f332d0596592e72f57275a14b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DA.%2BS.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DStreicher%26aufirst%3DS.%26aulast%3DDennis%26aufirst%3DP.%2BA.%26atitle%3DConstitutive%2520and%2520inducible%2520Akt%2520activity%2520promotes%2520resistance%2520to%2520chemotherapy%252C%2520trastuzumab%252C%2520or%2520tamoxifen%2520in%2520breast%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D707%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span>Maestro, version 9.1, Glide, version 5.6, MacroModel, version 9.8, Schrödinger, LLC, New York,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+9.1%2C+Glide%2C+version+5.6%2C+MacroModel%2C+version+9.8%2C+Schr%C3%B6dinger%2C+LLC%2C+New+York%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span>Marvin 5.3.6, ChemAxon,<span class="NLM_x"> </span><span class="NLM_year">2010</span>. <a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a> (accessed <span class="NLM_access-date">January 2014</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Marvin+5.3.6%2C+ChemAxon%2C+2010.+http%3A%2F%2Fwww.chemaxon.com+%28accessed+January+2014%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sadowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasteiger, J.</span><span> </span><span class="NLM_article-title">From atoms and bonds to three-dimensional atomic coordinates: automatic model builders</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">2567</span><span class="NLM_x">–</span> <span class="NLM_lpage">2581</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00023a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1993&pages=2567-2581&author=J.+Sadowskiauthor=J.+Gasteiger&title=From+atoms+and+bonds+to+three-dimensional+atomic+coordinates%3A+automatic+model+builders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51a&amp;dbid=16384&amp;doi=10.1021%2Fcr00023a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00023a012%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26aulast%3DGasteiger%26aufirst%3DJ.%26atitle%3DFrom%2520atoms%2520and%2520bonds%2520to%2520three-dimensional%2520atomic%2520coordinates%253A%2520automatic%2520model%2520builders%26jtitle%3DChem.%2520Rev.%26date%3D1993%26volume%3D93%26spage%3D2567%26epage%3D2581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit51b"><span><span class="NLM_label">(b) </span>CORINA—Fast Generation of High-Quality 3D Molecular Models. <a href="http://www.molecular-networks.com/products/corina" class="extLink">http://www.molecular-networks.com/products/corina</a> (accessed <span class="NLM_access-date">January 2014</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CORINA%E2%80%94Fast+Generation+of+High-Quality+3D+Molecular+Models.+http%3A%2F%2Fwww.molecular-networks.com%2Fproducts%2Fcorina+%28accessed+January+2014%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Barascu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Floch, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bougnoux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, M.-L.</span><span> </span><span class="NLM_article-title">CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.biocel.2005.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=16194618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1aqu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=196-208&author=A.+Barascuauthor=P.+Bessonauthor=O.+Le+Flochauthor=P.+Bougnouxauthor=M.-L.+Jourdan&title=CDK1-cyclin+B1+mediates+the+inhibition+of+proliferation+induced+by+omega-3+fatty+acids+in+MDA-MB-231+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells</span></div><div class="casAuthors">Barascu, Aurelia; Besson, Pierre; Le Floch, Olivier; Bougnoux, Philippe; Jourdan, Marie-Lise</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-208</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Long-chain omega-3 polyunsatd. fatty acids are thought to inhibit the development of breast cancer.  We investigated the effects of docosahexaenoic and eicosapentaenoic acids on the proliferation of MDA-MB-231 human mammary epithelial cells.  Both docosahexaenoic and eicosapentaenoic acids decreased cell growth with a higher efficiency for docosahexaenoic acid (87% at 100 μM vs. 74% for eicosapentaenoic acid).  The effect on specific cell cycle phases was studied.  G2/M duration was markedly increased by docosahexaenoic and by eicosapentaenoic acids (resp. by more than seven- and six-fold at 50 μM) when cells were synchronized at the G1/S boundary and released in the cell cycle.  In contrast, there was no alteration of G1 or S phases.  The expression of cyclin A, cyclin B1 and cyclin-dependent kinase 1, the regulators required for the progression from G2 to mitosis, were all decreased by these fatty acids (western blot).  Since omega-3 fatty acids had no effect on the S phase, thus ruling out an involvement of cyclin A in their anti-proliferative effect, we examd. whether the regulation of the cyclin-dependent kinase 1-cyclin B1 complex was altered.  Upon omega-3 fatty acids treatment, cyclin B1 phosphorylation was inhibited and the expression of the cell division cycle 25C phosphatase, which dephosphorylates cyclin-dependent kinase 1, was decreased.  We conclude that the anti-proliferative effect of omega-3 fatty acids occurs via the regulation of the cyclin-dependent kinase 1-cyclin B1 complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnF14iemjz7rVg90H21EOLACvtfcHk0lgAA1R8Q1LO3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1aqu7jL&md5=1c48d033e8e7bf945377e74692813294</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2005.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2005.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DBarascu%26aufirst%3DA.%26aulast%3DBesson%26aufirst%3DP.%26aulast%3DLe%2BFloch%26aufirst%3DO.%26aulast%3DBougnoux%26aufirst%3DP.%26aulast%3DJourdan%26aufirst%3DM.-L.%26atitle%3DCDK1-cyclin%2520B1%2520mediates%2520the%2520inhibition%2520of%2520proliferation%2520induced%2520by%2520omega-3%2520fatty%2520acids%2520in%2520MDA-MB-231%2520breast%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2006%26volume%3D38%26spage%3D196%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b','cit19c','cit19d','cit19e','cit19f','cit19g','cit19h','cit19i','cit19j'],'ref20':['cit20a','cit20b'],'ref21':['cit21a','cit21b'],'ref22':['cit22a','cit22b','cit22c'],'ref23':['cit23a','cit23b','cit23c','cit23d'],'ref24':['cit24a','cit24b','cit24c'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30a','cit30b'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51a','cit51b'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 48 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Aisha A. K. Al-Ashmawy, Khaled M. Elokely, Oscar Perez-Leal, Mario Rico, John Gordon, George Mateo, Abdelsattar M. Omar, Magid Abou-Gharbia, <span class="NLM_string-name hlFld-ContribAuthor">Wayne E. Childers, Jr.</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and SAR of Novel Disubstituted Quinazolines as Dual PI3Kalpha/mTOR Inhibitors Targeting Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2156-2164. <a href="https://doi.org/10.1021/acsmedchemlett.0c00289" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00289%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BSAR%252Bof%252BNovel%252BDisubstituted%252BQuinazolines%252Bas%252BDual%252BPI3Kalpha%25252FmTOR%252BInhibitors%252BTargeting%252BBreast%252BCancer%26aulast%3DAl-Ashmawy%26aufirst%3DAisha%2BA.%2BK.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28052020%26date%3D06102020%26date%3D12102020%26volume%3D11%26issue%3D11%26spage%3D2156%26epage%3D2164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aimie
E. Garces, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Stocks</span>. </span><span class="cited-content_cbyCitation_article-title">Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 4815-4850. <a href="https://doi.org/10.1021/acs.jmedchem.8b01492" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01492%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DClass%252B1%252BPI3K%252BClinical%252BCandidates%252Band%252BRecent%252BInhibitor%252BDesign%252BStrategies%25253A%252BA%252BMedicinal%252BChemistry%252BPerspective%26aulast%3DGarces%26aufirst%3DAimie%2BE.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D25092018%26date%3D24122018%26volume%3D62%26issue%3D10%26spage%3D4815%26epage%3D4850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 5822-5880. <a href="https://doi.org/10.1021/acs.jmedchem.7b01788" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFluorine%252Band%252BFluorinated%252BMotifs%252Bin%252Bthe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bfor%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D05122017%26date%3D05022018%26volume%3D61%26issue%3D14%26spage%3D5822%26epage%3D5880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Clohessy</span>, <span class="hlFld-ContribAuthor ">Alastair  Roberts</span>, <span class="hlFld-ContribAuthor ">Eric S.  Manas</span>, <span class="hlFld-ContribAuthor ">Vipulkumar K.  Patel</span>, <span class="hlFld-ContribAuthor ">Niall A.  Anderson</span>, and <span class="hlFld-ContribAuthor ">Allan J. B.  Watson</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemoselective One-Pot Synthesis of Functionalized Amino-azaheterocycles Enabled by COware. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (23)
                                     , 6368-6371. <a href="https://doi.org/10.1021/acs.orglett.7b03214" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b03214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b03214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b03214%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DChemoselective%252BOne-Pot%252BSynthesis%252Bof%252BFunctionalized%252BAmino-azaheterocycles%252BEnabled%252Bby%252BCOware%26aulast%3DClohessy%26aufirst%3DThomas%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14102017%26date%3D14112017%26date%3D01122017%26volume%3D19%26issue%3D23%26spage%3D6368%26epage%3D6371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony  Champiré</span>, <span class="hlFld-ContribAuthor ">Christine  Vala</span>, <span class="hlFld-ContribAuthor ">Achraf  Laabid</span>, <span class="hlFld-ContribAuthor ">Ahmed  Benharref</span>, <span class="hlFld-ContribAuthor ">Mathieu  Marchivie</span>, <span class="hlFld-ContribAuthor ">Karen  Plé</span>, and <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>  . </span><span class="cited-content_cbyCitation_article-title">Controlled Dimroth Rearrangement in the Suzuki–Miyaura Cross Coupling of Triazolopyridopyrimidines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (24)
                                     , 12506-12513. <a href="https://doi.org/10.1021/acs.joc.6b02357" title="DOI URL">https://doi.org/10.1021/acs.joc.6b02357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b02357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b02357%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DControlled%252BDimroth%252BRearrangement%252Bin%252Bthe%252BSuzuki%2525E2%252580%252593Miyaura%252BCross%252BCoupling%252Bof%252BTriazolopyridopyrimidines%26aulast%3DChampir%25C3%25A9%26aufirst%3DAnthony%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D27092016%26date%3D05122016%26date%3D16122016%26date%3D15112016%26volume%3D81%26issue%3D24%26spage%3D12506%26epage%3D12513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Xiang</span>, <span class="hlFld-ContribAuthor ">Lin  He</span>, <span class="hlFld-ContribAuthor ">Minghai  Tang</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Taijin  Wang</span>, <span class="hlFld-ContribAuthor ">Zhuang  Yang</span>, <span class="hlFld-ContribAuthor ">Yuyao  Yi</span>, <span class="hlFld-ContribAuthor ">Hairong  Wang</span>, <span class="hlFld-ContribAuthor ">Ting  Niu</span>, <span class="hlFld-ContribAuthor ">Li  Zheng</span>, <span class="hlFld-ContribAuthor ">Lei  Lei</span>, <span class="hlFld-ContribAuthor ">Xiaobin  Li</span>, <span class="hlFld-ContribAuthor ">Hang  Song</span>, and <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (11)
                                     , 5488-5504. <a href="https://doi.org/10.1021/acs.jmedchem.6b00579" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00579</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00579%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BPurine-Based%252BHydroxamic%252BAcid%252BDerivatives%25253A%252BPotent%252BHistone%252BDeacetylase%252BInhibitors%252Bwith%252BMarked%252Bin%252BVitro%252Band%252Bin%252BVivo%252BAntitumor%252BActivities%26aulast%3DChen%26aufirst%3DYong%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D15042016%26date%3D24052016%26date%3D09062016%26date%3D17052016%26volume%3D59%26issue%3D11%26spage%3D5488%26epage%3D5504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek B.  Panchabhai</span>, <span class="hlFld-ContribAuthor ">Santosh R.  Butle</span>, <span class="hlFld-ContribAuthor ">Parag G.  Ingole</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization and molecular docking studies on some new N-substituted 2-phenylpyrido[2,3-d]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Research Journal of Pharmacy and Technology</span><span> <strong>2021,</strong> <em> </em>, 3846-3854. <a href="https://doi.org/10.52711/0974-360X.2021.00667" title="DOI URL">https://doi.org/10.52711/0974-360X.2021.00667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.52711/0974-360X.2021.00667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.52711%2F0974-360X.2021.00667%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520Journal%2520of%2520Pharmacy%2520and%2520Technology%26atitle%3DSynthesis%25252C%252Bcharacterization%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bon%252Bsome%252Bnew%252BN-substituted%252B2-phenylpyrido%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%26aulast%3DPanchabhai%26aufirst%3DVivek%2BB.%26date%3D2021%26date%3D2021%26spage%3D3846%26epage%3D3854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhixu  Zhou</span>, <span class="hlFld-ContribAuthor ">Ye  Liu</span>, <span class="hlFld-ContribAuthor ">Qian  Ren</span>, <span class="hlFld-ContribAuthor ">Dehou  Yu</span>, <span class="hlFld-ContribAuthor ">Hongguang  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, crystal structure and DFT study of a novel compound N-(4-(2,4-dimorpholinopyrido[2,3-d]pyrimidin-6-yl)phenyl)pyrrolidine-1-carboxamide. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1235 </em>, 130261. <a href="https://doi.org/10.1016/j.molstruc.2021.130261" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.130261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.130261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.130261%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bcrystal%252Bstructure%252Band%252BDFT%252Bstudy%252Bof%252Ba%252Bnovel%252Bcompound%252BN-%2525284-%2525282%25252C4-dimorpholinopyrido%25255B2%25252C3-d%25255Dpyrimidin-6-yl%252529phenyl%252529pyrrolidine-1-carboxamide%26aulast%3DZhou%26aufirst%3DZhixu%26date%3D2021%26volume%3D1235%26spage%3D130261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manouchehr  Mamaghani</span>, <span class="hlFld-ContribAuthor ">Shaghayegh  Ansar</span>, <span class="hlFld-ContribAuthor ">Parivash  Jahanshahi</span>. </span><span class="cited-content_cbyCitation_article-title">A Convergent One-Pot Synthesis of Novel Pyrrole-Pyridopyrimidines Hybrids Using 1-Carboxymethyl-2,3-Dimethylimidazolium Iodide {[cmdmim]I} as a Recyclable Catalyst. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2021,</strong> <em>33 </em>, 1-14. <a href="https://doi.org/10.1080/10406638.2021.1931368" title="DOI URL">https://doi.org/10.1080/10406638.2021.1931368</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2021.1931368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2021.1931368%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DA%252BConvergent%252BOne-Pot%252BSynthesis%252Bof%252BNovel%252BPyrrole-Pyridopyrimidines%252BHybrids%252BUsing%252B1-Carboxymethyl-2%25252C3-Dimethylimidazolium%252BIodide%252B%25257B%25255Bcmdmim%25255DI%25257D%252Bas%252Ba%252BRecyclable%252BCatalyst%26aulast%3DMamaghani%26aufirst%3DManouchehr%26date%3D2021%26date%3D2021%26volume%3D33%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mazarine  Laurent</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bostyn</span>, <span class="hlFld-ContribAuthor ">Mathieu  Marchivie</span>, <span class="hlFld-ContribAuthor ">Yves  Robin</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Frédéric  Buron</span>. </span><span class="cited-content_cbyCitation_article-title">Aminations and arylations by direct C–O activation for the design of 7,8-dihydro-6
              H
              -5,8-ethanopyrido[3,2-
              d
              ]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (32)
                                     , 19363-19377. <a href="https://doi.org/10.1039/D1RA03092B" title="DOI URL">https://doi.org/10.1039/D1RA03092B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA03092B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA03092B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAminations%252Band%252Barylations%252Bby%252Bdirect%252BC%2525E2%252580%252593O%252Bactivation%252Bfor%252Bthe%252Bdesign%252Bof%252B7%25252C8-dihydro-6%252BH%252B-5%25252C8-ethanopyrido%25255B3%25252C2-%252Bd%252B%25255Dpyrimidines%26aulast%3DLaurent%26aufirst%3DMazarine%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D32%26spage%3D19363%26epage%3D19377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.  Devi</span>, <span class="hlFld-ContribAuthor ">A.  Bishnoi</span>, <span class="hlFld-ContribAuthor ">V.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">A Multicomponent Synthesis of 4H-Pyrido[1,2-a]pyrimidine-2-hydroxy-4-one Derivatives and Assessment of Their Antimicrobial Activity. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>57 </em>
                                    (2)
                                     , 265-271. <a href="https://doi.org/10.1134/S1070428021020184" title="DOI URL">https://doi.org/10.1134/S1070428021020184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428021020184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428021020184%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BMulticomponent%252BSynthesis%252Bof%252B4H-Pyrido%25255B1%25252C2-a%25255Dpyrimidine-2-hydroxy-4-one%252BDerivatives%252Band%252BAssessment%252Bof%252BTheir%252BAntimicrobial%252BActivity%26aulast%3DDevi%26aufirst%3DP.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D2%26spage%3D265%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiranjeevi  Abba</span>, <span class="hlFld-ContribAuthor ">Naveen  Puram</span>, <span class="hlFld-ContribAuthor ">Sailu  Betala</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Novel Amide Functionalized Pyrido[2,3-d]pyrimidine
Derivatives and their Anticancer Activity. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Chemistry</span><span> <strong>2021,</strong> <em>33 </em>
                                    (7)
                                     , 1579-1584. <a href="https://doi.org/10.14233/ajchem.2021.23225" title="DOI URL">https://doi.org/10.14233/ajchem.2021.23225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14233/ajchem.2021.23225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14233%2Fajchem.2021.23225%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%252Bof%252BNovel%252BAmide%252BFunctionalized%252BPyrido%25255B2%25252C3-d%25255Dpyrimidine%252BDerivatives%252Band%252Btheir%252BAnticancer%252BActivity%26aulast%3DAbba%26aufirst%3DChiranjeevi%26date%3D2021%26date%3D2021%26volume%3D33%26issue%3D7%26spage%3D1579%26epage%3D1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amira A.  Helwa</span>, <span class="hlFld-ContribAuthor ">Nehad M.  El-Dydamony</span>, <span class="hlFld-ContribAuthor ">Rasha A.  Radwan</span>, <span class="hlFld-ContribAuthor ">Sahar M.  Abdelraouf</span>, <span class="hlFld-ContribAuthor ">Rana M.  Abdelnaby</span>. </span><span class="cited-content_cbyCitation_article-title">Novel antiproliferative agents bearing morpholinopyrimidine scaffold as PI3K inhibitors and apoptosis inducers; design, synthesis and molecular docking. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>102 </em>, 104051. <a href="https://doi.org/10.1016/j.bioorg.2020.104051" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Bantiproliferative%252Bagents%252Bbearing%252Bmorpholinopyrimidine%252Bscaffold%252Bas%252BPI3K%252Binhibitors%252Band%252Bapoptosis%252Binducers%25253B%252Bdesign%25252C%252Bsynthesis%252Band%252Bmolecular%252Bdocking%26aulast%3DHelwa%26aufirst%3DAmira%2BA.%26date%3D2020%26volume%3D102%26spage%3D104051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian  Xu</span>, <span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>199 </em>, 112391. <a href="https://doi.org/10.1016/j.ejmech.2020.112391" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112391%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BmTOR%252Bfor%252Bfighting%252Bdiseases%25253A%252BA%252Brevisited%252Breview%252Bof%252BmTOR%252Binhibitors%26aulast%3DXu%26aufirst%3DTian%26date%3D2020%26volume%3D199%26spage%3D112391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eirik  Solum</span>, <span class="hlFld-ContribAuthor ">Trond Vidar  Hansen</span>, <span class="hlFld-ContribAuthor ">Reidun  Aesoy</span>, <span class="hlFld-ContribAuthor ">Lars  Herfindal</span>. </span><span class="cited-content_cbyCitation_article-title">New CDK8 inhibitors as potential anti-leukemic agents – Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (10)
                                     , 115461. <a href="https://doi.org/10.1016/j.bmc.2020.115461" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115461%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNew%252BCDK8%252Binhibitors%252Bas%252Bpotential%252Banti-leukemic%252Bagents%252B%2525E2%252580%252593%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DSolum%26aufirst%3DEirik%26date%3D2020%26volume%3D28%26issue%3D10%26spage%3D115461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yassine  Riadi</span>. </span><span class="cited-content_cbyCitation_article-title">Green, rapid and efficient synthesis of new antibacterial pyridopyrimidinone mediated by eutectic mixture of Urea/CuCl2. </span><span class="cited-content_cbyCitation_journal-name">Sustainable Chemistry and Pharmacy</span><span> <strong>2020,</strong> <em>15 </em>, 100233. <a href="https://doi.org/10.1016/j.scp.2020.100233" title="DOI URL">https://doi.org/10.1016/j.scp.2020.100233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.scp.2020.100233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.scp.2020.100233%26sid%3Dliteratum%253Aachs%26jtitle%3DSustainable%2520Chemistry%2520and%2520Pharmacy%26atitle%3DGreen%25252C%252Brapid%252Band%252Befficient%252Bsynthesis%252Bof%252Bnew%252Bantibacterial%252Bpyridopyrimidinone%252Bmediated%252Bby%252Beutectic%252Bmixture%252Bof%252BUrea%25252FCuCl2%26aulast%3DRiadi%26aufirst%3DYassine%26date%3D2020%26volume%3D15%26spage%3D100233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Cong  Wu</span>, <span class="hlFld-ContribAuthor ">Xin-Yue  Ren</span>, <span class="hlFld-ContribAuthor ">Guo-Wu  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Research Progress of Diphenyl Urea Derivatives as Anticancer Agents and Synthetic Methodologies. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Organic Chemistry</span><span> <strong>2019,</strong> <em>16 </em>
                                    (7)
                                     , 617-630. <a href="https://doi.org/10.2174/1570193X15666181029130418" title="DOI URL">https://doi.org/10.2174/1570193X15666181029130418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570193X15666181029130418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570193X15666181029130418%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Organic%2520Chemistry%26atitle%3DResearch%252BProgress%252Bof%252BDiphenyl%252BUrea%252BDerivatives%252Bas%252BAnticancer%252BAgents%252Band%252BSynthetic%252BMethodologies%26aulast%3DWu%26aufirst%3DYi-Cong%26date%3D2019%26volume%3D16%26issue%3D7%26spage%3D617%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shubham  Srivastava</span>, <span class="hlFld-ContribAuthor ">Ajeesh  Vengamthodi</span>, <span class="hlFld-ContribAuthor ">Inderpal  Singh</span>, <span class="hlFld-ContribAuthor ">Bhanwar Singh  Choudhary</span>, <span class="hlFld-ContribAuthor ">Manish  Sharma</span>, <span class="hlFld-ContribAuthor ">Ruchi  Malik</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of comprehensive in silico determinants as a strategy for identification of novel PI3Kα inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2019,</strong> <em>30 </em>
                                    (5)
                                     , 1761-1778. <a href="https://doi.org/10.1007/s11224-019-01303-2" title="DOI URL">https://doi.org/10.1007/s11224-019-01303-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-019-01303-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-019-01303-2%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DDetermination%252Bof%252Bcomprehensive%252Bin%252Bsilico%252Bdeterminants%252Bas%252Ba%252Bstrategy%252Bfor%252Bidentification%252Bof%252Bnovel%252BPI3K%2525CE%2525B1%252Binhibitors%26aulast%3DSrivastava%26aufirst%3DShubham%26date%3D2019%26date%3D2019%26volume%3D30%26issue%3D5%26spage%3D1761%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Chunlan  Pu</span>, <span class="hlFld-ContribAuthor ">Suke  Lan</span>, <span class="hlFld-ContribAuthor ">Xinxin  Zhong</span>, <span class="hlFld-ContribAuthor ">Meng  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueyan  Hou</span>, <span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Huifang  Shan</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Rui  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and orally active PI3K/mTOR dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 667-686. <a href="https://doi.org/10.1016/j.ejmech.2019.06.021" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-phenyl-2H-benzo%25255Bb%25255D%25255B1%25252C4%25255Doxazin-3%2525284H%252529-one%252Bderivatives%252Bas%252Bpotent%252Band%252Borally%252Bactive%252BPI3K%25252FmTOR%252Bdual%252Binhibitors%26aulast%3DYan%26aufirst%3DGuoyi%26date%3D2019%26volume%3D178%26spage%3D667%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yassine  Riadi</span>. </span><span class="cited-content_cbyCitation_article-title">UV Light-mediated regioselective methylsulfanyl discrimination
              via
              Pd-catalyzed cross-coupling reactions of 2,4-dimethylsulfanylpyrido[2,3-
              d
              ]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Sulfur Chemistry</span><span> <strong>2019,</strong> <em>40 </em>
                                    (4)
                                     , 351-360. <a href="https://doi.org/10.1080/17415993.2019.1590581" title="DOI URL">https://doi.org/10.1080/17415993.2019.1590581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17415993.2019.1590581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17415993.2019.1590581%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Sulfur%2520Chemistry%26atitle%3DUV%252BLight-mediated%252Bregioselective%252Bmethylsulfanyl%252Bdiscrimination%252Bvia%252BPd-catalyzed%252Bcross-coupling%252Breactions%252Bof%252B2%25252C4-dimethylsulfanylpyrido%25255B2%25252C3-%252Bd%252B%25255Dpyrimidines%26aulast%3DRiadi%26aufirst%3DYassine%26date%3D2019%26date%3D2019%26volume%3D40%26issue%3D4%26spage%3D351%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yassine  Riadi</span>, <span class="hlFld-ContribAuthor ">Saïd  Lazar</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective palladium-catalyzed Suzuki–Miyaura coupling reaction of 2,4,6-trihalogenopyrido[2,3-d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Comptes Rendus Chimie</span><span> <strong>2019,</strong> <em>22 </em>
                                    (4)
                                     , 294-298. <a href="https://doi.org/10.1016/j.crci.2019.01.006" title="DOI URL">https://doi.org/10.1016/j.crci.2019.01.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.crci.2019.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.crci.2019.01.006%26sid%3Dliteratum%253Aachs%26jtitle%3DComptes%2520Rendus%2520Chimie%26atitle%3DRegioselective%252Bpalladium-catalyzed%252BSuzuki%2525E2%252580%252593Miyaura%252Bcoupling%252Breaction%252Bof%252B2%25252C4%25252C6-trihalogenopyrido%25255B2%25252C3-d%25255Dpyrimidines%26aulast%3DRiadi%26aufirst%3DYassine%26date%3D2019%26volume%3D22%26issue%3D4%26spage%3D294%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatima  Arshad</span>, <span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">Mohammad Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Lalit Mohan  Nainwal</span>, <span class="hlFld-ContribAuthor ">Sumit Kumar  Kaushik</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">Suhel  Parvez</span>, <span class="hlFld-ContribAuthor ">Syed Misbahul  Hasan</span>, <span class="hlFld-ContribAuthor ">Mohammad  Shaquiquzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing quinquennial anticancer journey of morpholine: A SAR based review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 324-356. <a href="https://doi.org/10.1016/j.ejmech.2019.02.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRevealing%252Bquinquennial%252Banticancer%252Bjourney%252Bof%252Bmorpholine%25253A%252BA%252BSAR%252Bbased%252Breview%26aulast%3DArshad%26aufirst%3DFatima%26date%3D2019%26volume%3D167%26spage%3D324%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagy M.  Khalifa</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Al-Omar</span>, <span class="hlFld-ContribAuthor ">Hamad M.  Alkahtani</span>, <span class="hlFld-ContribAuthor ">Ahmed H.  Bakheit</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors of Novel Pyridopyrimidinone Candidates: Synthesis and
              In Vitro
              Anticancer Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>, 1-10. <a href="https://doi.org/10.1155/2019/2635219" title="DOI URL">https://doi.org/10.1155/2019/2635219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2019/2635219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2019%2F2635219%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemistry%26atitle%3DKinase%252BInhibitors%252Bof%252BNovel%252BPyridopyrimidinone%252BCandidates%25253A%252BSynthesis%252Band%252BIn%252BVitro%252BAnticancer%252BProperties%26aulast%3DKhalifa%26aufirst%3DNagy%2BM.%26date%3D2019%26volume%3D2019%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed S.  Abdel‐Maksoud</span>, <span class="hlFld-ContribAuthor ">Mohammed I.  El‐Gamal</span>, <span class="hlFld-ContribAuthor ">Dalia Reyane  Benhalilou</span>, <span class="hlFld-ContribAuthor ">Sandy  Ashraf</span>, <span class="hlFld-ContribAuthor ">Shatha Abdulghaffar  Mohammed</span>, <span class="hlFld-ContribAuthor ">Chang‐Hyun  Oh</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic/mammalian target of rapamycin: Recent pathological aspects and inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (2)
                                     , 631-664. <a href="https://doi.org/10.1002/med.21535" title="DOI URL">https://doi.org/10.1002/med.21535</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21535%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMechanistic%25252Fmammalian%252Btarget%252Bof%252Brapamycin%25253A%252BRecent%252Bpathological%252Baspects%252Band%252Binhibitors%26aulast%3DAbdel%25E2%2580%2590Maksoud%26aufirst%3DMohammed%2BS.%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D2%26spage%3D631%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. V.  Komkov</span>, <span class="hlFld-ContribAuthor ">T. V.  Potapova</span>, <span class="hlFld-ContribAuthor ">M. I.  Zuev</span>, <span class="hlFld-ContribAuthor ">S. V.  Baranin</span>, <span class="hlFld-ContribAuthor ">Yu. N.  Bubnov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new trichloromethyl- and alkoxy-substituted pyrido[2,3-d]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2019,</strong> <em>68 </em>
                                    (2)
                                     , 365-373. <a href="https://doi.org/10.1007/s11172-019-2394-6" title="DOI URL">https://doi.org/10.1007/s11172-019-2394-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-019-2394-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-019-2394-6%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DSynthesis%252Bof%252Bnew%252Btrichloromethyl-%252Band%252Balkoxy-substituted%252Bpyrido%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%26aulast%3DKomkov%26aufirst%3DA.%2BV.%26date%3D2019%26date%3D2019%26volume%3D68%26issue%3D2%26spage%3D365%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Quan  Sun</span>, <span class="hlFld-ContribAuthor ">Chao-Yang  Zong</span>, <span class="hlFld-ContribAuthor ">Jin-Yu  Ji</span>, <span class="hlFld-ContribAuthor ">Qing  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient and library-friendly synthesis of 4-N-substituted 6-bromopyrido[2,3-d]pyrimidines under microwave irradiation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Papers</span><span> <strong>2018,</strong> <em>72 </em>
                                    (12)
                                     , 2965-2972. <a href="https://doi.org/10.1007/s11696-018-0498-3" title="DOI URL">https://doi.org/10.1007/s11696-018-0498-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11696-018-0498-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11696-018-0498-3%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Papers%26atitle%3DEfficient%252Band%252Blibrary-friendly%252Bsynthesis%252Bof%252B4-N-substituted%252B6-bromopyrido%25255B2%25252C3-d%25255Dpyrimidines%252Bunder%252Bmicrowave%252Birradiation%26aulast%3DSun%26aufirst%3DYa-Quan%26date%3D2018%26date%3D2018%26volume%3D72%26issue%3D12%26spage%3D2965%26epage%3D2972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiu-Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi  Jia</span>, <span class="hlFld-ContribAuthor ">Hui-Hui  Yang</span>, <span class="hlFld-ContribAuthor ">Yun-Jun  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Dibenzoxanthenes induce apoptosis and autophagy in HeLa cells by modeling the PI3K/Akt pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Photochemistry and Photobiology B: Biology</span><span> <strong>2018,</strong> <em>187 </em>, 76-88. <a href="https://doi.org/10.1016/j.jphotobiol.2018.08.001" title="DOI URL">https://doi.org/10.1016/j.jphotobiol.2018.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jphotobiol.2018.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jphotobiol.2018.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Photochemistry%2520and%2520Photobiology%2520B%253A%2520Biology%26atitle%3DDibenzoxanthenes%252Binduce%252Bapoptosis%252Band%252Bautophagy%252Bin%252BHeLa%252Bcells%252Bby%252Bmodeling%252Bthe%252BPI3K%25252FAkt%252Bpathway%26aulast%3DWang%26aufirst%3DXiu-Zhen%26date%3D2018%26volume%3D187%26spage%3D76%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yinyin  Liu</span>, <span class="hlFld-ContribAuthor ">Qinhua  Xia</span>, <span class="hlFld-ContribAuthor ">Lei  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of alkyl substituted pyridino[2,3-D]pyrimidine compounds as PI3Kα/mTOR dual inhibitors with improved pharmacokinetic properties and potent in vivo antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (14)
                                     , 3992-4000. <a href="https://doi.org/10.1016/j.bmc.2018.06.025" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.06.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.06.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Balkyl%252Bsubstituted%252Bpyridino%25255B2%25252C3-D%25255Dpyrimidine%252Bcompounds%252Bas%252BPI3K%2525CE%2525B1%25252FmTOR%252Bdual%252Binhibitors%252Bwith%252Bimproved%252Bpharmacokinetic%252Bproperties%252Band%252Bpotent%252Bin%252Bvivo%252Bantitumor%252Bactivity%26aulast%3DLiu%26aufirst%3DYinyin%26date%3D2018%26volume%3D26%26issue%3D14%26spage%3D3992%26epage%3D4000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun  Li</span>, <span class="hlFld-ContribAuthor ">Xunhua  Lu</span>, <span class="hlFld-ContribAuthor ">Yuanyong  Yang</span>, <span class="hlFld-ContribAuthor ">Shenggang  Yang</span>, <span class="hlFld-ContribAuthor ">Lin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Ionic liquid promoted synthesis of heterocycle-fused pyrimidine-2,4(1H,3H)-diones utilising CO2. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (25)
                                     , 2463-2466. <a href="https://doi.org/10.1016/j.tetlet.2018.05.043" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.05.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.05.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.05.043%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DIonic%252Bliquid%252Bpromoted%252Bsynthesis%252Bof%252Bheterocycle-fused%252Bpyrimidine-2%25252C4%2525281H%25252C3H%252529-diones%252Butilising%252BCO2%26aulast%3DLi%26aufirst%3DChun%26date%3D2018%26volume%3D59%26issue%3D25%26spage%3D2463%26epage%3D2466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yassine  Riadi</span>, <span class="hlFld-ContribAuthor ">Mohammed  Geesi</span>. </span><span class="cited-content_cbyCitation_article-title">Photochemical route for the synthesis of novel 2-monosubstituted pyrido[2,3-d]pyrimidines by palladium-catalyzed cross-coupling reactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Papers</span><span> <strong>2018,</strong> <em>72 </em>
                                    (3)
                                     , 697-701. <a href="https://doi.org/10.1007/s11696-017-0325-2" title="DOI URL">https://doi.org/10.1007/s11696-017-0325-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11696-017-0325-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11696-017-0325-2%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Papers%26atitle%3DPhotochemical%252Broute%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bnovel%252B2-monosubstituted%252Bpyrido%25255B2%25252C3-d%25255Dpyrimidines%252Bby%252Bpalladium-catalyzed%252Bcross-coupling%252Breactions%26aulast%3DRiadi%26aufirst%3DYassine%26date%3D2018%26date%3D2017%26volume%3D72%26issue%3D3%26spage%3D697%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Bosc</span>, <span class="hlFld-ContribAuthor ">Christophe  Meyer</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>. </span><span class="cited-content_cbyCitation_article-title">The use of novel selectivity metrics in kinase research. </span><span class="cited-content_cbyCitation_journal-name">BMC Bioinformatics</span><span> <strong>2017,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12859-016-1413-y" title="DOI URL">https://doi.org/10.1186/s12859-016-1413-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12859-016-1413-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12859-016-1413-y%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Bioinformatics%26atitle%3DThe%252Buse%252Bof%252Bnovel%252Bselectivity%252Bmetrics%252Bin%252Bkinase%252Bresearch%26aulast%3DBosc%26aufirst%3DNicolas%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Lu  Zhou</span>, <span class="hlFld-ContribAuthor ">Yingjun  Zhu</span>, <span class="hlFld-ContribAuthor ">Min  Zhang</span>, <span class="hlFld-ContribAuthor ">Liping  Song</span>, <span class="hlFld-ContribAuthor ">Hongmei  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Unexpected straightforward formation of trifluoromethylated pyrido[2,3- d ]pyrimidine derivatives via one-pot, MCRs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2017,</strong> <em>200 </em>, 162-168. <a href="https://doi.org/10.1016/j.jfluchem.2017.06.016" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2017.06.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2017.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2017.06.016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DUnexpected%252Bstraightforward%252Bformation%252Bof%252Btrifluoromethylated%252Bpyrido%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine%252Bderivatives%252Bvia%252Bone-pot%25252C%252BMCRs%26aulast%3DWang%26aufirst%3DYang%26date%3D2017%26volume%3D200%26spage%3D162%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aisha A.K.  Al-Ashmawy</span>, <span class="hlFld-ContribAuthor ">Fatma A.  Ragab</span>, <span class="hlFld-ContribAuthor ">Khaled M.  Elokely</span>, <span class="hlFld-ContribAuthor ">Manal M.  Anwar</span>, <span class="hlFld-ContribAuthor ">Oscar  Perez-Leal</span>, <span class="hlFld-ContribAuthor ">Mario C.  Rico</span>, <span class="hlFld-ContribAuthor ">John  Gordon</span>, <span class="hlFld-ContribAuthor ">Eugeney  Bichenkov</span>, <span class="hlFld-ContribAuthor ">George  Mateo</span>, <span class="hlFld-ContribAuthor ">Emad M.M.  Kassem</span>, <span class="hlFld-ContribAuthor ">Gehan H.  Hegazy</span>, <span class="hlFld-ContribAuthor ">Magid  Abou-Gharbia</span>, <span class="hlFld-ContribAuthor ">Wayne  Childers</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and SAR of new-di-substituted pyridopyrimidines as ATP-competitive dual PI3Kα/mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (14)
                                     , 3117-3122. <a href="https://doi.org/10.1016/j.bmcl.2017.05.044" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.05.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.05.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.05.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252BSAR%252Bof%252Bnew-di-substituted%252Bpyridopyrimidines%252Bas%252BATP-competitive%252Bdual%252BPI3K%2525CE%2525B1%25252FmTOR%252Binhibitors%26aulast%3DAl-Ashmawy%26aufirst%3DAisha%2BA.K.%26date%3D2017%26volume%3D27%26issue%3D14%26spage%3D3117%26epage%3D3122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yassine  Riadi</span>, <span class="hlFld-ContribAuthor ">Mohammed  Geesi</span>, <span class="hlFld-ContribAuthor ">Oussama  Dehbi</span>, <span class="hlFld-ContribAuthor ">Mohammed A.  Bakht</span>, <span class="hlFld-ContribAuthor ">Mohammed  Alshammari</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Viaud-Massuarde</span>. </span><span class="cited-content_cbyCitation_article-title">Novel animal-bone-meal-supported palladium as a green and efficient catalyst for Suzuki coupling reaction in water, under sunlight. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry Letters and Reviews</span><span> <strong>2017,</strong> <em>10 </em>
                                    (2)
                                     , 101-106. <a href="https://doi.org/10.1080/17518253.2017.1300687" title="DOI URL">https://doi.org/10.1080/17518253.2017.1300687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17518253.2017.1300687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17518253.2017.1300687%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%2520Letters%2520and%2520Reviews%26atitle%3DNovel%252Banimal-bone-meal-supported%252Bpalladium%252Bas%252Ba%252Bgreen%252Band%252Befficient%252Bcatalyst%252Bfor%252BSuzuki%252Bcoupling%252Breaction%252Bin%252Bwater%25252C%252Bunder%252Bsunlight%26aulast%3DRiadi%26aufirst%3DYassine%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D2%26spage%3D101%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-zhu  Wan</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Guan-lian  Zhou</span>, <span class="hlFld-ContribAuthor ">Xin-guang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 7181-7200. <a href="https://doi.org/10.18632/oncotarget.12742" title="DOI URL">https://doi.org/10.18632/oncotarget.12742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.12742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.12742%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DRecent%252Bdevelopment%252Bof%252BATP-competitive%252Bsmall%252Bmolecule%252Bphosphatidylinostitol-3-kinase%252Binhibitors%252Bas%252Banticancer%252Bagents%26aulast%3DLiu%26aufirst%3DYu%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D7181%26epage%3D7200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed S.  Behalo</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Mele</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Pyrido[2,3-d]pyrimidine and 1,8-Naphthyridine Derivatives as Potential Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2017,</strong> <em>54 </em>
                                    (1)
                                     , 295-300. <a href="https://doi.org/10.1002/jhet.2581" title="DOI URL">https://doi.org/10.1002/jhet.2581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2581%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BPyrido%25255B2%25252C3-d%25255Dpyrimidine%252Band%252B1%25252C8-Naphthyridine%252BDerivatives%252Bas%252BPotential%252BAntitumor%252BAgents%26aulast%3DBehalo%26aufirst%3DMohamed%2BS.%26date%3D2017%26date%3D2016%26volume%3D54%26issue%3D1%26spage%3D295%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiankang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Ming  Li</span>, <span class="hlFld-ContribAuthor ">Yanmei  Zhao</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Liu</span>, <span class="hlFld-ContribAuthor ">Shuyu  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 3-amidoquinoline derivatives as PI3K/mTOR dual inhibitors with potential for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (4)
                                     , 2342-2350. <a href="https://doi.org/10.1039/C6RA26971K" title="DOI URL">https://doi.org/10.1039/C6RA26971K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA26971K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA26971K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DIdentification%252Bof%252B3-amidoquinoline%252Bderivatives%252Bas%252BPI3K%25252FmTOR%252Bdual%252Binhibitors%252Bwith%252Bpotential%252Bfor%252Bcancer%252Btherapy%26aulast%3DZhang%26aufirst%3DJiankang%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D4%26spage%3D2342%26epage%3D2350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagi Reddy  Modugu</span>, <span class="hlFld-ContribAuthor ">Praveen Kumar  Pittala</span>. </span><span class="cited-content_cbyCitation_article-title">Polyethylene glycol (PEG-400) promoted as an efficient and recyclable reaction medium for the one-pot eco-friendly synthesis of functionalized isoxazole substituted spirooxindole derivatives. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2017,</strong> <em>41 </em>
                                    (23)
                                     , 14062-14066. <a href="https://doi.org/10.1039/C7NJ03515B" title="DOI URL">https://doi.org/10.1039/C7NJ03515B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7NJ03515B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7NJ03515B%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DPolyethylene%252Bglycol%252B%252528PEG-400%252529%252Bpromoted%252Bas%252Ban%252Befficient%252Band%252Brecyclable%252Breaction%252Bmedium%252Bfor%252Bthe%252Bone-pot%252Beco-friendly%252Bsynthesis%252Bof%252Bfunctionalized%252Bisoxazole%252Bsubstituted%252Bspirooxindole%252Bderivatives%26aulast%3DModugu%26aufirst%3DNagi%2BReddy%26date%3D2017%26date%3D2017%26volume%3D41%26issue%3D23%26spage%3D14062%26epage%3D14066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengyu  Sun</span>, <span class="hlFld-ContribAuthor ">Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Shan  Xu</span>, <span class="hlFld-ContribAuthor ">Jianqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Dejia  Kong</span>, <span class="hlFld-ContribAuthor ">Hong  Tao</span>, <span class="hlFld-ContribAuthor ">Mengjia  Jin</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activity of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives bearing chromone moiety. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (16)
                                     , 3862-3869. <a href="https://doi.org/10.1016/j.bmc.2016.06.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.06.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.06.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivity%252Bof%252Bnovel%252B4-morpholino-7%25252C8-dihydro-5H-thiopyrano%25255B4%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bbearing%252Bchromone%252Bmoiety%26aulast%3DSun%26aufirst%3DChengyu%26date%3D2016%26volume%3D24%26issue%3D16%26spage%3D3862%26epage%3D3869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Chen</span>, <span class="hlFld-ContribAuthor ">Miao  Yu</span>, <span class="hlFld-ContribAuthor ">Li-Hui  Xu</span>, <span class="hlFld-ContribAuthor ">Bao  Cheng</span>, <span class="hlFld-ContribAuthor ">Yong-Sheng  Lin</span>, <span class="hlFld-ContribAuthor ">Qiong  Gu</span>, <span class="hlFld-ContribAuthor ">Xian-Hui  He</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovering new mTOR inhibitors for cancer treatment through virtual screening methods and in vitro assays. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep18987" title="DOI URL">https://doi.org/10.1038/srep18987</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep18987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep18987%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovering%252Bnew%252BmTOR%252Binhibitors%252Bfor%252Bcancer%252Btreatment%252Bthrough%252Bvirtual%252Bscreening%252Bmethods%252Band%252Bin%252Bvitro%252Bassays%26aulast%3DWang%26aufirst%3DLing%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chloé  Copin</span>, <span class="hlFld-ContribAuthor ">Frédéric  Buron</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Amination of C-5 Bromoimidazo[2,1-
              b
              ]­[1,3,4]­thiadiazoles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (11)
                                     , 1958-1962. <a href="https://doi.org/10.1002/ejoc.201600145" title="DOI URL">https://doi.org/10.1002/ejoc.201600145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600145%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium-Catalyzed%252BAmination%252Bof%252BC-5%252BBromoimidazo%25255B2%25252C1-%252Bb%252B%25255D%2525C2%2525AD%25255B1%25252C3%25252C4%25255D%2525C2%2525ADthiadiazoles%26aulast%3DCopin%26aufirst%3DChlo%25C3%25A9%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D11%26spage%3D1958%26epage%3D1962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomasz  Rzymski</span>, <span class="hlFld-ContribAuthor ">Michał  Mikula</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Wiklik</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Brzózka</span>. </span><span class="cited-content_cbyCitation_article-title">CDK8 kinase—An emerging target in targeted cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2015,</strong> <em>1854 </em>
                                    (10)
                                     , 1617-1629. <a href="https://doi.org/10.1016/j.bbapap.2015.05.011" title="DOI URL">https://doi.org/10.1016/j.bbapap.2015.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2015.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2015.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DCDK8%252Bkinase%2525E2%252580%252594An%252Bemerging%252Btarget%252Bin%252Btargeted%252Bcancer%252Btherapy%26aulast%3DRzymski%26aufirst%3DTomasz%26date%3D2015%26volume%3D1854%26issue%3D10%26spage%3D1617%26epage%3D1629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Huazhou  Ying</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Ni  Qiu</span>, <span class="hlFld-ContribAuthor ">Peng  Wu</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 4-alkynyl-quinoline derivatives as PI3K/mTOR dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>99 </em>, 36-50. <a href="https://doi.org/10.1016/j.ejmech.2015.05.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.05.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.05.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B4-alkynyl-quinoline%252Bderivatives%252Bas%252BPI3K%25252FmTOR%252Bdual%252Binhibitors%26aulast%3DLv%26aufirst%3DXiaoqing%26date%3D2015%26volume%3D99%26spage%3D36%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F.  Buron</span>, <span class="hlFld-ContribAuthor ">J.Y.  Mérour</span>, <span class="hlFld-ContribAuthor ">M.  Akssira</span>, <span class="hlFld-ContribAuthor ">G.  Guillaumet</span>, <span class="hlFld-ContribAuthor ">S.  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the chemistry and biology of pyridopyrimidines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>95 </em>, 76-95. <a href="https://doi.org/10.1016/j.ejmech.2015.03.029" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.029%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bchemistry%252Band%252Bbiology%252Bof%252Bpyridopyrimidines%26aulast%3DBuron%26aufirst%3DF.%26date%3D2015%26volume%3D95%26spage%3D76%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Min-Hang  Xin</span>, <span class="hlFld-ContribAuthor ">Jing  Xu</span>, <span class="hlFld-ContribAuthor ">Bo-Rui  Kang</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">She-Min  Lu</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>96 </em>, 382-395. <a href="https://doi.org/10.1016/j.ejmech.2015.04.037" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.04.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.04.037%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantitumor%252Bactivities%252Bevaluation%252Bof%252Bm-%2525284-morpholinoquinazolin-2-yl%252529benzamides%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DWang%26aufirst%3DXiao-Meng%26date%3D2015%26volume%3D96%26spage%3D382%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gemma  Triola</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical tools for modulating autophagy. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (3)
                                     , 387-406. <a href="https://doi.org/10.1016/j.tet.2014.10.057" title="DOI URL">https://doi.org/10.1016/j.tet.2014.10.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.10.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.10.057%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DChemical%252Btools%252Bfor%252Bmodulating%252Bautophagy%26aulast%3DTriola%26aufirst%3DGemma%26date%3D2015%26volume%3D71%26issue%3D3%26spage%3D387%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atanu  Bhaumik</span>, <span class="hlFld-ContribAuthor ">Tarun Kumar  Pal</span>, <span class="hlFld-ContribAuthor ">Tanmaya  Pathak</span>. </span><span class="cited-content_cbyCitation_article-title">1,1-Dioxothiomorpholines with asymmetric environments: protecting group directed diastereoselectivity of glyco divinyl sulfone cyclization. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (35)
                                     , 27706-27710. <a href="https://doi.org/10.1039/C5RA03276H" title="DOI URL">https://doi.org/10.1039/C5RA03276H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA03276H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA03276H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3D1%25252C1-Dioxothiomorpholines%252Bwith%252Basymmetric%252Benvironments%25253A%252Bprotecting%252Bgroup%252Bdirected%252Bdiastereoselectivity%252Bof%252Bglyco%252Bdivinyl%252Bsulfone%252Bcyclization%26aulast%3DBhaumik%26aufirst%3DAtanu%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D35%26spage%3D27706%26epage%3D27710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Yves  Mérour</span>, <span class="hlFld-ContribAuthor ">Frédéric  Buron</span>, <span class="hlFld-ContribAuthor ">Karen  Plé</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">The Azaindole Framework in the Design of Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (12)
                                     , 19935-19979. <a href="https://doi.org/10.3390/molecules191219935" title="DOI URL">https://doi.org/10.3390/molecules191219935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules191219935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules191219935%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BAzaindole%252BFramework%252Bin%252Bthe%252BDesign%252Bof%252BKinase%252BInhibitors%26aulast%3DM%25C3%25A9rour%26aufirst%3DJean-Yves%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D12%26spage%3D19935%26epage%3D19979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of PI3K inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Disubstituted pyridopyrimidine libraries <b>I</b> and <b>II</b> from precursors <b>III</b> and <b>IV</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amine, Et<sub>3</sub>N, THF, rt, 12 h; (b) 3-HOC<sub>6</sub>H<sub>4</sub>B(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME, MW, 150 °C, 1 h. For yields see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Het)ArB(OH)<sub>2</sub> or (Het)ArBF<sub>3</sub>K, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME, MW, 150 °C, 1 h. For yields see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-(MOM)C<sub>6</sub>H<sub>4</sub>BF<sub>3</sub>K, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, 100 °C, 2 h, 45%; (b) morpholine, Et<sub>3</sub>N, THF, reflux, 12 h, 68%; (c) HCl (4 N), EtOH, rt, 1 h, 60%; (d) morpholine, Et<sub>3</sub>N, THF, rt, 12 h, 80%; (e) (Het)ArB(OH)<sub>2</sub> or (Het)ArBF<sub>3</sub>K, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME, MW, 150 °C, 1 h. For exact structures and yields see Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) triphosgene, DIPEA, THF, −78 °C, 40 min, then RNH<sub>2</sub>, DIPEA, THF, rt, 24 h. For exact structures and yields see Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representation of the predicted binding mode of compound <b>3a</b> in the active site of PI3Kα. Hydrogen bonds are represented in yellow-black dotted lines. For clarity, only polar hydrogens are represented and residues 767–772 overlaying the ligands are hidden in the ribbon representation (PDB reference codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HHM">3HHM</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a> for the positioning of Lys802).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representation of the predicted binding mode of compound <b>13c</b> in the active site of PI3Kα. Hydrogen bonds are represented in yellow-black dotted lines. For clarity, nonpolar H atoms are not represented and residues 767–772 overlaying the ligands are hidden in the ribbon representation (PDB reference codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HHM">3HHM</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a> for the positioning of Lys802).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of <b>13b</b> and <b>13c</b> on the AKT and mTORC1 activity in breast cancer cells by Western blotting.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/medium/jm-2013-01138v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of the best inhibitors <b>13b</b> and <b>13c</b> on the growth of breast cancer cell lines: left, distribution in the cell cycle; right, rate of apoptosis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-3/jm401138v/production/images/large/jm-2013-01138v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401138v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">The phosphoinositide 3-kinase pathway</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1126%2Fscience.296.5573.1655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=12040186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1655-1657&author=L.+C.+Cantley&title=The+phosphoinositide+3-kinase+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphoinositide 3-kinase pathway</span></div><div class="casAuthors">Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5573</span>),
    <span class="NLM_cas:pages">1655-1657</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 8 refs.  Phosphorylated lipids are produced at cellular membranes during signaling events and contribute to the recruitment and activation of various signaling components.  The role of phosphoinositide 3-kinase (PI3K), which catalyzes the prodn. of phosphatidylinositol 3,4,5-trisphosphate, in cell survival pathways; the regulation of gene expression and cell metab.; and cytoskeletal rearrangements are highlighted.  The PI3K pathway is implicated in human diseases including diabetes and cancer, and understanding the intricacies of this pathway may provide new avenues for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9pxSplxmS1rVg90H21EOLACvtfcHk0ljdaPDDVNO0AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D&md5=110c8a351448aed6ab938b9ccf90a655</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1126%2Fscience.296.5573.1655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.296.5573.1655%26sid%3Dliteratum%253Aachs%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520phosphoinositide%25203-kinase%2520pathway%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D1655%26epage%3D1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1038%2Fnrg1879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=16847462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFCnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=606-619&author=J.+A.+Engelmanauthor=J.+Luoauthor=L.+C.+Cantley&title=The+evolution+of+phosphatidylinositol+3-kinases+as+regulators+of+growth+and+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism</span></div><div class="casAuthors">Engelman, Jeffrey A.; Luo, Ji; Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">606-619</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphatidylinositol 3-kinases (PI3Ks) evolved from a single enzyme that regulates vesicle trafficking in unicellular eukaryotes into a family of enzymes that regulate cellular metab. and growth in multicellular organisms.  In this review, we examine how the PI3K pathway has evolved to control these fundamental processes, and how this pathway is in turn regulated by intricate feedback and crosstalk mechanisms.  In light of the recent advances in our understanding of the function of PI3Ks in the pathogenesis of diabetes and cancer, we discuss the exciting therapeutic opportunities for targeting this pathway to treat these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphucxYJIwcQLVg90H21EOLACvtfcHk0ljdaPDDVNO0AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFCnu7Y%253D&md5=cd9eb85158710db6b33336af4e0a8cfe</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnrg1879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg1879%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520evolution%2520of%2520phosphatidylinositol%25203-kinases%2520as%2520regulators%2520of%2520growth%2520and%2520metabolism%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2006%26volume%3D7%26spage%3D606%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Meier, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radding, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingaraj, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. C.</span><span> </span><span class="NLM_article-title">Cloning, expression, purification, and characterization of the human class Ia phosphoinositide 3-kinase isoforms</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.pep.2003.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=15135396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsl2msrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2004&pages=218-224&author=T.+I.+Meierauthor=J.+A.+Cookauthor=J.+E.+Thomasauthor=J.+A.+Raddingauthor=C.+Hornauthor=T.+Lingarajauthor=M.+C.+Smith&title=Cloning%2C+expression%2C+purification%2C+and+characterization+of+the+human+class+Ia+phosphoinositide+3-kinase+isoforms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms</span></div><div class="casAuthors">Meier, Timothy I.; Cook, James A.; Thomas, James E.; Radding, Jeffrey A.; Horn, Candice; Lingaraj, Trupti; Smith, Michele C.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">218-224</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The Class I phosphoinositide 3-kinases (PI3Ks) are lipid kinases that phosphorylate the 3-hydroxyl group of the inositol ring of phosphatidylinositides.  Although closely related, exptl. evidence suggests that the four Class I PI3Ks may be functionally distinct.  To further study their unique biochem. properties, the three human Class Ia PI3K (α, β, and δ) p110 catalytic domains were cloned and co-expressed with the p85α regulatory domain in Sf9 cells.  None of the p110 subunits were successfully expressed in the absence of p85α.  Successful expression and purifn. of each p85α/p110 protein required using an excess of the p110 vector over the p85 vector during co-infection of Sf9 cells.  Proteins were purified as the p85α/p110 complex by nickel affinity chromatog. through an N-terminal His-tag on the p110 subunit using an imidazole gradient.  The purifn. yields were high using the optimized ratio of p85/p110 vector and small culture vols., with 24 mg/L cell culture media for p85α/p110α, 17.5 mg/L for p85α/p110δ, and 3.5 mg/L for p85α/p110β.  The identity of each purified isoform was confirmed by mass spectral anal. and immunoblotting.  The activities of the three p85α/p110 proteins and the Class Ib p110γ catalytic domain were investigated using phosphatidylinositol 4,5-bisphosphate (PIP2) as the substrate in a PIP2/phosphatidylserine (PS) liposome.  All four enzymes exhibited reaction velocities that were dependent on the surface concn. of PIP2.  The surface concns. that gave maximal activity for each human isoform with 0.5 mM PIP2 were 2.5 mol% PIP2 for p110γ, 7.5 mol% for p85α/p110β, and 10 mol% PIP2 for p85α/p110α and p85α/p110δ.  The specific activity of p85α/p110α was three to five times higher than that of the other human isoforms.  These kinetic differences may contribute to the unique roles of these isoforms in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8gaKRYiaAH7Vg90H21EOLACvtfcHk0litRJom3u5HDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsl2msrs%253D&md5=167564a41fdf98822b5bb2ee854d8421</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2003.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2003.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DMeier%26aufirst%3DT.%2BI.%26aulast%3DCook%26aufirst%3DJ.%2BA.%26aulast%3DThomas%26aufirst%3DJ.%2BE.%26aulast%3DRadding%26aufirst%3DJ.%2BA.%26aulast%3DHorn%26aufirst%3DC.%26aulast%3DLingaraj%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DM.%2BC.%26atitle%3DCloning%252C%2520expression%252C%2520purification%252C%2520and%2520characterization%2520of%2520the%2520human%2520class%2520Ia%2520phosphoinositide%25203-kinase%2520isoforms%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2004%26volume%3D35%26spage%3D218%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Ali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rückle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span> </span><span class="NLM_article-title">Isoform-specific functions of phosphoinositide 3-kinases: p110δ but not p110γ promotes optimal allergic responses in vivo</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">2538</span><span class="NLM_x">–</span> <span class="NLM_lpage">2544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=2538-2544&author=K.+Aliauthor=M.+Campsauthor=W.+P.+Pearceauthor=H.+Jiauthor=T.+R%C3%BCckleauthor=N.+Kuehnauthor=C.+Pasqualiauthor=C.+Chabertauthor=C.+Rommelauthor=B.+Vanhaesebroeck&title=Isoform-specific+functions+of+phosphoinositide+3-kinases%3A+p110%CE%B4+but+not+p110%CE%B3+promotes+optimal+allergic+responses+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DK.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DPearce%26aufirst%3DW.%2BP.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DKuehn%26aufirst%3DN.%26aulast%3DPasquali%26aufirst%3DC.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26atitle%3DIsoform-specific%2520functions%2520of%2520phosphoinositide%25203-kinases%253A%2520p110%25CE%25B4%2520but%2520not%2520p110%25CE%25B3%2520promotes%2520optimal%2520allergic%2520responses%2520in%2520vivo%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D2538%26epage%3D2544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilancio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilfillan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkaczyk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giddings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskett, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okkenhaug, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span> </span><span class="NLM_article-title">Essential role for the p110δ phosphoinositide 3-kinase in the allergic response</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">431</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1011</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=2004&pages=1007-1011&author=K.+Aliauthor=A.+Bilancioauthor=M.+Thomasauthor=W.+Pearceauthor=A.+M.+Gilfillanauthor=C.+Tkaczykauthor=N.+Kuehnauthor=A.+Grayauthor=J.+Giddingsauthor=E.+Peskettauthor=R.+Foxauthor=I.+Bruceauthor=C.+Walkerauthor=C.+Sawyerauthor=K.+Okkenhaugauthor=P.+Finanauthor=B.+Vanhaesebroeck&title=Essential+role+for+the+p110%CE%B4+phosphoinositide+3-kinase+in+the+allergic+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DK.%26aulast%3DBilancio%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DPearce%26aufirst%3DW.%26aulast%3DGilfillan%26aufirst%3DA.%2BM.%26aulast%3DTkaczyk%26aufirst%3DC.%26aulast%3DKuehn%26aufirst%3DN.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DGiddings%26aufirst%3DJ.%26aulast%3DPeskett%26aufirst%3DE.%26aulast%3DFox%26aufirst%3DR.%26aulast%3DBruce%26aufirst%3DI.%26aulast%3DWalker%26aufirst%3DC.%26aulast%3DSawyer%26aufirst%3DC.%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26atitle%3DEssential%2520role%2520for%2520the%2520p110%25CE%25B4%2520phosphoinositide%25203-kinase%2520in%2520the%2520allergic%2520response%26jtitle%3DNature%26date%3D2004%26volume%3D431%26spage%3D1007%26epage%3D1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenwaelder, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goncalves, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesbitt, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dopheide, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturgeon, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabaharan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniele, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saylik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughan, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, H. H.</span><span> </span><span class="NLM_article-title">PI3-kinase p110β: a new target for antithrombotic therapy</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1038%2Fnm1232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=15834429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=507-514&author=S.+P.+Jacksonauthor=S.+M.+Schoenwaelderauthor=I.+Goncalvesauthor=W.+S.+Nesbittauthor=C.+L.+Yapauthor=C.+E.+Wrightauthor=V.+Kencheauthor=K.+E.+Andersonauthor=S.+M.+Dopheideauthor=Y.+Yuanauthor=S.+A.+Sturgeonauthor=H.+Prabaharanauthor=P.+E.+Thompsonauthor=G.+D.+Smithauthor=P.+R.+Shepherdauthor=N.+Danieleauthor=S.+Kulkarniauthor=B.+Abbottauthor=D.+Saylikauthor=C.+Jonesauthor=L.+Luauthor=S.+Giulianoauthor=S.+C.+Hughanauthor=J.+A.+Angusauthor=A.+D.+Robertsonauthor=H.+H.+Salem&title=PI3-kinase+p110%CE%B2%3A+a+new+target+for+antithrombotic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PI 3-kinase p110β: a new target for antithrombotic therapy</span></div><div class="casAuthors">Jackson, Shaun P.; Schoenwaelder, Simone M.; Goncalves, Isaac; Nesbitt, Warwick S.; Yap, Cindy L.; Wright, Christine E.; Kenche, Vijaya; Anderson, Karen E.; Dopheide, Sacha M.; Yuan, Yuping; Sturgeon, Sharelle A.; Prabaharan, Hishani; Thompson, Philip E.; Smith, Gregg D.; Shepherd, Peter R.; Daniele, Nathalie; Kulkarni, Suhasini; Abbott, Belinda; Saylik, Dilek; Jones, Catherine; Lu, Lucy; Giuliano, Simon; Hughan, Sascha C.; Angus, James A.; Robertson, Alan D.; Salem, Hatem H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-514</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Platelet activation at sites of vascular injury is essential for the arrest of bleeding; however, excessive platelet accumulation at regions of atherosclerotic plaque rupture can result in the development of arterial thrombi, pptg. diseases such as acute myocardial infarction and ischemic stroke.  Rheol. disturbances (high shear stress) have an important role in promoting arterial thrombosis by enhancing the adhesive and signaling function of platelet integrin αIIbβ3 (GPIIb-IIIa).  In this study we have defined a key role for the Type Ia phosphoinositide 3-kinase (PI3K) p110β isoform in regulating the formation and stability of integrin αIIbβ3 adhesion bonds, necessary for shear activation of platelets.  Isoform-selective PI3K p110β inhibitors have been developed which prevent formation of stable integrin αIIbβ3 adhesion contacts, leading to defective platelet thrombus formation.  In vivo, these inhibitors eliminate occlusive thrombus formation but do not prolong bleeding time.  These studies define PI3K p110β as an important new target for antithrombotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYYnYolzsDrrVg90H21EOLACvtfcHk0lgOEsRrXljv8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOlsrk%253D&md5=c8dc7ba1955e86104ae913d39f22674b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnm1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1232%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DSchoenwaelder%26aufirst%3DS.%2BM.%26aulast%3DGoncalves%26aufirst%3DI.%26aulast%3DNesbitt%26aufirst%3DW.%2BS.%26aulast%3DYap%26aufirst%3DC.%2BL.%26aulast%3DWright%26aufirst%3DC.%2BE.%26aulast%3DKenche%26aufirst%3DV.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DDopheide%26aufirst%3DS.%2BM.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DSturgeon%26aufirst%3DS.%2BA.%26aulast%3DPrabaharan%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DSmith%26aufirst%3DG.%2BD.%26aulast%3DShepherd%26aufirst%3DP.%2BR.%26aulast%3DDaniele%26aufirst%3DN.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DAbbott%26aufirst%3DB.%26aulast%3DSaylik%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DGiuliano%26aufirst%3DS.%26aulast%3DHughan%26aufirst%3DS.%2BC.%26aulast%3DAngus%26aufirst%3DJ.%2BA.%26aulast%3DRobertson%26aufirst%3DA.%2BD.%26aulast%3DSalem%26aufirst%3DH.%2BH.%26atitle%3DPI3-kinase%2520p110%25CE%25B2%253A%2520a%2520new%2520target%2520for%2520antithrombotic%2520therapy%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D507%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katanaev, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garlanda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzolino, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silengo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sozzani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantovani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altruda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span> </span><span class="NLM_article-title">Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=1049-1053&author=E.+Hirschauthor=V.+L.+Katanaevauthor=C.+Garlandaauthor=O.+Azzolinoauthor=L.+Pirolaauthor=L.+Silengoauthor=S.+Sozzaniauthor=A.+Mantovaniauthor=F.+Altrudaauthor=M.+P.+Wymann&title=Central+role+for+G+protein-coupled+phosphoinositide+3-kinase+%CE%B3+in+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DKatanaev%26aufirst%3DV.%2BL.%26aulast%3DGarlanda%26aufirst%3DC.%26aulast%3DAzzolino%26aufirst%3DO.%26aulast%3DPirola%26aufirst%3DL.%26aulast%3DSilengo%26aufirst%3DL.%26aulast%3DSozzani%26aufirst%3DS.%26aulast%3DMantovani%26aufirst%3DA.%26aulast%3DAltruda%26aufirst%3DF.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DCentral%2520role%2520for%2520G%2520protein-coupled%2520phosphoinositide%25203-kinase%2520%25CE%25B3%2520in%2520inflammation%26jtitle%3DScience%26date%3D2000%26volume%3D287%26spage%3D1049%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Campbell, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choong, D. Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciavarella, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooi, C. S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristiano, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, W. A.</span><span> </span><span class="NLM_article-title">Mutation of the PIK3CA gene in ovarian and breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">7678</span><span class="NLM_x">–</span> <span class="NLM_lpage">7681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7678-7681&author=I.+G.+Campbellauthor=S.+E.+Russellauthor=D.+Y.+H.+Choongauthor=K.+G.+Montgomeryauthor=M.+L.+Ciavarellaauthor=C.+S.+F.+Hooiauthor=B.+E.+Cristianoauthor=R.+B.+Pearsonauthor=W.+A.+Phillips&title=Mutation+of+the+PIK3CA+gene+in+ovarian+and+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DI.%2BG.%26aulast%3DRussell%26aufirst%3DS.%2BE.%26aulast%3DChoong%26aufirst%3DD.%2BY.%2BH.%26aulast%3DMontgomery%26aufirst%3DK.%2BG.%26aulast%3DCiavarella%26aufirst%3DM.%2BL.%26aulast%3DHooi%26aufirst%3DC.%2BS.%2BF.%26aulast%3DCristiano%26aufirst%3DB.%2BE.%26aulast%3DPearson%26aufirst%3DR.%2BB.%26aulast%3DPhillips%26aufirst%3DW.%2BA.%26atitle%3DMutation%2520of%2520the%2520PIK3CA%2520gene%2520in%2520ovarian%2520and%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7678%26epage%3D7681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P. K.</span><span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=802-807&author=S.+Kangauthor=A.+G.+Baderauthor=P.+K.+Vogt&title=Phosphatidylinositol+3-kinase+mutations+identified+in+human+cancer+are+oncogenic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DS.%26aulast%3DBader%26aufirst%3DA.%2BG.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DPhosphatidylinositol%25203-kinase%2520mutations%2520identified%2520in%2520human%2520cancer%2520are%2520oncogenic%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D802%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">High frequency of mutations of the PIK3CA gene in human cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1126%2Fscience.1096502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=15016963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=554&author=Y.+Samuelsauthor=Z.+Wangauthor=A.+Bardelliauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=H.+Yanauthor=A.+Gazdarauthor=S.+M.+Powellauthor=G.+J.+Rigginsauthor=J.+K.+V.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=High+frequency+of+mutations+of+the+PIK3CA+gene+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Brevia: High frequency of mutations of the PIK3Ca gene in human cancers</span></div><div class="casAuthors">Samuels, Yardena; Wang, Zhenghe; Bardelli, Alberto; Silliman, Natalie; Ptak, Janine; Szabo, Steve; Yan, Hai; Gazdar, Adi; Powell, Steven M.; Riggins, Gregory J.; Willson, James K. V.; Markowitz, Sanford; Kinzler, Kenneth W.; Vogelstein, Bert; Velculescu, Victor E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5670</span>),
    <span class="NLM_cas:pages">554</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr74Tv7Oo80NbVg90H21EOLACvtfcHk0lgjnEuK13VAeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVGmsbk%253D&md5=be8d63bf0c909971c3b7a5f475ce8fab</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1096502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1096502%26sid%3Dliteratum%253Aachs%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DS.%2BM.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%2BV.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DHigh%2520frequency%2520of%2520mutations%2520of%2520the%2520PIK3CA%2520gene%2520in%2520human%2520cancers%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Yuan, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">PI3K pathway alterations in cancer: variations on a theme</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5497</span><span class="NLM_x">–</span> <span class="NLM_lpage">5510</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5497-5510&author=T.+L.+Yuanauthor=L.+C.+Cantley&title=PI3K+pathway+alterations+in+cancer%3A+variations+on+a+theme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DT.%2BL.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DPI3K%2520pathway%2520alterations%2520in%2520cancer%253A%2520variations%2520on%2520a%2520theme%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5497%26epage%3D5510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Manning, B. D.</span><span> </span><span class="NLM_article-title">Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2004&pages=399-403&author=B.+D.+Manning&title=Balancing+Akt+with+S6K%3A+implications+for+both+metabolic+diseases+and+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26atitle%3DBalancing%2520Akt%2520with%2520S6K%253A%2520implications%2520for%2520both%2520metabolic%2520diseases%2520and%2520tumorigenesis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2004%26volume%3D167%26spage%3D399%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span> </span><span class="NLM_article-title">Targeting the phosphoinositide 3-kinase pathway in cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=19644473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-644&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Targeting+the+phosphoinositide+3-kinase+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0lgLZMS_jRKtwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520phosphoinositide%25203-kinase%2520pathway%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D627%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Jiang, B.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.-Z.</span><span> </span><span class="NLM_article-title">Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.drup.2008.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=18440854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlGhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=63-76&author=B.-H.+Jiangauthor=L.-Z.+Liu&title=Role+of+mTOR+in+anticancer+drug+resistance%3A+perspectives+for+improved+drug+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment</span></div><div class="casAuthors">Jiang, Bing-Hua; Liu, Ling-Zhi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">63-76</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR) pathway plays a central role in regulating protein synthesis, ribosomal protein translation, and cap-dependent translation.  Deregulations in mTOR signaling are frequently assocd. with tumorigenesis, angiogenesis, tumor growth and metastasis.  This review highlights the role of the mTOR in anticancer drug resistance.  We discuss the network of signaling pathways in which the mTOR kinase is involved, including the structure and activation of the mTOR complex and the pathways upstream and downstream of mTOR as well as other mol. interactions of mTOR.  Major upstream signaling components in control of mTOR activity are PI3K/PTEN/AKT and Ras/Raf/MEK/ERK pathways.  We discuss the central role of mTOR in mediating the translation of mRNAs of proteins related to cell cycle progression, those involved in cell survival such as c-myc, hypoxia inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF), cyclin A, cyclin dependent kinases (cdk1/2), cdk inhibitors (p21Cip1 and p27Kip1), retinoblastoma (Rb) protein, and RNA polymerases I and III.  We then discuss the potential therapeutic opportunities for using mTOR inhibitors rapamycin, CCI-779, RAD001, and AP-23573 in cancer therapy as single agents or in combinations to reverse drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLkKe2ZBODqrVg90H21EOLACvtfcHk0lgLZMS_jRKtwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlGhsL8%253D&md5=091e8e0620e6ae0a909138b6bf87d4dd</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2008.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2008.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DB.-H.%26aulast%3DLiu%26aufirst%3DL.-Z.%26atitle%3DRole%2520of%2520mTOR%2520in%2520anticancer%2520drug%2520resistance%253A%2520perspectives%2520for%2520improved%2520drug%2520treatment%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2008%26volume%3D11%26spage%3D63%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chalhoub, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span> </span><span class="NLM_article-title">PTEN and the PI3-kinase pathway in cancer</span> <span class="citation_source-journal">Annu. Rev. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1146%2Fannurev.pathol.4.110807.092311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=18767981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1aiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=127-150&author=N.+Chalhoubauthor=S.+J.+Baker&title=PTEN+and+the+PI3-kinase+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN and the PI3-kinase pathway in cancer</span></div><div class="casAuthors">Chalhoub, Nader; Baker, Suzanne J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-150</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  PI3-kinase and PTEN are major pos. and neg. regulators, resp., of the PI3-kinase pathway, which regulates growth, survival, and proliferation.  These key signaling components are two of the most frequently mutated proteins in human cancers, resulting in unregulated activation of PI3K signaling and providing irrefutable genetic evidence of the central role of this pathway in tumorigenesis.  PTEN regulates PI3K signaling by dephosphorylating the lipid signaling intermediate PIP3, but PTEN may have addnl. phosphatase-independent activities, as well as other functions in the nucleus.  In this review, we highlight current work showing cancer-relevant complexities in the regulation of PTEN and PI3K activity, potential novel functions for PTEN, and feedback regulation within the pathway.  The significance and complexity of PI3K signaling make it an important but challenging therapeutic target for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYL7OEFJS0L7Vg90H21EOLACvtfcHk0ljifKKDRTiLKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1aiu78%253D&md5=3a85209dd4803ce16557d4cdafc51613</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pathol.4.110807.092311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pathol.4.110807.092311%26sid%3Dliteratum%253Aachs%26aulast%3DChalhoub%26aufirst%3DN.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26atitle%3DPTEN%2520and%2520the%2520PI3-kinase%2520pathway%2520in%2520cancer%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%26date%3D2009%26volume%3D4%26spage%3D127%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">O’Reilly, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Q.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solit, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span> </span><span class="NLM_article-title">mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1500</span><span class="NLM_x">–</span> <span class="NLM_lpage">1508</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1500-1508&author=K.+E.+O%E2%80%99Reillyauthor=F.+Rojoauthor=Q.-B.+Sheauthor=D.+Solitauthor=G.+B.+Millsauthor=D.+Smithauthor=H.+Laneauthor=F.+Hofmannauthor=D.+J.+Hicklinauthor=D.+L.+Ludwigauthor=J.+Baselgaauthor=N.+Rosen&title=mTOR+inhibition+induces+upstream+receptor+tyrosine+kinase+signaling+and+activates+Akt"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DK.%2BE.%26aulast%3DRojo%26aufirst%3DF.%26aulast%3DShe%26aufirst%3DQ.-B.%26aulast%3DSolit%26aufirst%3DD.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DLane%26aufirst%3DH.%26aulast%3DHofmann%26aufirst%3DF.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DLudwig%26aufirst%3DD.%2BL.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26atitle%3DmTOR%2520inhibition%2520induces%2520upstream%2520receptor%2520tyrosine%2520kinase%2520signaling%2520and%2520activates%2520Akt%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D1500%26epage%3D1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Peng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5575</span><span class="NLM_x">–</span> <span class="NLM_lpage">5584</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1128%2FMCB.22.15.5575-5584.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=12101249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlGnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=5575-5584&author=T.+Pengauthor=T.+R.+Golubauthor=D.+M.+Sabatini&title=The+immunosuppressant+rapamycin+mimics+a+starvation-like+signal+distinct+from+amino+acid+and+glucose+deprivation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation</span></div><div class="casAuthors">Peng, Tao; Golub, Todd R.; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5575-5584</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">RAFT1/FRAP/mTOR is a key regulator of cell growth and division and the mammalian target of rapamycin, an immunosuppressive and anticancer drug.  Rapamycin deprivation and nutrient deprivation have similar effects on the activity of S6 kinase 1 (S6K1) and 4E-BP1, two downstream effectors of RAFT1, but the relationship between nutrient- and rapamycin-sensitive pathways is unknown.  Using transcriptional profiling, we show that, in human BJAB B-lymphoma cells and murine CTLL-2 T lymphocytes, rapamycin treatment affects the expression of many genes involved in nutrient and protein metab.  The rapamycin-induced transcriptional profile is distinct from those induced by glucose, glutamine, or leucine deprivation but is most similar to that induced by amino acid deprivation.  In particular, rapamycin treatment and amino acid deprivation up-regulate genes involved in nutrient catabolism and energy prodn. and down-regulate genes participating in lipid and nucleotide synthesis and in protein synthesis, turnover, and folding.  Surprisingly, however, rapamycin had effects opposite from those of amino acid starvation on the expression of a large group of genes involved in the synthesis, transport, and use of amino acids.  Supported by measurements of nutrient use, the data suggest that RAFT1 is an energy and nutrient sensor and that rapamycin mimics a signal generated by the starvation of amino acids but that the signal is unlikely to be the absence of amino acids themselves.  These observations underscore the importance of metab. in controlling lymphocyte proliferation and offer a novel explanation for immunosuppression by rapamycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6e8qWqNJ4-7Vg90H21EOLACvtfcHk0lh19fkJ6s4wCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlGnt7g%253D&md5=e6efd63b037090ed2273e071d6ed01cd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.15.5575-5584.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.15.5575-5584.2002%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DT.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DThe%2520immunosuppressant%2520rapamycin%2520mimics%2520a%2520starvation-like%2520signal%2520distinct%2520from%2520amino%2520acid%2520and%2520glucose%2520deprivation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26spage%3D5575%26epage%3D5584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Shaw, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">Ras, PI3K and mTOR signalling controls tumour cell growth</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2006&pages=424-430&author=R.+J.+Shawauthor=L.+C.+Cantley&title=Ras%2C+PI3K+and+mTOR+signalling+controls+tumour+cell+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DR.%2BJ.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DRas%252C%2520PI3K%2520and%2520mTOR%2520signalling%2520controls%2520tumour%2520cell%2520growth%26jtitle%3DNature%26date%3D2006%26volume%3D441%26spage%3D424%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Cleary, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer</span> <span class="citation_source-journal">Curr. Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1007%2Fs11912-010-0091-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=20425592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Cjsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=87-94&author=J.+M.+Clearyauthor=G.+I.+Shapiro&title=Development+of+phosphoinositide-3+kinase+pathway+inhibitors+for+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer</span></div><div class="casAuthors">Cleary, James M.; Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Oncology Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-94</span>CODEN:
                <span class="NLM_cas:coden">CORUAT</span>;
        ISSN:<span class="NLM_cas:issn">1534-6269</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide-3 kinase (PI3K) pathway plays a crit. role in cancer cell growth and survival.  PI3K is activated in human cancers by elevated receptor tyrosine kinase activity, RAS mutation, as well as by mutation, amplification, and deletion of genes encoding components of the pathway.  Addnl., PI3K pathway activation plays an important role in acquired resistance to both chemotherapy and targeted agents.  The essential role of PI3K in human cancer has led to the development of PI3K pathway inhibitors that have shown promise in preclin. models and have entered phase I clin. trials.  This article reviews preclin. and clin. data on members of this novel drug class, as well as data justifying the combination of PI3K inhibitors with other anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon-44aT68pebVg90H21EOLACvtfcHk0lh19fkJ6s4wCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Cjsb%252FN&md5=647bf5a5f1d7b05a3ce4d6361913fb19</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs11912-010-0091-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11912-010-0091-6%26sid%3Dliteratum%253Aachs%26aulast%3DCleary%26aufirst%3DJ.%2BM.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DDevelopment%2520of%2520phosphoinositide-3%2520kinase%2520pathway%2520inhibitors%2520for%2520advanced%2520cancer%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2010%26volume%3D12%26spage%3D87%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span> </span><span class="NLM_article-title">Drug discovery approaches targeting the PI3K/Akt pathway in cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5511</span><span class="NLM_x">–</span> <span class="NLM_lpage">5526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5511-5526&author=C.+Garcia-Echeverriaauthor=W.+R.+Sellers&title=Drug+discovery+approaches+targeting+the+PI3K%2FAkt+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26atitle%3DDrug%2520discovery%2520approaches%2520targeting%2520the%2520PI3K%252FAkt%2520pathway%2520in%2520cancer%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5511%26epage%3D5526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mahadevan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiorean, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Hoff, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stejskal-Barnett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younger, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rensvold, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordova, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garlich, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durden, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, R. K.</span><span> </span><span class="NLM_article-title">Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3319</span><span class="NLM_x">–</span> <span class="NLM_lpage">3327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=3319-3327&author=D.+Mahadevanauthor=E.+G.+Chioreanauthor=W.+B.+Harrisauthor=D.+D.+Von+Hoffauthor=A.+Stejskal-Barnettauthor=W.+Qiauthor=S.+P.+Anthonyauthor=A.+E.+Youngerauthor=D.+M.+Rensvoldauthor=F.+Cordovaauthor=C.+F.+Sheltonauthor=M.+D.+Beckerauthor=J.+R.+Garlichauthor=D.+L.+Durdenauthor=R.+K.+Ramanathan&title=Phase+I+pharmacokinetic+and+pharmacodynamic+study+of+the+pan-PI3K%2FmTORC+vascular+targeted+pro-drug+SF1126+in+patients+with+advanced+solid+tumours+and+B-cell+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahadevan%26aufirst%3DD.%26aulast%3DChiorean%26aufirst%3DE.%2BG.%26aulast%3DHarris%26aufirst%3DW.%2BB.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DStejskal-Barnett%26aufirst%3DA.%26aulast%3DQi%26aufirst%3DW.%26aulast%3DAnthony%26aufirst%3DS.%2BP.%26aulast%3DYounger%26aufirst%3DA.%2BE.%26aulast%3DRensvold%26aufirst%3DD.%2BM.%26aulast%3DCordova%26aufirst%3DF.%26aulast%3DShelton%26aufirst%3DC.%2BF.%26aulast%3DBecker%26aufirst%3DM.%2BD.%26aulast%3DGarlich%26aufirst%3DJ.%2BR.%26aulast%3DDurden%26aufirst%3DD.%2BL.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26atitle%3DPhase%2520I%2520pharmacokinetic%2520and%2520pharmacodynamic%2520study%2520of%2520the%2520pan-PI3K%252FmTORC%2520vascular%2520targeted%2520pro-drug%2520SF1126%2520in%2520patients%2520with%2520advanced%2520solid%2520tumours%2520and%2520B-cell%2520malignancies%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2012%26volume%3D48%26spage%3D3319%26epage%3D3327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chang, K.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, B.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.-Y.</span><span> </span><span class="NLM_article-title">Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7116</span><span class="NLM_x">–</span> <span class="NLM_lpage">7126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1158%2F1078-0432.CCR-11-0796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=21976531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKht7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=7116-7126&author=K.-Y.+Changauthor=S.-Y.+Tsaiauthor=C.-M.+Wuauthor=C.-J.+Yenauthor=B.-F.+Chuangauthor=J.-Y.+Chang&title=Novel+phosphoinositide+3-kinase%2FmTOR+dual+inhibitor%2C+NVP-BGT226%2C+displays+potent+growth-inhibitory+activity+against+human+head+and+neck+cancer+cells+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Phosphoinositide 3-Kinase/mTOR Dual Inhibitor, NVP-BGT226, Displays Potent Growth-Inhibitory Activity against Human Head and Neck Cancer Cells In Vitro and In Vivo</span></div><div class="casAuthors">Chang, Kwang-Yu; Tsai, Shan-Yin; Wu, Ching-Ming; Yen, Chia-Jui; Chuang, Bin-Fay; Chang, Jang-Yang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7116-7126</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Dysregulation of the phosphoinositide 3-kinase (PI3K)/AKT/mTOR signaling pathway frequently accounts for the tumorigenesis in head and neck cancer.  To develop a new treatment, we investigated the effect of a novel dual PI3K/mTOR inhibitor, NVP-BGT226 (BGT226), in head and neck cancer cells.  Exptl. Design: The in vitro antitumor effect of BGT226 was detd. in various cancer cell lines.  Animal models were also applied to examine drug potency.  The inhibitory ability of BGT226 on the PI3K/AKT/mTOR signaling pathway was analyzed.  RESULTS: The growth inhibition assay revealed that BGT226 was active against all tested cancer cell lines.  Cross-resistance was not obsd. in the cisplatin-resistant cell line.  The activation of the AKT/mTOR signal cascade was suppressed by BGT226 in a concn.- and time-dependent manner.  Flow cytometric anal. revealed an accumulation of cells in the G0-G1 phase with concomitant loss in the S-phase.  Results of the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay and the anal. of caspase 3/7 and PARP indicated that BGT226 induced cancer cell death through an apoptosis-independent pathway.  BGT226 induced autophagy as indicated by the aggregation and upregulation of the microtubule-assocd. protein light chain 3B-II, and p62 degrdn.  Gene silencing of Beclin1 or cotreatment of the autophagosome inhibitor, 3-methyladenine, inhibited the BGT226-induced autophagy and led to the retrieval of colony survival.  In a xenografted animal model, BGT226 significantly delayed tumor growth in a dose-dependent manner, along with suppressed cytoplasmic expression of p-p70 S6 kinase and the presence of autophagosome formation.  CONCLUSIONS: These data indicate that BGT226 is a potential drug in the treatment of head and neck cancer.  Clin Cancer Res; 17(22); 7116-26.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCgjQvdZ3pn7Vg90H21EOLACvtfcHk0lg6fevKqlhHUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKht7nP&md5=20163ec3099aa3c33eac1eed54a3e1b1</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-0796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-0796%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DK.-Y.%26aulast%3DTsai%26aufirst%3DS.-Y.%26aulast%3DWu%26aufirst%3DC.-M.%26aulast%3DYen%26aufirst%3DC.-J.%26aulast%3DChuang%26aufirst%3DB.-F.%26aulast%3DChang%26aufirst%3DJ.-Y.%26atitle%3DNovel%2520phosphoinositide%25203-kinase%252FmTOR%2520dual%2520inhibitor%252C%2520NVP-BGT226%252C%2520displays%2520potent%2520growth-inhibitory%2520activity%2520against%2520human%2520head%2520and%2520neck%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D7116%26epage%3D7126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cleary, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer</span> <span class="citation_source-journal">Curr. Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1007%2Fs11912-010-0091-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=20425592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Cjsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=87-94&author=J.+M.+Clearyauthor=G.+I.+Shapiro&title=Development+of+phosphoinositide-3+kinase+pathway+inhibitors+for+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer</span></div><div class="casAuthors">Cleary, James M.; Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Oncology Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-94</span>CODEN:
                <span class="NLM_cas:coden">CORUAT</span>;
        ISSN:<span class="NLM_cas:issn">1534-6269</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide-3 kinase (PI3K) pathway plays a crit. role in cancer cell growth and survival.  PI3K is activated in human cancers by elevated receptor tyrosine kinase activity, RAS mutation, as well as by mutation, amplification, and deletion of genes encoding components of the pathway.  Addnl., PI3K pathway activation plays an important role in acquired resistance to both chemotherapy and targeted agents.  The essential role of PI3K in human cancer has led to the development of PI3K pathway inhibitors that have shown promise in preclin. models and have entered phase I clin. trials.  This article reviews preclin. and clin. data on members of this novel drug class, as well as data justifying the combination of PI3K inhibitors with other anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon-44aT68pebVg90H21EOLACvtfcHk0ljWpXWZlr6a3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Cjsb%252FN&md5=647bf5a5f1d7b05a3ce4d6361913fb19</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1007%2Fs11912-010-0091-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11912-010-0091-6%26sid%3Dliteratum%253Aachs%26aulast%3DCleary%26aufirst%3DJ.%2BM.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DDevelopment%2520of%2520phosphoinositide-3%2520kinase%2520pathway%2520inhibitors%2520for%2520advanced%2520cancer%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2010%26volume%3D12%26spage%3D87%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ihle, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span> </span><span class="NLM_article-title">Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1158%2F1535-7163.MCT-08-0801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=19139107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFSntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1-9&author=N.+T.+Ihleauthor=G.+Powis&title=Take+your+PIK%3A+phosphatidylinositol+3-kinase+inhibitors+race+through+the+clinic+and+toward+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19dR"><div class="casContent"><span class="casTitleNuber">19d</span><div class="casTitle"><span class="NLM_cas:atitle">Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy</span></div><div class="casAuthors">Ihle, Nathan T.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is currently one of the most exciting drug targets in oncol.  However, only a short time ago, the paradigm existed that drugs targeted to the four PI3K class I isoforms would be too toxic for use in cancer therapy due to effects on physiol. signaling.  Since that time, studies have delineated the roles of these four isoforms in nonpathol. signaling as well as their roles in cancer.  An extensive effort has gone into developing agents that inhibit one or more PI3K isoforms, as well as closely related proteins implicated in cancer.  These agents have proved to be tolerable and therapeutically beneficial in animal studies, and a no. are in clin. testing.  The agents, their properties, and their mol. targets are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtwozBC-h437Vg90H21EOLACvtfcHk0ljWpXWZlr6a3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFSntA%253D%253D&md5=4bc339da7fdd1dc74e13eadf76ae53ce</span></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0801%26sid%3Dliteratum%253Aachs%26aulast%3DIhle%26aufirst%3DN.%2BT.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DTake%2520your%2520PIK%253A%2520phosphatidylinositol%25203-kinase%2520inhibitors%2520race%2520through%2520the%2520clinic%2520and%2520toward%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Marone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cmiljanovic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span> </span><span class="NLM_article-title">Targeting phosphoinositide 3-kinase: moving towards therapy</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1784</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1784&publication_year=2008&pages=159-185&author=R.+Maroneauthor=V.+Cmiljanovicauthor=B.+Gieseauthor=M.+P.+Wymann&title=Targeting+phosphoinositide+3-kinase%3A+moving+towards+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarone%26aufirst%3DR.%26aulast%3DCmiljanovic%26aufirst%3DV.%26aulast%3DGiese%26aufirst%3DB.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DTargeting%2520phosphoinositide%25203-kinase%253A%2520moving%2520towards%2520therapy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1784%26spage%3D159%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Yap, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19f&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.coph.2008.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19f&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=18721898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19f&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=393-412&author=T.+A.+Yapauthor=M.+D.+Garrettauthor=M.+I.+Waltonauthor=F.+Raynaudauthor=J.+S.+De+Bonoauthor=P.+Workman&title=Targeting+the+PI3K-AKT-mTOR+pathway%3A+progress%2C+pitfalls%2C+and+promises"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19fR"><div class="casContent"><span class="casTitleNuber">19f</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises</span></div><div class="casAuthors">Yap, Timothy A.; Garrett, Michelle D.; Walton, Mike I.; Raynaud, Florence; de Bono, Johann S.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">393-412</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The strategy of drugging the cancer kinome' has led to the successful development and regulatory approval of several novel mol. targeted agents.  The spotlight is now shifting to the phosphatidylinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway as a key potential target.  This review details the role of the pathway in oncogenesis and the rationale for inhibiting its vital components.  The focus will be on the progress made in the development of novel therapies for cancer treatment, with emphasis placed on agents that have entered clin. development.  Strategies involving horizontal and vertical blockade of the pathway, as well as the use of biomarkers to select appropriate patients and to provide proof of target modulation will also be highlighted.  Finally, we discuss the issues and limitations involved with targeting the PI3K-AKT-mTOR pathway, and predict what the future may hold for these novel anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmwezNSKUfbVg90H21EOLACvtfcHk0liKhBmiqWIURg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E&md5=b6a4f3c01a6776977d61cde8222d7201</span></div><a href="/servlet/linkout?suffix=cit19f&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DDe%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520PI3K-AKT-mTOR%2520pathway%253A%2520progress%252C%2520pitfalls%252C%2520and%2520promises%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D393%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Eichhorn, P. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gili, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaltriti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nijkamp, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beijersbergen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seoane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">9221</span><span class="NLM_x">–</span> <span class="NLM_lpage">9230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=9221-9230&author=P.+J.+A.+Eichhornauthor=M.+Giliauthor=M.+Scaltritiauthor=V.+Serraauthor=M.+Guzmanauthor=W.+Nijkampauthor=R.+L.+Beijersbergenauthor=V.+Valeroauthor=J.+Seoaneauthor=R.+Bernardsauthor=J.+Baselga&title=Phosphatidylinositol+3-kinase+hyperactivation+results+in+lapatinib+resistance+that+is+reversed+by+the+mTOR%2Fphosphatidylinositol+3-kinase+inhibitor+NVP-BEZ235"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEichhorn%26aufirst%3DP.%2BJ.%2BA.%26aulast%3DGili%26aufirst%3DM.%26aulast%3DScaltriti%26aufirst%3DM.%26aulast%3DSerra%26aufirst%3DV.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3DNijkamp%26aufirst%3DW.%26aulast%3DBeijersbergen%26aufirst%3DR.%2BL.%26aulast%3DValero%26aufirst%3DV.%26aulast%3DSeoane%26aufirst%3DJ.%26aulast%3DBernards%26aufirst%3DR.%26aulast%3DBaselga%26aufirst%3DJ.%26atitle%3DPhosphatidylinositol%25203-kinase%2520hyperactivation%2520results%2520in%2520lapatinib%2520resistance%2520that%2520is%2520reversed%2520by%2520the%2520mTOR%252Fphosphatidylinositol%25203-kinase%2520inhibitor%2520NVP-BEZ235%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D9221%26epage%3D9230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Maira, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chène, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pover, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Echeverría, C.</span><span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19h&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19h&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=18606717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19h&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&author=S.-M.+Mairaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Ch%C3%A8neauthor=A.+D.+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garc%C3%ADa-Echeverr%C3%ADa&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19hR"><div class="casContent"><span class="casTitleNuber">19h</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span></div><div class="casAuthors">Maira, Sauveur-Michel; Stauffer, Frederic; Brueggen, Josef; Furet, Pascal; Schnell, Christian; Fritsch, Christine; Brachmann, Saskia; Chene, Patrick; De Pover, Alain; Schoemaker, Kevin; Fabbro, Doriano; Gabriel, Daniela; Simonen, Marjo; Murphy, Leon; Finan, Peter; Sellers, William; Garcia-Echeverria, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1851-1863</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin inhibitor (mTOR) pathway is often constitutively activated in human tumor cells, providing unique opportunities for anticancer therapeutic intervention.  NVP-BEZ235 is an imidazo[4,5-c]quinoline deriv. that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes.  In cellular settings using human tumor cell lines, this mol. is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest.  The cellular activity of NVP-BEZ235 translates well in in vivo models of human cancer.  Thus, the compd. was well tolerated, displayed disease stasis when administered orally, and enhanced the efficacy of other anticancer agents when used in in vivo combination studies.  Ex vivo pharmacokinetic/pharmacodynamic analyses of tumor tissues showed a time-dependent correlation between compd. concn. and PI3K/Akt pathway inhibition.  Collectively, the preclin. data show that NVP-BEZ235 is a potent dual PI3K/mTOR modulator with favorable pharmaceutical properties.  NVP-BEZ235 is currently in phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyO784qv52vrVg90H21EOLACvtfcHk0li6kLPzXPZLzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslCgtb4%253D&md5=5b1979e134dd12065198d86dbc11ce15</span></div><a href="/servlet/linkout?suffix=cit19h&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaira%26aufirst%3DS.-M.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DCh%25C3%25A8ne%26aufirst%3DP.%26aulast%3DPover%26aufirst%3DA.%2BD.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarc%25C3%25ADa-Echeverr%25C3%25ADa%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Howes, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2505</span><span class="NLM_x">–</span> <span class="NLM_lpage">2514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19i&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1158%2F1535-7163.MCT-06-0698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19i&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=17766839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19i&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCgur7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=2505-2514&author=A.+L.+Howesauthor=G.+G.+Chiangauthor=E.+S.+Langauthor=C.+B.+Hoauthor=G.+Powisauthor=K.+Vuoriauthor=R.+T.+Abraham&title=The+phosphatidylinositol+3-kinase+inhibitor%2C+PX-866%2C+is+a+potent+inhibitor+of+cancer+cell+motility+and+growth+in+three-dimensional+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19iR"><div class="casContent"><span class="casTitleNuber">19i</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures</span></div><div class="casAuthors">Howes, Amy L.; Chiang, Gary G.; Lang, Elizabeth S.; Ho, Caroline B.; Powis, Garth; Vuori, Kristiina; Abraham, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2505-2514</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K) pathway is activated in many human tumors and mediates processes such as cell proliferation, survival, adhesion, and motility.  The natural product, wortmannin, has been widely used to study the functional consequences of PI3K inhibition in both normal and transformed cells in culture but is not a suitable cancer chemotherapeutic agent due to stability and toxicity issues.  PX-866, an improved wortmannin analog, displays significant antitumor activity in xenograft models.  Here, we directly compare PX-866 and wortmannin in human cancer cell lines cultured in monolayer or as three-dimensional spheroids.  Both PI3K inhibitors failed to inhibit monolayer cell growth at concns. up to 100 nmol/L but strongly suppressed spheroid growth at low nanomolar concns., with PX-866 showing greater potency than wortmannin.  Relative to wortmannin, PX-866 treatment results in a more sustained loss of Akt phosphorylation, suggesting that the increased potency of PX-866 is related to a more durable inhibition of PI3K signaling.  PX-866 and wortmannin both inhibit spheroid growth without causing cytotoxicity, similar to known cytostatic agents, such as rapamycin.  PX-866 also inhibits cancer cell motility at subnanomolar concns.  These findings suggest that the antitumor activities of PX-866 stem from prolonged inhibition of the PI3K pathway and inhibition of cell motility.  In addn., we propose that the use of three-dimensional tumor models is more predictive of in vivo growth inhibition by PI3K inhibitors in cancer cell lines lacking phosphatase and tensin homolog activity or expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopwYCvvi3YnrVg90H21EOLACvtfcHk0li6kLPzXPZLzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCgur7E&md5=2e04aade456fc6dca5e6aea10ef198c6</span></div><a href="/servlet/linkout?suffix=cit19i&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0698%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DA.%2BL.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DLang%26aufirst%3DE.%2BS.%26aulast%3DHo%26aufirst%3DC.%2BB.%26aulast%3DPowis%26aufirst%3DG.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DThe%2520phosphatidylinositol%25203-kinase%2520inhibitor%252C%2520PX-866%252C%2520is%2520a%2520potent%2520inhibitor%2520of%2520cancer%2520cell%2520motility%2520and%2520growth%2520in%2520three-dimensional%2520cultures%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D2505%26epage%3D2514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19j"><span><span class="NLM_label">(j) </span> Phase I Trial of Oral PX-866. <a href="http://www.clinicaltrials.gov/ct2/show/NCT00726583?term=PX866&amp;rank=5" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT00726583?term=PX866&rank=5</a> (accessed <span class="NLM_access-date">January 2014</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Phase+I+Trial+of+Oral+PX-866.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT00726583%3Fterm%3DPX866%26rank%3D5+%28accessed+January+2014%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">mTOR mediated anti-cancer drug discovery</span> <span class="citation_source-journal">Drug Discovery Today: Ther. Strategies</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.ddstr.2009.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=20622997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosFGnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=47-55&author=Q.+Liuauthor=C.+Thoreenauthor=J.+Wangauthor=D.+Sabatiniauthor=N.+S.+Gray&title=mTOR+mediated+anti-cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR mediated anti-cancer drug discovery</span></div><div class="casAuthors">Liu, Qingsong; Thoreen, Carson; Wang, Jinhua; Sabatini, David; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Therapeutic Strategies</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">47-55</span>CODEN:
                <span class="NLM_cas:coden">DDTTC6</span>;
        ISSN:<span class="NLM_cas:issn">1740-6773</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine kinase and the founding member of a signaling pathway that regulates many fundamental features of cell growth and division.  In cells, mTOR acts as the catalytic subunit of two functionally distinct complexes, called mTOR Complex 1 (mTORC1) and mTOR Complex 2 (mTORC2).  Together, these complexes coordinate a variety of processes that include protein translation, autophagy, proliferation, survival and metab. in response to nutrient, energy and growth factor signals.  Consistent with its role as a growth-promoting pathway, numerous studies have found that mTOR signaling is hyper-activated in a broad spectrum of human cancers.  In particular, mTORC2 is considered a primary effector of the phosphatidylinositol-3-kinase (PI3K) signaling pathway, which is mutated in a majority of human cancers, in part through its ability to phosphorylate and regulate the proto-oncogene Akt/PKB.  Many biol. functions of mTOR have been pharmacol. explored using the natural product rapamycin, an allosteric inhibitor that has been reviewed extensively elsewhere.  This review will focus specifically on the development of small mol. ATP-competitive inhibitors of mTOR and their prospects as a targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo708zVFEp5VLVg90H21EOLACvtfcHk0lhdyrEwRP1qhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosFGnur8%253D&md5=93364d568c3a23dd0fcf0c3980841e7e</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2Fj.ddstr.2009.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddstr.2009.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DThoreen%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSabatini%26aufirst%3DD.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DmTOR%2520mediated%2520anti-cancer%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Ther.%2520Strategies%26date%3D2009%26volume%3D6%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazif, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aizenstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span> </span><span class="NLM_article-title">Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1038%2Fnchembio.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=18849971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=691-699&author=B.+Apselauthor=J.+A.+Blairauthor=B.+Gonzalezauthor=T.+M.+Nazifauthor=M.+E.+Feldmanauthor=B.+Aizensteinauthor=R.+Hoffmanauthor=R.+L.+Williamsauthor=K.+M.+Shokatauthor=Z.+A.+Knight&title=Targeted+polypharmacology%3A+discovery+of+dual+inhibitors+of+tyrosine+and+phosphoinositide+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases</span></div><div class="casAuthors">Apsel, Beth; Blair, Jimmy A.; Gonzalez, Beatriz; Nazif, Tamim M.; Feldman, Morri E.; Aizenstein, Brian; Hoffman, Randy; Williams, Roger L.; Shokat, Kevan M.; Knight, Zachary A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">691-699</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. success of multitargeted kinase inhibitors has stimulated efforts to identify promiscuous drugs with optimal selectivity profiles.  It remains unclear to what extent such drugs can be rationally designed, particularly for combinations of targets that are structurally divergent.  Here we report the systematic discovery of mols. that potently inhibit both tyrosine kinases and phosphatidylinositol-3-OH kinases, two protein families that are among the most intensely pursued cancer drug targets.  Through iterative chem. synthesis, X-ray crystallog. and kinome-level biochem. profiling, we identified compds. that inhibit a spectrum of new target combinations in these two families.  Crystal structures revealed that the dual selectivity of these mols. is controlled by a hydrophobic pocket conserved in both enzyme classes and accessible through a rotatable bond in the drug skeleton.  We show that compd. I blocks the proliferation of tumor cells by direct inhibition of oncogenic tyrosine kinases and phosphatidylinositol-3-OH kinases.  These mols. demonstrate the feasibility of accessing a chem. space that intersects two families of oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7xlegha5YF7Vg90H21EOLACvtfcHk0lhdyrEwRP1qhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7bF&md5=4da10a973f6895f92a644ca82ca5cdcd</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.117%26sid%3Dliteratum%253Aachs%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DBlair%26aufirst%3DJ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DNazif%26aufirst%3DT.%2BM.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DAizenstein%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26atitle%3DTargeted%2520polypharmacology%253A%2520discovery%2520of%2520dual%2520inhibitors%2520of%2520tyrosine%2520and%2520phosphoinositide%2520kinases%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D691%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, K. K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagrodia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greasley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knighton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafidi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span> </span><span class="NLM_article-title">Quinazolines with intra-molecular hydrogen bonding scaffold (iMHBS) as PI3K/mTOR dual inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1270-1274&author=K.+K.+C.+Liuauthor=X.+Huangauthor=S.+Bagrodiaauthor=J.+H.+Chenauthor=S.+Greasleyauthor=H.+Chengauthor=S.+Sunauthor=D.+Knightonauthor=C.+Rodgersauthor=K.+Rafidiauthor=A.+Zouauthor=J.+Xiaoauthor=S.+Yan&title=Quinazolines+with+intra-molecular+hydrogen+bonding+scaffold+%28iMHBS%29+as+PI3K%2FmTOR+dual+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BK.%2BC.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBagrodia%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DKnighton%26aufirst%3DD.%26aulast%3DRodgers%26aufirst%3DC.%26aulast%3DRafidi%26aufirst%3DK.%26aulast%3DZou%26aufirst%3DA.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DS.%26atitle%3DQuinazolines%2520with%2520intra-molecular%2520hydrogen%2520bonding%2520scaffold%2520%2528iMHBS%2529%2520as%2520PI3K%252FmTOR%2520dual%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1270%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, K. K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagrodia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greasley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knighton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninkovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafidi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, C. M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, A.</span><span> </span><span class="NLM_article-title">4-Methylpteridinones as orally active and selective PI3K/mTOR dual inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6096</span><span class="NLM_x">–</span> <span class="NLM_lpage">6099</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6096-6099&author=K.+K.-C.+Liuauthor=S.+Bagrodiaauthor=S.+Baileyauthor=H.+Chengauthor=H.+Chenauthor=L.+Gaoauthor=S.+Greasleyauthor=J.+E.+Hoffmanauthor=Q.+Huauthor=T.+O.+Johnsonauthor=D.+Knightonauthor=Z.+Liuauthor=M.+A.+Marxauthor=M.+D.+Nambuauthor=S.+Ninkovicauthor=B.+Pascualauthor=K.+Rafidiauthor=C.+M.-L.+Rodgersauthor=G.+L.+Smithauthor=S.+Sunauthor=H.+Wangauthor=A.+Yangauthor=J.+Yuanauthor=A.+Zou&title=4-Methylpteridinones+as+orally+active+and+selective+PI3K%2FmTOR+dual+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BK.-C.%26aulast%3DBagrodia%26aufirst%3DS.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DHoffman%26aufirst%3DJ.%2BE.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DKnighton%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMarx%26aufirst%3DM.%2BA.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DPascual%26aufirst%3DB.%26aulast%3DRafidi%26aufirst%3DK.%26aulast%3DRodgers%26aufirst%3DC.%2BM.-L.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DA.%26atitle%3D4-Methylpteridinones%2520as%2520orally%2520active%2520and%2520selective%2520PI3K%252FmTOR%2520dual%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6096%26epage%3D6099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagrodia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knighton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninkovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, E.</span><span> </span><span class="NLM_article-title">Discovery of the highly potent PI3K/mTOR dual inhibitor PF-04691502 through structure based drug design</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=139&author=H.+Chengauthor=S.+Bagrodiaauthor=S.+Baileyauthor=M.+Edwardsauthor=J.+Hoffmanauthor=Q.+Huauthor=R.+Kaniaauthor=D.+R.+Knightonauthor=M.+A.+Marxauthor=S.+Ninkovicauthor=S.+Sunauthor=E.+Zhang&title=Discovery+of+the+highly+potent+PI3K%2FmTOR+dual+inhibitor+PF-04691502+through+structure+based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DBagrodia%26aufirst%3DS.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DKania%26aufirst%3DR.%26aulast%3DKnighton%26aufirst%3DD.%2BR.%26aulast%3DMarx%26aufirst%3DM.%2BA.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520the%2520highly%2520potent%2520PI3K%252FmTOR%2520dual%2520inhibitor%2520PF-04691502%2520through%2520structure%2520based%2520drug%2520design%26jtitle%3DMedChemComm%26date%3D2010%26volume%3D1%26spage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donatelli, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgers, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarpong, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garver, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gontarek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershner, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherk, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegrzyn, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span> </span><span class="NLM_article-title">Discovery of GSK2126458, a highly potent inhibitor of PI3K and the mammalian target of rapamycin</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml900028r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=39-43&author=S.+D.+Knightauthor=N.+D.+Adamsauthor=J.+L.+Burgessauthor=A.+M.+Chaudhariauthor=M.+G.+Darcyauthor=C.+A.+Donatelliauthor=J.+I.+Luengoauthor=K.+A.+Newlanderauthor=C.+A.+Parrishauthor=L.+H.+Ridgersauthor=M.+A.+Sarpongauthor=S.+J.+Schmidtauthor=G.+S.+Van+Allerauthor=J.+D.+Carsonauthor=M.+A.+Diamondauthor=P.+A.+Elkinsauthor=C.+M.+Gardinerauthor=E.+Garverauthor=S.+A.+Gilbertauthor=R.+R.+Gontarekauthor=J.+R.+Jacksonauthor=K.+L.+Kershnerauthor=L.+Luoauthor=K.+Rahaauthor=C.+S.+Sherkauthor=C.-M.+Sungauthor=D.+Suttonauthor=P.+J.+Tumminoauthor=R.+J.+Wegrzynauthor=K.+R.+Augerauthor=D.+Dhanak&title=Discovery+of+GSK2126458%2C+a+highly+potent+inhibitor+of+PI3K+and+the+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span></div><div class="casAuthors">Knight, Steven D.; Adams, Nicholas D.; Burgess, Joelle L.; Chaudhari, Amita M.; Darcy, Michael G.; Donatelli, Carla A.; Luengo, Juan I.; Newlander, Ken A.; Parrish, Cynthia A.; Ridgers, Lance H.; Sarpong, Martha A.; Schmidt, Stanley J.; Van Aller, Glenn S.; Carson, Jeffrey D.; Diamond, Melody A.; Elkins, Patricia A.; Gardiner, Christine M.; Garver, Eric; Gilbert, Seth A.; Gontarek, Richard R.; Jackson, Jeffrey R.; Kershner, Kevin L.; Luo, Lusong; Raha, Kaushik; Sherk, Christian S.; Sung, Chiu-Mei; Sutton, David; Tummino, Peter J.; Wegrzyn, Ronald J.; Auger, Kurt R.; Dhanak, Dashyant</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-43</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase α (PI3Kα) is a crit. regulator of cell growth and transformation, and its signaling pathway is the most commonly mutated pathway in human cancers.  The mammalian target of rapamycin (mTOR), a class IV PI3K protein kinase, is also a central regulator of cell growth, and mTOR inhibitors are believed to augment the antiproliferative efficacy of PI3K/AKT pathway inhibition. 2,4-Difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide (GSK2126458, 1 (I)) has been identified as a highly potent, orally bioavailable inhibitor of PI3Kα and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.  Compd. 1 is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBH6_ywCnjCrVg90H21EOLACvtfcHk0lh3vTfiMcj8lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D&md5=72fcca85702dba95529ac03281e0bdbc</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fml900028r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900028r%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DChaudhari%26aufirst%3DA.%2BM.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DDonatelli%26aufirst%3DC.%2BA.%26aulast%3DLuengo%26aufirst%3DJ.%2BI.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DParrish%26aufirst%3DC.%2BA.%26aulast%3DRidgers%26aufirst%3DL.%2BH.%26aulast%3DSarpong%26aufirst%3DM.%2BA.%26aulast%3DSchmidt%26aufirst%3DS.%2BJ.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DDiamond%26aufirst%3DM.%2BA.%26aulast%3DElkins%26aufirst%3DP.%2BA.%26aulast%3DGardiner%26aufirst%3DC.%2BM.%26aulast%3DGarver%26aufirst%3DE.%26aulast%3DGilbert%26aufirst%3DS.%2BA.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DKershner%26aufirst%3DK.%2BL.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DRaha%26aufirst%3DK.%26aulast%3DSherk%26aufirst%3DC.%2BS.%26aulast%3DSung%26aufirst%3DC.-M.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DWegrzyn%26aufirst%3DR.%2BJ.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520GSK2126458%252C%2520a%2520highly%2520potent%2520inhibitor%2520of%2520PI3K%2520and%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D39%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wen, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omuro, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nghiemphu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norden, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendreau, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T.</span><span> </span><span class="NLM_article-title">Abstract B265: a phase 1 safety and pharmacokinetic study of XL765 (SAR245409), a novel PI3K/TORC1/TORC2 inhibitor, in combination with temozolomide (TMZ) in patients (pts) with malignant glioma</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">B265</span><span class="NLM_x">–</span> <span class="NLM_lpage">B265</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=B265-B265&author=P.+Y.+Wenauthor=A.+M.+Omuroauthor=T.+T.+Batchelorauthor=A.+Laiauthor=I.+K.+Mellinghoffauthor=L.+Nghiemphuauthor=A.+Nordenauthor=S.+B.+Gendreauauthor=A.+D.+Lairdauthor=L.+Nguyenauthor=T.+Cloughesy&title=Abstract+B265%3A+a+phase+1+safety+and+pharmacokinetic+study+of+XL765+%28SAR245409%29%2C+a+novel+PI3K%2FTORC1%2FTORC2+inhibitor%2C+in+combination+with+temozolomide+%28TMZ%29+in+patients+%28pts%29+with+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DOmuro%26aufirst%3DA.%2BM.%26aulast%3DBatchelor%26aufirst%3DT.%2BT.%26aulast%3DLai%26aufirst%3DA.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DNghiemphu%26aufirst%3DL.%26aulast%3DNorden%26aufirst%3DA.%26aulast%3DGendreau%26aufirst%3DS.%2BB.%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DCloughesy%26aufirst%3DT.%26atitle%3DAbstract%2520B265%253A%2520a%2520phase%25201%2520safety%2520and%2520pharmacokinetic%2520study%2520of%2520XL765%2520%2528SAR245409%2529%252C%2520a%2520novel%2520PI3K%252FTORC1%252FTORC2%2520inhibitor%252C%2520in%2520combination%2520with%2520temozolomide%2520%2528TMZ%2529%2520in%2520patients%2520%2528pts%2529%2520with%2520malignant%2520glioma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3DB265%26epage%3DB265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tikad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akssira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léger, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">Efficient synthesis of 2-substituted pyrido[3,2-<i>d</i>]pyrimidines involving S<sub>N</sub>Ar and palladium-catalyzed cross-coupling reactions</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">2379</span><span class="NLM_x">–</span> <span class="NLM_lpage">2284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFGktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=2379-2284&author=A.+Tikadauthor=S.+Routierauthor=M.+Akssiraauthor=J.-M.+L%C3%A9gerauthor=C.+Jarryauthor=G.+Guillaumet&title=Efficient+synthesis+of+2-substituted+pyrido%5B3%2C2-d%5Dpyrimidines+involving+SNAr+and+palladium-catalyzed+cross-coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis of 2-substituted pyrido[3,2-d]pyrimidines involving SNAr and palladium-catalyzed cross-coupling reactions</span></div><div class="casAuthors">Tikad, Abdellatif; Routier, Sylvain; Akssira, Mohamed; Leger, Jean-Michel; Jarry, Christian; Guillaumet, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2379-2384</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The efficient and original synthesis of various 2-substituted pyrido[3,2-d]pyrimidines is reported.  Starting from 2,4-dichloropyrido[3,2-d]pyrimidine, a regioselective pallado-dehalogenation led to 2-chloropyrido[3,2-d]pyrimidine, which was used in SNAr and Pd-catalyzed cross-couplings to afford highly functionalized products in very good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZQMyOn1tMCrVg90H21EOLACvtfcHk0lh3vTfiMcj8lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFGktb0%253D&md5=910cbd8df6e5ea4bf664933eade87044</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTikad%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DAkssira%26aufirst%3DM.%26aulast%3DL%25C3%25A9ger%26aufirst%3DJ.-M.%26aulast%3DJarry%26aufirst%3DC.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DEfficient%2520synthesis%2520of%25202-substituted%2520pyrido%255B3%252C2-d%255Dpyrimidines%2520involving%2520SNAr%2520and%2520palladium-catalyzed%2520cross-coupling%2520reactions%26jtitle%3DSynthesis%26date%3D2009%26spage%3D2379%26epage%3D2284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tikad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akssira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">Efficient one-pot synthesis of 2,4-di(het)aryl and 2,4-diamino pyrido[3,2-<i>d</i>]pyrimidines involving regioselective S<sub>N</sub>Ar and palladium-catalyzed reactions</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">5113</span><span class="NLM_x">–</span> <span class="NLM_lpage">5118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=5113-5118&author=A.+Tikadauthor=S.+Routierauthor=M.+Akssiraauthor=G.+Guillaumet&title=Efficient+one-pot+synthesis+of+2%2C4-di%28het%29aryl+and+2%2C4-diamino+pyrido%5B3%2C2-d%5Dpyrimidines+involving+regioselective+SNAr+and+palladium-catalyzed+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTikad%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DAkssira%26aufirst%3DM.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DEfficient%2520one-pot%2520synthesis%2520of%25202%252C4-di%2528het%2529aryl%2520and%25202%252C4-diamino%2520pyrido%255B3%252C2-d%255Dpyrimidines%2520involving%2520regioselective%2520SNAr%2520and%2520palladium-catalyzed%2520reactions%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D5113%26epage%3D5118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tikad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akssira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">New efficient route to dissymmetric 2,4-di(het)aryl-pyrido[3,2-<i>d</i>]pyrimidines via regioselective cross-coupling reactions</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">4673</span><span class="NLM_x">–</span> <span class="NLM_lpage">4676</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol7014434" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=4673-4676&author=A.+Tikadauthor=S.+Routierauthor=M.+Akssiraauthor=J.-M.+Legerauthor=C.+Jarryauthor=G.+Guillaumet&title=New+efficient+route+to+dissymmetric+2%2C4-di%28het%29aryl-pyrido%5B3%2C2-d%5Dpyrimidines+via+regioselective+cross-coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1021%2Fol7014434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol7014434%26sid%3Dliteratum%253Aachs%26aulast%3DTikad%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DAkssira%26aufirst%3DM.%26aulast%3DLeger%26aufirst%3DJ.-M.%26aulast%3DJarry%26aufirst%3DC.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DNew%2520efficient%2520route%2520to%2520dissymmetric%25202%252C4-di%2528het%2529aryl-pyrido%255B3%252C2-d%255Dpyrimidines%2520via%2520regioselective%2520cross-coupling%2520reactions%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D4673%26epage%3D4676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Tikad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akssira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">Efficient access to novel mono- and disubstituted pyrido[3,2-<i>d</i>]pyrimidines</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">1938</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=1938-1942&author=A.+Tikadauthor=S.+Routierauthor=M.+Akssiraauthor=J.-M.+Legerauthor=C.+Jarryauthor=G.+Guillaumet&title=Efficient+access+to+novel+mono-+and+disubstituted+pyrido%5B3%2C2-d%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTikad%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DAkssira%26aufirst%3DM.%26aulast%3DLeger%26aufirst%3DJ.-M.%26aulast%3DJarry%26aufirst%3DC.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DEfficient%2520access%2520to%2520novel%2520mono-%2520and%2520disubstituted%2520pyrido%255B3%252C2-d%255Dpyrimidines%26jtitle%3DSynlett%26date%3D2006%26spage%3D1938%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritomo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110α inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6847</span><span class="NLM_x">–</span> <span class="NLM_lpage">6858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6847-6858&author=M.+Hayakawaauthor=H.+Kaizawaauthor=H.+Moritomoauthor=T.+Koizumiauthor=T.+Ohishiauthor=M.+Okadaauthor=M.+Ohtaauthor=S.+Tsukamotoauthor=P.+Parkerauthor=P.+Workmanauthor=M.+Waterfield&title=Synthesis+and+biological+evaluation+of+4-morpholino-2-phenylquinazolines+and+related+derivatives+as+novel+PI3+kinase+p110%CE%B1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DMoritomo%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWaterfield%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204-morpholino-2-phenylquinazolines%2520and%2520related%2520derivatives%2520as%2520novel%2520PI3%2520kinase%2520p110%25CE%25B1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6847%26epage%3D6858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hayakawa, M.; Kaizawa, H.; Moritomo, H.; Kawaguchi, K.; Koizumi, T.; Yamano, M.; Matsuda, K.; Okada, M.; Ohta, M.</span><span> </span><span class="NLM_article-title">Preparation of condensed heteroaryl derivatives as phosphatidylinositol 3-kinase inhibitors and anticancer agents</span>. PCT Int. Appl. WO 2001083456 A1 20011108,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=M.+Hayakawa&author=H.+Kaizawa&author=H.+Moritomo&author=K.+Kawaguchi&author=T.+Koizumi&author=M.+Yamano&author=K.+Matsuda&author=M.+Okada&author=M.+Ohta&title=Preparation+of+condensed+heteroaryl+derivatives+as+phosphatidylinositol+3-kinase+inhibitors+and+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520condensed%2520heteroaryl%2520derivatives%2520as%2520phosphatidylinositol%25203-kinase%2520inhibitors%2520and%2520anticancer%2520agents%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisconte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chantry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondru, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadin, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reif, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safina, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staben, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seward, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waszkowycz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, B.</span><span> </span><span class="NLM_article-title">Potent and selective inhibitors of PI3Kδ: obtaining isoform selectivity from the affinity pocket and tryptophan shelf</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4296</span><span class="NLM_x">–</span> <span class="NLM_lpage">4302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.bmcl.2012.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=22672799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVegur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4296-4302&author=D.+P.+Sutherlinauthor=S.+Bakerauthor=A.+Bisconteauthor=P.+M.+Blaneyauthor=A.+Brownauthor=B.+K.+Chanauthor=D.+Chantryauthor=G.+Castanedoauthor=P.+DePledgeauthor=P.+Goldsmithauthor=D.+M.+Goldsteinauthor=T.+Hancoxauthor=J.+Kaurauthor=D.+Knowlesauthor=R.+Kondruauthor=J.+Lesnickauthor=M.+C.+Lucasauthor=C.+Lewisauthor=J.+Murrayauthor=A.+J.+Nadinauthor=J.+Nonomiyaauthor=J.+Pangauthor=N.+Peggauthor=S.+Priceauthor=K.+Reifauthor=B.+S.+Safinaauthor=L.+Salphatiauthor=S.+Stabenauthor=E.+M.+Sewardauthor=S.+Shuttleworthauthor=S.+Sohalauthor=Z.+K.+Sweeneyauthor=M.+Ultschauthor=B.+Waszkowyczauthor=B.+Wei&title=Potent+and+selective+inhibitors+of+PI3K%CE%B4%3A+obtaining+isoform+selectivity+from+the+affinity+pocket+and+tryptophan+shelf"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective inhibitors of PI3Kδ: Obtaining isoform selectivity from the affinity pocket and tryptophan shelf</span></div><div class="casAuthors">Sutherlin, Daniel P.; Baker, Stewart; Bisconte, Angelina; Blaney, Paul M.; Brown, Anthony; Chan, Bryan K.; Chantry, David; Castanedo, Georgette; DePledge, Paul; Goldsmith, Paul; Goldstein, David M.; Hancox, Timothy; Kaur, Jasmit; Knowles, David; Kondru, Rama; Lesnick, John; Lucas, Matthew C.; Lewis, Cristina; Murray, Jeremy; Nadin, Alan J.; Nonomiya, Jim; Pang, Jodie; Pegg, Neil; Price, Steve; Reif, Karin; Safina, Brian S.; Salphati, Laurent; Staben, Steven; Seward, Eileen M.; Shuttleworth, Stephen; Sohal, Sukhjit; Sweeney, Zachary K.; Ultsch, Mark; Waszkowycz, Bohdan; Wei, Binqing</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4296-4302</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A potent inhibitor of PI3Kδ that is ≥200 fold selective for the remaining three Class I PI3K isoforms and addnl. kinases is described.  The hypothesis for selectivity is illustrated through structure activity relationships and crystal structures of compds. bound to a K802T mutant of PI3Kγ.  Pharmacokinetic data in rats and mice support the use of 3 as a useful tool compd. to use for in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaSfg4K5zqbLVg90H21EOLACvtfcHk0lg7trvwnDA4FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVegur0%253D&md5=d15c7cd8ce626cc5e9a13ac355557ce8</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DBaker%26aufirst%3DS.%26aulast%3DBisconte%26aufirst%3DA.%26aulast%3DBlaney%26aufirst%3DP.%2BM.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChantry%26aufirst%3DD.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DDePledge%26aufirst%3DP.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DHancox%26aufirst%3DT.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKnowles%26aufirst%3DD.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNadin%26aufirst%3DA.%2BJ.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPegg%26aufirst%3DN.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DReif%26aufirst%3DK.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DStaben%26aufirst%3DS.%26aulast%3DSeward%26aufirst%3DE.%2BM.%26aulast%3DShuttleworth%26aufirst%3DS.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DWei%26aufirst%3DB.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520PI3K%25CE%25B4%253A%2520obtaining%2520isoform%2520selectivity%2520from%2520the%2520affinity%2520pocket%2520and%2520tryptophan%2520shelf%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4296%26epage%3D4302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Vlahos, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. F.</span><span> </span><span class="NLM_article-title">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=8106507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=5241-5248&author=C.+J.+Vlahosauthor=W.+F.+Matterauthor=K.+Y.+Huiauthor=R.+F.+Brown&title=A+specific+inhibitor+of+phosphatidylinositol+3-kinase%2C+2-%284-morpholinyl%29-8-phenyl-4H-1-benzopyran-4-one+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)</span></div><div class="casAuthors">Vlahos, Chris J.; Matter, William F.; Hui, Kwan Y.; Brown, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5241-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Phosphatidylinositol (PtIns) 3-kinase is an enzyme implicated in growth factor signal transduction by assocg. with receptor and nonreceptor tyrosine kinases, including the platelet-derived growth factor receptor.  Inhibitors of PtdIns 3-kinase could potentially give a better understanding of the function and regulatory mechanisms of the enzyme.  Quercetin, a naturally occurring bioflavonoid, was previously shown to inhibit PtdIns 3-kinase with an IC50 of 1.3 μg/mL (3.8 μM); inhibition appeared to be directed at the ATP-binding site of the kinase.  Analogs of quercetin were investigated as PtdIns 3-kinase inhibitors, with the most potent ones exhibiting IC50 values in the range of 1.7-8.4 μg/mL.  In contrast, genistein, a potent tyrosine kinase inhibitor of the isoflavone class, did not inhibit PtdIns 3-kinase significantly (IC50 > 30 μg/mL).  Since quercetin has also been shown to inhibit other PtdIns and protein kinases, other chromones were evaluated as inhibitors of PtdIns 3-kinase without affecting PtdIns 4-kinase or selected protein kinases.  One such compd., 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (also known as 2-(4-morpholinyl)-8-phenylchromone, LY294002), completely and specifically abolished PtdIns 3-kinase activity (IC50 = 0.43 μg/mL; 1.40 μM) but did not inhibit PtdIns 4-kinase or tested protein and lipid kinases.  Analogs of LY294002 demonstrated a very selective structure-activity relationship, with slight changes in structure causing marked decreases in inhibition.  LY294002 was shown to completely abolish PtdIns 3-kinase activity in fMet-Leu-Phe-stimulated human neutrophils, as well as inhibit proliferation of smooth muscle cells in cultured rabbit aortic segments.  Since PtdIns 3-kinase appears to be centrally involved with growth factor signal transduction, the development of specific inhibitors against the kinase may be beneficial in the treatment of proliferative diseases as well as in elucidating the biol. role of the kinase in cellular proliferation and growth factor response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Ii0f457BC7Vg90H21EOLACvtfcHk0lg7trvwnDA4FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D&md5=2635c03af206ce35d55b899f92921477</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlahos%26aufirst%3DC.%2BJ.%26aulast%3DMatter%26aufirst%3DW.%2BF.%26aulast%3DHui%26aufirst%3DK.%2BY.%26aulast%3DBrown%26aufirst%3DR.%2BF.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520phosphatidylinositol%25203-kinase%252C%25202-%25284-morpholinyl%2529-8-phenyl-4H-1-benzopyran-4-one%2520%2528LY294002%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D5241%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Pomel, V.; Gaillard, P.; Desforges, G.; Quattropani, A.; Montagne, C.</span><span> </span><span class="NLM_article-title">Preparation of 4-morpholino-pyrido[3,2-d]pyrimidine compounds as PI3K inhibitors for therapeutic applications</span>. PCT Int. Appl. WO 2010037765 A2 20100408,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=V.+Pomel&author=P.+Gaillard&author=G.+Desforges&author=A.+Quattropani&author=C.+Montagne&title=Preparation+of+4-morpholino-pyrido%5B3%2C2-d%5Dpyrimidine+compounds+as+PI3K+inhibitors+for+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPomel%26aufirst%3DV.%26atitle%3DPreparation%2520of%25204-morpholino-pyrido%255B3%252C2-d%255Dpyrimidine%2520compounds%2520as%2520PI3K%2520inhibitors%2520for%2520therapeutic%2520applications%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Castanedo, G.; Chan, B.; Lucas, M.; Safina, B.; Sutherlin, D.; Sweeney, Z.</span><span> </span><span class="NLM_article-title">Preparation of pyrido[3,2-d]pyrimidine as PI3kδ inhibitors</span>. PCT Int. Appl. WO 2011101429 A1 20110825,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Castanedo&author=B.+Chan&author=M.+Lucas&author=B.+Safina&author=D.+Sutherlin&author=Z.+Sweeney&title=Preparation+of+pyrido%5B3%2C2-d%5Dpyrimidine+as+PI3k%CE%B4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%26atitle%3DPreparation%2520of%2520pyrido%255B3%252C2-d%255Dpyrimidine%2520as%2520PI3k%25CE%25B4%2520inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0lhzLSZExidMnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.-Y.</span><span> </span><span class="NLM_article-title">Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901284w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1086-1097&author=D.+P.+Sutherlinauthor=D.+Sampathauthor=M.+Berryauthor=G.+Castanedoauthor=Z.+Changauthor=I.+Chuckowreeauthor=J.+Dotsonauthor=A.+Folkesauthor=L.+Friedmanauthor=R.+Goldsmithauthor=T.+Heffronauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=J.+Pangauthor=W.+W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=Q.+Tianauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=C.+Wiesmannauthor=S.+Wongauthor=B.-Y.+Zhu&title=Discovery+of+%28thienopyrimidin-2-yl%29aminopyrimidines+as+potent%2C+selective%2C+and+orally+available+pan-PI3-kinase+and+dual+pan-PI3-kinase%2FmTOR+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm901284w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901284w%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeffron%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DB.-Y.%26atitle%3DDiscovery%2520of%2520%2528thienopyrimidin-2-yl%2529aminopyrimidines%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520pan-PI3-kinase%2520and%2520dual%2520pan-PI3-kinase%252FmTOR%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1086%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lavecchia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berteina-Raboin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">Selective bifunctionalization of pyrido[2,3-<i>d</i>]pyrimidines in positions 2 and 4 by SN<sub>Ar</sub> and palladium-catalyzed coupling reactions</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5851</span><span class="NLM_x">–</span> <span class="NLM_lpage">5855</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=5851-5855&author=G.+Lavecchiaauthor=S.+Berteina-Raboinauthor=G.+Guillaumet&title=Selective+bifunctionalization+of+pyrido%5B2%2C3-d%5Dpyrimidines+in+positions+2+and+4+by+SNAr+and+palladium-catalyzed+coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLavecchia%26aufirst%3DG.%26aulast%3DBerteina-Raboin%26aufirst%3DS.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DSelective%2520bifunctionalization%2520of%2520pyrido%255B2%252C3-d%255Dpyrimidines%2520in%2520positions%25202%2520and%25204%2520by%2520SNAr%2520and%2520palladium-catalyzed%2520coupling%2520reactions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D5851%26epage%3D5855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Riadi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massip, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">Convenient synthesis of 2,4-disubstituted pyrido[2,3-<i>d</i>]pyrimidines via regioselective palladium-catalyzed reactions</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">5018</span><span class="NLM_x">–</span> <span class="NLM_lpage">5024</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=5018-5024&author=Y.+Riadiauthor=S.+Massipauthor=J.+M.+Legerauthor=C.+Jarryauthor=S.+Lazarauthor=G.+Guillaumet&title=Convenient+synthesis+of+2%2C4-disubstituted+pyrido%5B2%2C3-d%5Dpyrimidines+via+regioselective+palladium-catalyzed+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiadi%26aufirst%3DY.%26aulast%3DMassip%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DJ.%2BM.%26aulast%3DJarry%26aufirst%3DC.%26aulast%3DLazar%26aufirst%3DS.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DConvenient%2520synthesis%2520of%25202%252C4-disubstituted%2520pyrido%255B2%252C3-d%255Dpyrimidines%2520via%2520regioselective%2520palladium-catalyzed%2520reactions%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D5018%26epage%3D5024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Neagoie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedrenne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buron, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mérour, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldeyrou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansiaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span> </span><span class="NLM_article-title">Synthesis of chromeno[3,4-<i>b</i>]indoles as lamellarin D analogues: a novel DYRK1A inhibitor class</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2012&pages=379-396&author=C.+Neagoieauthor=E.+Vedrenneauthor=F.+Buronauthor=J.-Y.+M%C3%A9rourauthor=S.+Roscaauthor=S.+Bourgauthor=O.+Lozachauthor=L.+Meijerauthor=B.+Baldeyrouauthor=A.+Lansiauxauthor=S.+Routier&title=Synthesis+of+chromeno%5B3%2C4-b%5Dindoles+as+lamellarin+D+analogues%3A+a+novel+DYRK1A+inhibitor+class"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeagoie%26aufirst%3DC.%26aulast%3DVedrenne%26aufirst%3DE.%26aulast%3DBuron%26aufirst%3DF.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DRosca%26aufirst%3DS.%26aulast%3DBourg%26aufirst%3DS.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBaldeyrou%26aufirst%3DB.%26aulast%3DLansiaux%26aufirst%3DA.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520chromeno%255B3%252C4-b%255Dindoles%2520as%2520lamellarin%2520D%2520analogues%253A%2520a%2520novel%2520DYRK1A%2520inhibitor%2520class%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D49%26spage%3D379%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefever, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Discovery of 4-morpholino-6-aryl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">8010</span><span class="NLM_x">–</span> <span class="NLM_lpage">8024</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9013828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=8010-8024&author=J.+C.+Verheijenauthor=D.+J.+Richardauthor=K.+Curranauthor=J.+Kaplanauthor=M.+Lefeverauthor=P.+Nowakauthor=D.+J.+Malwitzauthor=N.+Brooijmansauthor=L.+Toral-Barzaauthor=W.-G.+Zhangauthor=J.+Lucasauthor=I.+Hollanderauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=K.+Yuauthor=A.+Zask&title=Discovery+of+4-morpholino-6-aryl-1H-pyrazolo%5B3%2C4-d%5Dpyrimidines+as+highly+potent+and+selective+ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29%3A+optimization+of+the+6-aryl+substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1021%2Fjm9013828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9013828%26sid%3Dliteratum%253Aachs%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DLefever%26aufirst%3DM.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DDiscovery%2520of%25204-morpholino-6-aryl-1H-pyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520highly%2520potent%2520and%2520selective%2520ATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%253A%2520optimization%2520of%2520the%25206-aryl%2520substituent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D8010%26epage%3D8024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Smith, R.; Thompson, S.; Hosahalli, S.; Bejugam, M.; Nanduri, S.; Panigrahi, S.; Mahalingam, N.</span><span> </span><span class="NLM_article-title">Preparation of morpholinylheteroaryl-quinazolinylphenylcarbonylphenylurea derivatives and analogs for use as dual PI3K/mTOR inhibitors</span>. PCT Int. Appl. WO 2012058671 A1 20120503,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+Smith&author=S.+Thompson&author=S.+Hosahalli&author=M.+Bejugam&author=S.+Nanduri&author=S.+Panigrahi&author=N.+Mahalingam&title=Preparation+of+morpholinylheteroaryl-quinazolinylphenylcarbonylphenylurea+derivatives+and+analogs+for+use+as+dual+PI3K%2FmTOR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DR.%26atitle%3DPreparation%2520of%2520morpholinylheteroaryl-quinazolinylphenylcarbonylphenylurea%2520derivatives%2520and%2520analogs%2520for%2520use%2520as%2520dual%2520PI3K%252FmTOR%2520inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span>Biological Macromolecular Resource. <a href="http://www.rcsb.org/pdb/home/home.do" class="extLink">http://www.rcsb.org/pdb/home/home.do</a> (accessed <span class="NLM_access-date">January 2014</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Biological+Macromolecular+Resource.+http%3A%2F%2Fwww.rcsb.org%2Fpdb%2Fhome%2Fhome.do+%28accessed+January+2014%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Huang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Kittler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabelli, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amzel, L. M.</span><span> </span><span class="NLM_article-title">The structure of a human p110α/p85α complex elucidates the effects of oncogenic PI3Kα mutations</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1744</span><span class="NLM_x">–</span> <span class="NLM_lpage">1748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1744-1748&author=C.-H.+Huangauthor=D.+Mandelkerauthor=O.+Schmidt-Kittlerauthor=Y.+Samuelsauthor=V.+E.+Velculescuauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=S.+B.+Gabelliauthor=L.+M.+Amzel&title=The+structure+of+a+human+p110%CE%B1%2Fp85%CE%B1+complex+elucidates+the+effects+of+oncogenic+PI3K%CE%B1+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.-H.%26aulast%3DMandelker%26aufirst%3DD.%26aulast%3DSchmidt-Kittler%26aufirst%3DO.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DGabelli%26aufirst%3DS.%2BB.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DThe%2520structure%2520of%2520a%2520human%2520p110%25CE%25B1%252Fp85%25CE%25B1%2520complex%2520elucidates%2520the%2520effects%2520of%2520oncogenic%2520PI3K%25CE%25B1%2520mutations%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1744%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Mandelker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabelli, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Kittler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amzel, L. M.</span><span> </span><span class="NLM_article-title">A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">16996</span><span class="NLM_x">–</span> <span class="NLM_lpage">17001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=16996-17001&author=D.+Mandelkerauthor=S.+B.+Gabelliauthor=O.+Schmidt-Kittlerauthor=J.+Zhuauthor=I.+Cheongauthor=C.-H.+Huangauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=L.+M.+Amzel&title=A+frequent+kinase+domain+mutation+that+changes+the+interaction+between+PI3K%CE%B1+and+the+membrane"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandelker%26aufirst%3DD.%26aulast%3DGabelli%26aufirst%3DS.%2BB.%26aulast%3DSchmidt-Kittler%26aufirst%3DO.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DCheong%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DC.-H.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DA%2520frequent%2520kinase%2520domain%2520mutation%2520that%2520changes%2520the%2520interaction%2520between%2520PI3K%25CE%25B1%2520and%2520the%2520membrane%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D16996%26epage%3D17001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alaimo, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenski, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4749</span><span class="NLM_x">–</span> <span class="NLM_lpage">4759</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.bmc.2004.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=15358300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Oiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=4749-4759&author=Z.+A.+Knightauthor=G.+G.+Chiangauthor=P.+J.+Alaimoauthor=D.+M.+Kenskiauthor=C.+B.+Hoauthor=K.+Coanauthor=R.+T.+Abrahamauthor=K.+M.+Shokat&title=Isoform-specific+phosphoinositide+3-kinase+inhibitors+from+an+arylmorpholine+scaffold"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold</span></div><div class="casAuthors">Knight, Zachary A.; Chiang, Gary G.; Alaimo, Peter J.; Kenski, Denise M.; Ho, Caroline B.; Coan, Kristin; Abraham, Robert T.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4749-4759</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3-Ks) are an ubiquitous class of signaling enzymes that regulate diverse cellular processes including growth, differentiation, and motility.  Physiol. roles of PI3-Ks have traditionally been assigned using two pharmacol. inhibitors, LY294002 and wortmannin.  Although these compds. are broadly specific for the PI3-K family, they show little selectivity among family members, and the development of isoform-specific inhibitors of these enzymes has been long anticipated.  Herein, the prepn. of two classes of arylmorpholine PI3-K inhibitors and the characterization of their specificity against a comprehensive panel of targets within the PI3-K family are reported.  Multiplex inhibitors that potently inhibit distinct subsets of PI3-K isoforms, including the first selective inhibitor of p110β/p110δ (IC50 p110β = 0.13 μM, p110δ = 0.63 μM), were identified.  Trends that suggest certain PI3-K isoforms may be more sensitive to potent inhibition by arylmorpholines, thereby guiding future drug design based on this pharmacophore, were also identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvvlNyK2W7KLVg90H21EOLACvtfcHk0lhZJp_rD8cYbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Oiurc%253D&md5=46426eff73eb2fdf6cc6878081510005</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DAlaimo%26aufirst%3DP.%2BJ.%26aulast%3DKenski%26aufirst%3DD.%2BM.%26aulast%3DHo%26aufirst%3DC.%2BB.%26aulast%3DCoan%26aufirst%3DK.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DIsoform-specific%2520phosphoinositide%25203-kinase%2520inhibitors%2520from%2520an%2520arylmorpholine%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D4749%26epage%3D4759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5013</span><span class="NLM_x">–</span> <span class="NLM_lpage">5016</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900851f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5013-5016&author=A.+Zaskauthor=J.+C.+Verheijenauthor=K.+Curranauthor=J.+Kaplanauthor=D.+J.+Richardauthor=P.+Nowakauthor=D.+J.+Malwitzauthor=N.+Brooijmansauthor=J.+Bardauthor=K.+Svensonauthor=J.+Lucasauthor=L.+Toral-Barzaauthor=W.-G.+Zhangauthor=I.+Hollanderauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=K.+Yu&title=ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin%3A+design+and+synthesis+of+highly+potent+and+selective+pyrazolopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm900851f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900851f%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%253A%2520design%2520and%2520synthesis%2520of%2520highly%2520potent%2520and%2520selective%2520pyrazolopyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5013%26epage%3D5016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lhcruhUnR9ACA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Nakabayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taketa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, J.</span><span> </span><span class="NLM_article-title">Growth of human hepatoma cells lines with differentiated functions in chemically defined medium</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3858</span><span class="NLM_x">–</span> <span class="NLM_lpage">3863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=6286115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADyaL38Xlt1ens78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1982&pages=3858-3863&author=H.+Nakabayashiauthor=K.+Taketaauthor=K.+Miyanoauthor=T.+Yamaneauthor=J.+Sato&title=Growth+of+human+hepatoma+cells+lines+with+differentiated+functions+in+chemically+defined+medium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Growth of human hepatoma cell lines with differentiated functions in chemically defined medium</span></div><div class="casAuthors">Nakabayashi, Hidekazu; Taketa, Kazuhisa; Miyano, Keiko; Yamane, Takashi; Sato, Jiro</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3858-63</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">A human hepatoma cell line, HuH-7, which was established from a hepatocellular carcinoma, replicated continuously in a chem. defined medium when the medium was supplemented with Na2SeO3.  The cells grew better in this medium than in serum-contg. medium without any adaptation period.  Other established human hepatoma and hepatoblastoma cell lines, HuH-6 cl-5, PLC/PRF/5, huH-1, and huH-4, also grew in the defined medium.  Although HLEC-1 cells failed to proliferate continuously with Na2SeO3 alone, they grew if a cell-free conditioned medium from HuH-7 cells was added to the medium.  These cell lines, except the HLEC-1 cell line, produced the following human plasma proteins: albumin, prealbumin, α1-antitrypsin, ceruloplasmin, fibrinogen, fibronectin, haptoglobin, hemopexin, β-lipoprotein, α2-macroglobulin, β2-microglobulin, transferrin, complement components 3 and 4, and α1-fetoprotein.  Beside plasma proteins, the media from HuH-7, HuH-6 cl-5, PLC/PRF/5, and huH-1 contained anticarcinoembryonic antigen-reactive proteins, and those from PLC/PRF/5, huH-1, and huH-4 medium contained hepatitis B surface antigen.  These proteins were detected during periods of serial cultivation over 9 mo under the above culture conditions.  The hepatoma cell lines grown in the fully defined synthetic medium may provide a new approach for investigating the growth and metab. of human hepatoma cells in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0TOrW0aPitLVg90H21EOLACvtfcHk0liugTJTRWMPeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xlt1ens78%253D&md5=ea9da2cd2c0090618a3c2e5d924799e0</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakabayashi%26aufirst%3DH.%26aulast%3DTaketa%26aufirst%3DK.%26aulast%3DMiyano%26aufirst%3DK.%26aulast%3DYamane%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DJ.%26atitle%3DGrowth%2520of%2520human%2520hepatoma%2520cells%2520lines%2520with%2520differentiated%2520functions%2520in%2520chemically%2520defined%2520medium%26jtitle%3DCancer%2520Res.%26date%3D1982%26volume%3D42%26spage%3D3858%26epage%3D3863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Nakanishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto-Tamaoki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuyama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, E.</span><span> </span><span class="NLM_article-title">Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase</span> <span class="citation_source-journal">Clin. Exp. Metastasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1023%2FA%3A1006685218766" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=10763917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A280%3ADC%252BD3c3isV2rtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=507-514&author=K.+Nakanishiauthor=J.+Fujimotoauthor=T.+Uekiauthor=K.+Kishimotoauthor=T.+Hashimoto-Tamaokiauthor=J.+Furuyamaauthor=T.+Itohauthor=Y.+Sasakiauthor=E.+Okamoto&title=Hepatocyte+growth+factor+promotes+migration+of+human+hepatocellular+carcinoma+via+phosphatidylinositol+3-kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase</span></div><div class="casAuthors">Nakanishi K; Fujimoto J; Ueki T; Kishimoto K; Hashimoto-Tamaoki T; Furuyama J; Itoh T; Sasaki Y; Okamoto E</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & experimental metastasis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">507-14</span>
        ISSN:<span class="NLM_cas:issn">0262-0898</span>.
    </div><div class="casAbstract">Hepatocyte growth factor (HGF) is known to be a potent mitogen and motogen for epithelial cells.  Hepatocellular carcinoma (HCC) often metastasizes, and the c-Met/HGF receptor is highly expressed by HCC cells.  The aim of this study was to investigate the signaling pathways associated with the motogenic effect of HGF on HCC cells via c-Met.  HCC cell lines (Hep3B, HepG2, PLC, and Huh-7) and HCC cells harvested from patients were used for the Boyden chamber assay of chemotactic activity as well as for immunoprecipitation and immunoblotting studies.  HGF stimulated the motility of Hep3B, HepG2, and Huh-7 cells in a dose-dependent manner in association with tyrosine phosphorylation of c-Met and activation of phosphatidylinositol 3-kinase (PI3-K).  A tyrosine kinase inhibitor (genistein) and a PI3-K inhibitor (wortmannin) prevented the migration of HCC cells.  However, migration was not prevented by calphostin C, an inhibitor of protein kinase C (PKC), which is a downstream target of phospholipase Cgamma (PLCgamma).  HGF also stimulated the migration of HCC cells obtained from three patients, while wortmannin prevented the migration of these cells.  These results indicate that HGF stimulates the migration of HCC cells through the tyrosine phosphorylation of c-Met via activation of PI3-K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTNGwbZoo09dGxpATR2EQURfW6udTcc2ebUvF4l80a7abntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3isV2rtQ%253D%253D&md5=4c445617fdf72e7ddcf0daa2acdb9758</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006685218766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006685218766%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DK.%26aulast%3DFujimoto%26aufirst%3DJ.%26aulast%3DUeki%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DK.%26aulast%3DHashimoto-Tamaoki%26aufirst%3DT.%26aulast%3DFuruyama%26aufirst%3DJ.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DOkamoto%26aufirst%3DE.%26atitle%3DHepatocyte%2520growth%2520factor%2520promotes%2520migration%2520of%2520human%2520hepatocellular%2520carcinoma%2520via%2520phosphatidylinositol%25203-kinase%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D1999%26volume%3D17%26spage%3D507%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Gedaly, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hundley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daily, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, B. M.</span><span> </span><span class="NLM_article-title">PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4951</span><span class="NLM_x">–</span> <span class="NLM_lpage">4958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=21187475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVOktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=4951-4958&author=R.+Gedalyauthor=P.+Anguloauthor=J.+Hundleyauthor=M.+F.+Dailyauthor=C.+Chenauthor=A.+Kochauthor=B.+M.+Evers&title=PI-103+and+sorafenib+inhibit+hepatocellular+carcinoma+cell+proliferation+by+blocking+Ras%2FRaf%2FMAPK+and+PI3K%2FAKT%2FmTOR+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways</span></div><div class="casAuthors">Gedaly, Roberto; Angulo, Paul; Hundley, Jonathan; Daily, Michael F.; Chen, Changguo; Koch, Alvaro; Evers, B. Mark</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4951-4958</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Aberrant Ras/Raf/MAPK and PI3K/AKT/mTOR signaling pathways are found in hepatocellular carcinoma (HCC).  This study reports how sorafenib (a multi-kinase inhibitor) and PI-103 (a dual PI3K/mTOR inhibitor) alone and in combination inhibit the proliferation of the HCC cell line, Huh7.  Huh7 proliferation was assayed by 3H-thymidine incorporation and by MTT assay.  Western blot was used to detect phosphorylation of the key enzymes in the Ras/Raf and PI3K pathways.  Sorafenib and PI-103, as single agents inhibited Huh7 proliferation and epidermal growth factor (EGF)-stimulated Huh7 proliferation in a dose-dependent fashion; the combination of sorafenib and PI-103 produced synergistic effects.  EGF increased phosphorylation of MEK and ERK, key Ras/Raf downstream signaling proteins; this activation was inhibited by sorafenib.  However, sorafenib as a single agent increased AKT(Ser473) and mTOR phosphorylation.  EGF-stimulated activation of PI3K/AKT/mTOR pathway components was inhibited by PI-103.  PI-103 is a potent inhibitor of AKT(Ser473) phosphorylation; in contrast, rapamycin stimulated AKT(Ser473) phosphorylation.  It was found that PI-103, as a single agent, stimulated MEK and ERK phosphorylation.  However, the combination of sorafenib and PI-103 caused inhibition of all the tested kinases in the Ras/Raf and PI3K pathways.  The combination of sorafenib and PI-103 can significantly inhibit EGF-stimulated Huh7 proliferation by blocking both Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5ZuZBBqJpi7Vg90H21EOLACvtfcHk0linjBnLZD233g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVOktrg%253D&md5=496c0b84fc75aa250715fd89ac5107e7</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGedaly%26aufirst%3DR.%26aulast%3DAngulo%26aufirst%3DP.%26aulast%3DHundley%26aufirst%3DJ.%26aulast%3DDaily%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DA.%26aulast%3DEvers%26aufirst%3DB.%2BM.%26atitle%3DPI-103%2520and%2520sorafenib%2520inhibit%2520hepatocellular%2520carcinoma%2520cell%2520proliferation%2520by%2520blocking%2520Ras%252FRaf%252FMAPK%2520and%2520PI3K%252FAKT%252FmTOR%2520pathways%26jtitle%3DAnticancer%2520Res.%26date%3D2010%26volume%3D30%26spage%3D4951%26epage%3D4958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Ivison, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shobab, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kifayet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sly, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, T. S.</span><span> </span><span class="NLM_article-title">The p110α and p110β isoforms of class I phosphatidylinositol 3-kinase are involved in Toll-like receptor 5 signaling in epithelial cells</span> <span class="citation_source-journal">Mediators Inflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1155%2F2010%2F652098" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=1-12&author=S.+M.+Ivisonauthor=M.+A.+S.+Khanauthor=N.+R.+Grahamauthor=L.+A.+Shobabauthor=Y.+Yaoauthor=A.+Kifayetauthor=L.+M.+Slyauthor=T.+S.+Steiner&title=The+p110%CE%B1+and+p110%CE%B2+isoforms+of+class+I+phosphatidylinositol+3-kinase+are+involved+in+Toll-like+receptor+5+signaling+in+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1155%2F2010%2F652098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2010%252F652098%26sid%3Dliteratum%253Aachs%26aulast%3DIvison%26aufirst%3DS.%2BM.%26aulast%3DKhan%26aufirst%3DM.%2BA.%2BS.%26aulast%3DGraham%26aufirst%3DN.%2BR.%26aulast%3DShobab%26aufirst%3DL.%2BA.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DKifayet%26aufirst%3DA.%26aulast%3DSly%26aufirst%3DL.%2BM.%26aulast%3DSteiner%26aufirst%3DT.%2BS.%26atitle%3DThe%2520p110%25CE%25B1%2520and%2520p110%25CE%25B2%2520isoforms%2520of%2520class%2520I%2520phosphatidylinositol%25203-kinase%2520are%2520involved%2520in%2520Toll-like%2520receptor%25205%2520signaling%2520in%2520epithelial%2520cells%26jtitle%3DMediators%2520Inflammation%26date%3D2010%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Langlois, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernatchez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudreau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saucier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreault, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrier, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivard, N.</span><span> </span><span class="NLM_article-title">The PTEN phosphatase controls intestinal epithelial cell polarity and barrier function: role in colorectal cancer progression</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e15742</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e15742&author=M.-J.+Langloisauthor=S.+Bergeronauthor=G.+Bernatchezauthor=F.+Boudreauauthor=C.+Saucierauthor=N.+Perreaultauthor=J.+C.+Carrierauthor=N.+Rivard&title=The+PTEN+phosphatase+controls+intestinal+epithelial+cell+polarity+and+barrier+function%3A+role+in+colorectal+cancer+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLanglois%26aufirst%3DM.-J.%26aulast%3DBergeron%26aufirst%3DS.%26aulast%3DBernatchez%26aufirst%3DG.%26aulast%3DBoudreau%26aufirst%3DF.%26aulast%3DSaucier%26aufirst%3DC.%26aulast%3DPerreault%26aufirst%3DN.%26aulast%3DCarrier%26aufirst%3DJ.%2BC.%26aulast%3DRivard%26aufirst%3DN.%26atitle%3DThe%2520PTEN%2520phosphatase%2520controls%2520intestinal%2520epithelial%2520cell%2520polarity%2520and%2520barrier%2520function%253A%2520role%2520in%2520colorectal%2520cancer%2520progression%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De15742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Mordant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriot, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leteur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderaro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourhis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wislez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soria, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutsch, E.</span><span> </span><span class="NLM_article-title">Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (everolimus) in combination</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1158%2F1535-7163.MCT-09-1014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=20124452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslektb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=358-368&author=P.+Mordantauthor=Y.+Loriotauthor=C.+Leteurauthor=J.+Calderaroauthor=J.+Bourhisauthor=M.+Wislezauthor=J.-C.+Soriaauthor=E.+Deutsch&title=Dependence+on+phosphoinositide+3-kinase+and+RAS-RAF+pathways+drive+the+activity+of+RAF265%2C+a+novel+RAF%2FVEGFR2+inhibitor%2C+and+RAD001+%28everolimus%29+in+combination"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in Combination</span></div><div class="casAuthors">Mordant, Pierre; Loriot, Yohann; Leteur, Celine; Calderaro, Julien; Bourhis, Jean; Wislez, Marie; Soria, Jean-Charles; Deutsch, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">358-368</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activation of phosphatidylinositol-3-kinase (PI3K)-AKT and Kirsten rat sarcoma viral oncogene homolog (KRAS) can induce cellular immortalization, proliferation, and resistance to anticancer therapeutics such as epidermal growth factor receptor inhibitors or chemotherapy.  This study assessed the consequences of inhibiting these two pathways in tumor cells with activation of KRAS, PI3K-AKT, or both.  We investigated whether the combination of a novel RAF/vascular endothelial growth factor receptor inhibitor, RAF265, with a mammalian target of rapamycin (mTOR) inhibitor, RAD001 (everolimus), could lead to enhanced antitumoral effects in vitro and in vivo.  To address this question, we used cell lines with different status regarding KRAS, PIK3CA, and BRAF mutations, using immunoblotting to evaluate the inhibitors, and MTT and clonogenic assays for effects on cell viability and proliferation.  S.c. xenografts were used to assess the activity of the combination in vivo.  RAD001 inhibited mTOR downstream signaling in all cell lines, whereas RAF265 inhibited RAF downstream signaling only in BRAF mutant cells.  In vitro, addn. of RAF265 to RAD001 led to decreased AKT, S6, and Eukaryotic translation initiation factor 4E binding protein 1 phosphorylation in HCT116 cells.  In vitro and in vivo, RAD001 addn. enhanced the antitumoral effect of RAF265 in HCT116 and H460 cells (both KRAS mut, PIK3CA mut); in contrast, the combination of RAF265 and RAD001 yielded no addnl. activity in A549 and MDAMB231 cells.  The combination of RAF and mTOR inhibitors is effective for enhancing antitumoral effects in cells with deregulation of both RAS-RAF and PI3K, possibly through the cross-inhibition of 4E binding protein 1 and S6 protein.  Mol Cancer Ther; 9(2); 358-68.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBLcFcZujsVbVg90H21EOLACvtfcHk0lgibclIIv5tsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslektb0%253D&md5=d8f99d5865a37b36583fab0ae937a548</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1014%26sid%3Dliteratum%253Aachs%26aulast%3DMordant%26aufirst%3DP.%26aulast%3DLoriot%26aufirst%3DY.%26aulast%3DLeteur%26aufirst%3DC.%26aulast%3DCalderaro%26aufirst%3DJ.%26aulast%3DBourhis%26aufirst%3DJ.%26aulast%3DWislez%26aufirst%3DM.%26aulast%3DSoria%26aufirst%3DJ.-C.%26aulast%3DDeutsch%26aufirst%3DE.%26atitle%3DDependence%2520on%2520phosphoinositide%25203-kinase%2520and%2520RAS-RAF%2520pathways%2520drive%2520the%2520activity%2520of%2520RAF265%252C%2520a%2520novel%2520RAF%252FVEGFR2%2520inhibitor%252C%2520and%2520RAD001%2520%2528everolimus%2529%2520in%2520combination%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D358%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Bénistant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapuis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, S.</span><span> </span><span class="NLM_article-title">A specific function for phosphatidylinositol 3-kinase α (p85α-p110α) in cell survival and for phosphatidylinositol 3-kinase β (p85α-p110β) in de novo DNA synthesis of human colon carcinoma cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5083</span><span class="NLM_x">–</span> <span class="NLM_lpage">5090</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=5083-5090&author=C.+B%C3%A9nistantauthor=H.+Chapuisauthor=S.+Roche&title=A+specific+function+for+phosphatidylinositol+3-kinase+%CE%B1+%28p85%CE%B1-p110%CE%B1%29+in+cell+survival+and+for+phosphatidylinositol+3-kinase+%CE%B2+%28p85%CE%B1-p110%CE%B2%29+in+de+novo+DNA+synthesis+of+human+colon+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9nistant%26aufirst%3DC.%26aulast%3DChapuis%26aufirst%3DH.%26aulast%3DRoche%26aufirst%3DS.%26atitle%3DA%2520specific%2520function%2520for%2520phosphatidylinositol%25203-kinase%2520%25CE%25B1%2520%2528p85%25CE%25B1-p110%25CE%25B1%2529%2520in%2520cell%2520survival%2520and%2520for%2520phosphatidylinositol%25203-kinase%2520%25CE%25B2%2520%2528p85%25CE%25B1-p110%25CE%25B2%2529%2520in%2520de%2520novo%2520DNA%2520synthesis%2520of%2520human%2520colon%2520carcinoma%2520cells%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D5083%26epage%3D5090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Calay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vind-Kezunovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poumay, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gniadecki, R.</span><span> </span><span class="NLM_article-title">Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1136</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2010&pages=1136-1145&author=D.+Calayauthor=D.+Vind-Kezunovicauthor=A.+Frankartauthor=S.+Lambertauthor=Y.+Poumayauthor=R.+Gniadecki&title=Inhibition+of+Akt+signaling+by+exclusion+from+lipid+rafts+in+normal+and+transformed+epidermal+keratinocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalay%26aufirst%3DD.%26aulast%3DVind-Kezunovic%26aufirst%3DD.%26aulast%3DFrankart%26aufirst%3DA.%26aulast%3DLambert%26aufirst%3DS.%26aulast%3DPoumay%26aufirst%3DY.%26aulast%3DGniadecki%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520Akt%2520signaling%2520by%2520exclusion%2520from%2520lipid%2520rafts%2520in%2520normal%2520and%2520transformed%2520epidermal%2520keratinocytes%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2010%26volume%3D130%26spage%3D1136%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Hollestelle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elstrodt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, J. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallemeijn, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutte, M.</span><span> </span><span class="NLM_article-title">Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1158%2F1541-7786.MCR-06-0263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=17314276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFWrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=195-201&author=A.+Hollestelleauthor=F.+Elstrodtauthor=J.+H.+A.+Nagelauthor=W.+W.+Kallemeijnauthor=M.+Schutte&title=Phosphatidylinositol-3-OH+kinase+or+RAS+pathway+mutations+in+human+breast+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines</span></div><div class="casAuthors">Hollestelle, Antoinette; Elstrodt, Fons; Nagel, Jord H. A.; Kallemeijn, Wouter W.; Schutte, Mieke</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-201</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Constitutive activation of the phosphatidylinositol-3-OH kinase (PI3K) and RAS signaling pathways are important events in tumor formation.  This is illustrated by the frequent genetic alteration of several key players from these pathways in a wide variety of human cancers.  Here, we report a detailed sequence anal. of the PTEN, PIK3CA, KRAS, HRAS, NRAS, and BRAF genes in a collection of 40 human breast cancer cell lines.  We identified a surprisingly large proportion of cell lines with mutations in the PI3K or RAS pathways (54% and 25%, resp.), with mutants for each of the six genes.  The PIK3CA, KRAS, and BRAF mutation spectra of the breast cancer cell lines were similar to those of colorectal cancers.  Unlike in colorectal cancers, however, mutational activation of the PI3K pathway was mutually exclusive with mutational activation of the RAS pathway in all but 1 of 30 mutant breast cancer cell lines (P = 0.001).  These results suggest that there is a fine distinction between the signaling activators and downstream effectors of the oncogenic PI3K and RAS pathways in breast epithelium and those in other tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkA_wgqc842bVg90H21EOLACvtfcHk0ljVU_YNjTuNvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFWrtb8%253D&md5=b2149d14c32bd2c3c1e64b3852d5e817</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-06-0263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-06-0263%26sid%3Dliteratum%253Aachs%26aulast%3DHollestelle%26aufirst%3DA.%26aulast%3DElstrodt%26aufirst%3DF.%26aulast%3DNagel%26aufirst%3DJ.%2BH.%2BA.%26aulast%3DKallemeijn%26aufirst%3DW.%2BW.%26aulast%3DSchutte%26aufirst%3DM.%26atitle%3DPhosphatidylinositol-3-OH%2520kinase%2520or%2520RAS%2520pathway%2520mutations%2520in%2520human%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2007%26volume%3D5%26spage%3D195%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Clark, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streicher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, P. A.</span><span> </span><span class="NLM_article-title">Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=12479367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=707-717&author=A.+S.+Clarkauthor=K.+Westauthor=S.+Streicherauthor=P.+A.+Dennis&title=Constitutive+and+inducible+Akt+activity+promotes+resistance+to+chemotherapy%2C+trastuzumab%2C+or+tamoxifen+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells</span></div><div class="casAuthors">Clark, Amy S.; West, Kip; Streicher, Samantha; Dennis, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">707-717</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To evaluate the role of the phosphatidylinositol 3-kinase (Pl3K)/Akt pathway in breast cancer cell survival and therapeutic resistance, we analyzed a panel of six breast cancer cell lines that varied in erbB2 and estrogen receptor status.  Akt activity was constitutive in four cell lines and was assocd. with either PTEN mutations or erbB2 overexpression.  Akt promoted breast cancer cell survival because a Pl3K inhibitor, LY294002, or transient transfection of a dominant-neg. Akt mutant inhibited Akt activity and increased apoptosis.  When combined with therapies commonly used in breast cancer treatment, LY294002 potentiated apoptosis caused by doxorubicin, trastuzumab, paclitaxel, or etoposide.  Potentiation of apoptosis by LY294002 correlated with induction of Akt by doxorubicin or trastuzumab alone that occurred before the onset of apoptosis.  Similar results were obsd. with tamoxifen.  Combining LY294002 with tamoxifen in estrogen receptor-pos. cells greatly potentiated apoptosis, which was correlated with tamoxifen-induced Akt phosphorylation that preceded apoptosis.  To confirm that the effects of LY294002 on chemotherapy-induced apoptosis were attributable to inhibition of Akt, we transiently transfected breast cancer cells with dominant-neg. Akt and obsd. increased doxorubicin-induced apoptosis.  Conversely, stably transfecting cells with constitutively active Akt increased Akt activity and attenuated doxorubicin-induced apoptosis.  These studies show that endogenous Akt activity promotes breast cancer cell survival and therapeutic resistance, and that induction of Akt by chemotherapy, trastuzumab, or tamoxifen might be an early compensatory mechanism that could be exploited to increase the efficacy of these therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokFulbrsRhrLVg90H21EOLACvtfcHk0ljVU_YNjTuNvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmtLk%253D&md5=8524c66f332d0596592e72f57275a14b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DA.%2BS.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DStreicher%26aufirst%3DS.%26aulast%3DDennis%26aufirst%3DP.%2BA.%26atitle%3DConstitutive%2520and%2520inducible%2520Akt%2520activity%2520promotes%2520resistance%2520to%2520chemotherapy%252C%2520trastuzumab%252C%2520or%2520tamoxifen%2520in%2520breast%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D707%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span>Maestro, version 9.1, Glide, version 5.6, MacroModel, version 9.8, Schrödinger, LLC, New York,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+9.1%2C+Glide%2C+version+5.6%2C+MacroModel%2C+version+9.8%2C+Schr%C3%B6dinger%2C+LLC%2C+New+York%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span>Marvin 5.3.6, ChemAxon,<span class="NLM_x"> </span><span class="NLM_year">2010</span>. <a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a> (accessed <span class="NLM_access-date">January 2014</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Marvin+5.3.6%2C+ChemAxon%2C+2010.+http%3A%2F%2Fwww.chemaxon.com+%28accessed+January+2014%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sadowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasteiger, J.</span><span> </span><span class="NLM_article-title">From atoms and bonds to three-dimensional atomic coordinates: automatic model builders</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">2567</span><span class="NLM_x">–</span> <span class="NLM_lpage">2581</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00023a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1993&pages=2567-2581&author=J.+Sadowskiauthor=J.+Gasteiger&title=From+atoms+and+bonds+to+three-dimensional+atomic+coordinates%3A+automatic+model+builders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51a&amp;dbid=16384&amp;doi=10.1021%2Fcr00023a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00023a012%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26aulast%3DGasteiger%26aufirst%3DJ.%26atitle%3DFrom%2520atoms%2520and%2520bonds%2520to%2520three-dimensional%2520atomic%2520coordinates%253A%2520automatic%2520model%2520builders%26jtitle%3DChem.%2520Rev.%26date%3D1993%26volume%3D93%26spage%3D2567%26epage%3D2581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit51b"><span><span class="NLM_label">(b) </span>CORINA—Fast Generation of High-Quality 3D Molecular Models. <a href="http://www.molecular-networks.com/products/corina" class="extLink">http://www.molecular-networks.com/products/corina</a> (accessed <span class="NLM_access-date">January 2014</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=CORINA%E2%80%94Fast+Generation+of+High-Quality+3D+Molecular+Models.+http%3A%2F%2Fwww.molecular-networks.com%2Fproducts%2Fcorina+%28accessed+January+2014%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Barascu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Floch, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bougnoux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, M.-L.</span><span> </span><span class="NLM_article-title">CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm401138v&amp;key=10.1016%2Fj.biocel.2005.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm401138v&amp;key=16194618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm401138v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1aqu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=196-208&author=A.+Barascuauthor=P.+Bessonauthor=O.+Le+Flochauthor=P.+Bougnouxauthor=M.-L.+Jourdan&title=CDK1-cyclin+B1+mediates+the+inhibition+of+proliferation+induced+by+omega-3+fatty+acids+in+MDA-MB-231+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells</span></div><div class="casAuthors">Barascu, Aurelia; Besson, Pierre; Le Floch, Olivier; Bougnoux, Philippe; Jourdan, Marie-Lise</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-208</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Long-chain omega-3 polyunsatd. fatty acids are thought to inhibit the development of breast cancer.  We investigated the effects of docosahexaenoic and eicosapentaenoic acids on the proliferation of MDA-MB-231 human mammary epithelial cells.  Both docosahexaenoic and eicosapentaenoic acids decreased cell growth with a higher efficiency for docosahexaenoic acid (87% at 100 μM vs. 74% for eicosapentaenoic acid).  The effect on specific cell cycle phases was studied.  G2/M duration was markedly increased by docosahexaenoic and by eicosapentaenoic acids (resp. by more than seven- and six-fold at 50 μM) when cells were synchronized at the G1/S boundary and released in the cell cycle.  In contrast, there was no alteration of G1 or S phases.  The expression of cyclin A, cyclin B1 and cyclin-dependent kinase 1, the regulators required for the progression from G2 to mitosis, were all decreased by these fatty acids (western blot).  Since omega-3 fatty acids had no effect on the S phase, thus ruling out an involvement of cyclin A in their anti-proliferative effect, we examd. whether the regulation of the cyclin-dependent kinase 1-cyclin B1 complex was altered.  Upon omega-3 fatty acids treatment, cyclin B1 phosphorylation was inhibited and the expression of the cell division cycle 25C phosphatase, which dephosphorylates cyclin-dependent kinase 1, was decreased.  We conclude that the anti-proliferative effect of omega-3 fatty acids occurs via the regulation of the cyclin-dependent kinase 1-cyclin B1 complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnF14iemjz7rVg90H21EOLACvtfcHk0lgO7s9U1WQihA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1aqu7jL&md5=1c48d033e8e7bf945377e74692813294</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2005.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2005.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DBarascu%26aufirst%3DA.%26aulast%3DBesson%26aufirst%3DP.%26aulast%3DLe%2BFloch%26aufirst%3DO.%26aulast%3DBougnoux%26aufirst%3DP.%26aulast%3DJourdan%26aufirst%3DM.-L.%26atitle%3DCDK1-cyclin%2520B1%2520mediates%2520the%2520inhibition%2520of%2520proliferation%2520induced%2520by%2520omega-3%2520fatty%2520acids%2520in%2520MDA-MB-231%2520breast%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2006%26volume%3D38%26spage%3D196%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RD0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RD0','PDB','2RD0'); return false;">PDB: 2RD0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HIZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HIZ','PDB','3HIZ'); return false;">PDB: 3HIZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HHM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HHM','PDB','3HHM'); return false;">PDB: 3HHM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L16" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L16','PDB','3L16'); return false;">PDB: 3L16</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L17" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L17','PDB','3L17'); return false;">PDB: 3L17</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE','PDB','3IBE'); return false;">PDB: 3IBE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L54" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L54','PDB','3L54'); return false;">PDB: 3L54</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L08" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L08','PDB','3L08'); return false;">PDB: 3L08</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ML9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ML9','PDB','3ML9'); return false;">PDB: 3ML9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2X6K" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2X6K','PDB','2X6K'); return false;">PDB: 2X6K</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LS8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LS8','PDB','3LS8'); return false;">PDB: 3LS8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L13" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L13','PDB','3L13'); return false;">PDB: 3L13</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS','PDB','3DBS'); return false;">PDB: 3DBS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IEB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IEB','PDB','3IEB'); return false;">PDB: 3IEB</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i77"><a href="/doi/suppl/10.1021/jm401138v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61801"></div></div></div></div></div><hr /></hr><p class="last">Additional characterizations for compounds <b>2</b>–<b>13</b>, <sup>1</sup>H and <sup>13</sup> C NMR spectra for compounds <b>2</b>–<b>13</b>, and standard deviations for IC<sub>50</sub> (Table S1). This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401138v/suppl_file/jm401138v_si_001.pdf">jm401138v_si_001.pdf (5.53 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401138v/suppl_file/jm401138v_si_003.pdf">jm401138v_si_003.pdf (11.66 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Crystal structure PDB IDs for docking model construction used in this paper: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HHM">3HHM</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IEB">3IEB</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401138v&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-3%3Barticle%3Aarticle%3A10.1021%2Fjm401138v%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401138v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ada78ce821a6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
